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Abstract
The mechanisms that mediate innate recognition of infections in the immunospecialised
environment of the central nervous system (CNS) have not been characterised. This thesis
explores the capability of the CNS to detect infections and activate immune responses. The
majority of CNS neurones are post-mitotic and cannot be replaced if lost or damaged.
Consequently, the resting CNS is devoid of most immune processes, although substantial
inflammatory responses can be initiated by specialised glial cells. The innate immune system
recognises conserved molecular patterns on microorganisms by a set of pattern recognition
receptors which include the Toll-like Receptors (TLR). A growing consensus suggests they
are key to the initiation of innate immune responses. Cellular expression of TLR imparts the
ability to detect infection and determine pathogen type. A multitude of TLRs have now been
cloned, although their function and expression patterns have not been described in the CNS.
This thesis aims to explore whether cells of the CNS express TLRs and whether they are
capable of responding to different stimuli. To explore gene expression a novel custom
microarray was designed, developed and validated to assay the expression of selected gene
transcripts involved in innate immune responses. These included a multitude of pattern
precognition receptors, in addition to transcripts associated with stress responses and a
variety of cytokine, chemokine and interferon (IFN) transcripts. In addition, a highly
sensitive quantitative PCR technique was developed. Utilising both techniques this thesis
reports the first systematic analysis of TLR gene expression in the CNS.
Gene transcript levels were first studied in glial cells at rest. Cells were stimulated with
bacterial lipopolysaccharide, or by infection with the neuroinvasive Semliki Forest virus
(SFV). Both microglia and astrocytes in culture expressed a multitude of TLRs that were
differentially modulated in a specific manner depending on the nature of the stimulus. The
expression of TLR suggests glial cells are capable of recognising a vast array of microbial-
associated molecules. Such a strategy may be an essential requirement for an organ mostly
devoid of recognisable immune processes.
In vivo, the resting CNS exhibited extensive TLR expression with TLR 3 expressed at
exceptionally high levels, comparable to that of lymphoid tissue, but varying with mouse
strain. The data reported here show for the first time that TLRs in the brain are upregulated
during viral encephalitis. Furthermore, this response was appropriate to the pathogen, with
selective up-regulation of TLRs that sense viral infection. Intracerebral inoculation with
either SFV or rabies virus initiated substantial upregulation of TLR 2, 3 and 9. Type-I IFN
independent mechanisms mediated the up-regulation of TLR 2 following SFV infection,
whilst for the two TLRs that mediate recognition of viral nucleic acids, TLR 3 and TLR 9,
upregulation of gene expression was dependent upon and proportional to the type-I IFN
response. It is likely that by up-regulating TLR 3 and 9, type-I IFN acts to increase the
sensitivity of cells in the vicinity of virally infected cells. In this hypothesis, basal levels of
TLR detect viral RNA and induce type-I IFN synthesis. This IFN acts in both an autocrine
and paracrine way to up-regulate a number of genes including TLR itself. In this way cells in
the vicinity of virally infected cells have their virus sensing mechanisms upregulated. This
parallels events with protein kinase R, another interferon inducible activator of innate
cellular defences.
Transmissible spongiform encephalopathies are a group of diseases characterised by
chronic neurodegeneration and glial cell activation. This thesis demonstrates that the CNS
significantly upregulated several TLRs, and in the case of TLR 2, by 10-fold towards
terminal disease. This response further describes the apparent non-productive innate
immune activation of these cells during these diseases. In summary, the finding that the
brain has the ability via TLR expression to detect infection and discern its type provides an
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This thesis studies innate immune responses of the CNS during viral encephalitis and during
transmissible spongiform encephalopathy. This introduction will provide a background on
the innate immune system and its ability to recognise conserved molecular patterns on
microrganisms that are conferred by Toll-like receptors (TLR). TLR give the innate immune
system an ability to recognize both the presence of infection and the type of infection. This
introduction reviews the current state of knowledge of TLR, their ability to recognise
infection and to control the course of immune responses. Particular emphasis is given to the
mechanisms that control TLR expression. The ability of TLR to trigger the potent anti-viral
interferon system is also reviewed here. In addition, this introduction will describe immune
responses of the CNS. The resting CNS lacks almost all forms of recognisable immune
process, and yet infections can be detected and immune responses initiated. Specialised glial
cells reside in the CNS and are capable of producing inflammatory mediators and inducing
brain inflammation. Particular emphasis is given to innate immune responses to viruses and
viral encephalitis. The mechanisms that mediate and control inflammatory responses in the
CNS remain only partially characterised and are discussed at length. Semliki Forest Virus
(SFV) is a well-studied virus that is used as an experimental model of viral encephalitis and
is reviewed here. Finally, the transmissible spongiform encephalopathies represent a group
of uniquely transmissible neurodegenerative disorders that results in substantial




1.1.1 Innate and adaptive immune systems
The mechanisms by which a metazoan organism detect the presence of infectious agents and
eliminates them without massive damage to self-tissues is a problem that has troubled
scientists for the past century. Pathogens are almost infinite in their molecular diversity and
possess the ability to rapidly evolve with high replication and mutation rates. To combat this
threat, metazoan organisms have evolved a vast range of defences, which in vertebrates can
be broadly divided into two categories: the innate and adaptive immune systems.
Adaptive immunity relies on the production of millions of antigen receptors that differ in
their specificity. The system relies on one or more of these receptors being specific for any
pathogen that may infect a host, enabling the clonal expansion of specific antigen-
recognizing lymphocytes and the immunity that it brings. Whilst this adaptive response
provides so-called immunological memory, it has in isolation two fundamental flaws. Firstly,
randomly generated receptors cannot determine the biological context of the antigen, a
process that is necessary for stimulating the right type of effecter response. Secondly, the
clonal expansion takes 4 to 5 days before an effective defence is generated; this is too late to
repel many fast-replicating pathogens. Thus, successful adaptive immune responses rest on
an evolutionary ancient and more universal innate immune system. Innate immunity is not
only responsible for the almost instantaneous detection of infection and in determining its
form, but also has a role to play in controlling the initiation and the type of the adaptive
immune response. Indeed, the ability to detect pathogens is arguably the most important task
undertaken by the immune system, since appropriate recognition of microbes is critical for
mounting a response that can effectively combat invading pathogens.
Despite Elie Metchnikoff's seminal description of phagocytosis by starfish larvae cells in
1884, comparatively little has been published concerning the mechanisms that mediate
innate recognition of microbes - being overshadowed by developments in adaptive immune
research. It is now clear that innate recognition is mediated by a finite set of structurally and
functionally diverse receptors that can trigger defences such as complement activation,
phagocytosis, and the expression of pro-inflammatory genes, interferons and defensins. The
recent discovery of Toll-like receptors (TLR) has created a new wave of interest in the field
of innate immunity. TLR are thought to play a crucial role in the recognition of molecular
signatures of microbial infection, and engage differential signalling cascades that once
activated are pro-active in the control of T helper cell differentiation. This represents a
marked shifting in immunologist's thinking and has changed ideas about the pathogenesis
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and treatment of infectious, cancer, immune and allergic diseases. Accordingly, our
knowledge of TLR and their signalling pathways has increased greatly over the past few
years (Medzhitov and Janeway, Jr., 2000; Akira and Takeda, 2004).
1.1.2 Pathogen associated molecular patterns (PAMPs)
That the innate immune system detects constitutive and conserved molecules that result from
microbial metabolism was first suggested by Charles Janeway in what is now widely
regarded as a landmark paper (Janeway, Jr., 1989). There are a multitude of molecular
pathways unique to microrganisms, such as housekeeping functions or structural molecules
conserved within a given class of pathogen e.g. lipopolysaccharide, lipoproteins and
lipopteichoic acids are only made by bacteria, and as such can be regarded as molecular
signatures of bacterial invaders (Medzhitov, 2001; Janeway, Jr., 1989). These microbial
signatures may even be somewhat different in different species within a given microbial
class; however, these fine differences exist in the context of a common molecular pattern. An
example of this is the lipid-A portion of lipopolysaccharide (LPS), which is an invariant
molecular pattern found in all gram-negative bacteria and now known to be the vital trigger
of LPS-mediated inflammation. Conversely, the non-immunogenic O-antigen portion of LPS
is highly variable in LPS from differing strains and hence is not a molecule recognized by
the innate immune system. Janeway named these conserved microbial structures Pathogen
Associated Molecular Patterns (PAMPs). An individual PAMP was proposed to bind and be
recognized by receptors of the innate immune system - termed Pattern Recognition
Receptors (PRR) (Janeway, Jr., 1989).
1.1.3 The Pattern Recognition Receptors
Until 1999, well-defined PRR were few and far between. CD14, a GPI-linked lectin was
known to be vital for the recognition of LPS (Wright et al., 1990), whilst Scavenger
Receptors were suggested to have a role in recognizing bacterial proteins (Pearson, 1996),
the macrophage mannose receptor was shown to recognize bacterial sugars (Fraser et al.,
1998) and a small family of receptors were implicated in the recognition of highly
immunogenic N-formyl peptides (Le et al., 2001). Since then there has been a large increase




1.1.4 Toll in Drosophila
The involvement of Toll in innate immunity was first described in Drosophila. Toll is a
transmembrane protein that was first identified as a critical component of the pathway that
controls dorsal/ventral patterning in the developing embryo (Anderson et al., 1985)
(Hashimoto et ah, 1988). Toll is activated upon ligation to a secreted factor Spatzle, which in
turn activates the serine/threonine kinase Pelle via the adapter protein Tube. Pelle acts by
promoting the degradation of the ankyrin-repeat protein Cactus, which associates with the
Rel-type transcription factor Dorsal in the cytoplasm. Once Cactus is degraded, Dorsal is
free to translocate to the nucleus where it regulates transcription of specific genes (Belvin
and Anderson, 1996).
This pathway is strikingly similar to the mammalian IL-1 receptor pathway: activation of the
IL-1R leads to NF-kB activation by degradation of IkB in the cytoplasm, allowing
translocation of the transcription factor to the nucleus, where it initiates transcription of a
multitude of genes involved in inflammation and immune responses. Not only are the
pathways qualitatively similar but the composition of the key players possess striking
homology. Indeed, the cytoplasmic domains of Drosophila Toll and mammalian IL-1R are
highly conserved and have become known as the Toll/IL^l receptor (TIR) domain. Upon
observation of these intriguing similarities it was suggested Toll may regulate immune
responses in Drosophila (Belvin and Anderson, 1996). Within a remarkably short time this
suggestion was proved correct by several studies including an excellent report that
demonstrated several key players of the Toll pathway including Toll itself, Spatzle, Tube and
Pelle were involved in immune responses to fungal infection in adult flies (Lemaitre et al.,
1996). In this study the authors mutated all four genes and found the resultant mutants were
highly susceptible to fungal infection. This defect was due to their inability to mount
effective immune responses, including the expression of Drosomycin, an essential element of
the Drosophila immune response to pathogenic fungi. Further studies identified several
Dorsal-like transcription factors (similar to NF-. B in mammals) and found that Dorsal-type
immune factor was critical for anti-fungal responses, whilst Dorsal itself was primarily
involved in the Toll pathway that controls dorsal/ventral patterning (Meng et al., 1999;
Rutschmann et al., 2000). The Toll pathway also initiates immune responses to gram-
positive bacteria. In this pathway Relish, a Dorsal/NF-xB like transcription factor, was
shown to be critical for the induction of anti-bacterial peptides that play a role in resistance
to gram-positive bacteria (Rutschmann et al., 2002).
Spatzle is a secreted protein that is inactive until cleaved by a serine protease during
infection and only the cleaved form can bind to Toll. The serine protease inhibitor Spn43Ac,
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which prevents cleavage of Spatzle, further regulates this process (Levashina et al., 1999).
Thus it seems that Toll does not directly bind to microbes or their associated molecules, but
rather is activated upon infection by an elaborate upstream signalling system. The
mechanism by which fungal responses activate the Toll pathway is yet to be described.
However, recent work has suggested a mechanism for Toll activation following infection
with gram-positive bacteria: PGRP-SA is a peptidoglycan recognition protein that recognises
peptidoglycans within gram-positive bacteria walls. Flies mutated to lack PGRP-SA have an
impaired immune response to gram-positive bacteria but not to fungi. Thus PGRP-SA
appears to specifically recognise gram-positive bacterial infections and in turn activates the
Toll pathway (Michel et al., 2001; Werner et al., 2000).
Immune responses to gram-negative bacteria are mediated by a distinct pathway first
identified by a mutation in the immune deficiency (imd) gene (Lemaitre et al., 1995) that
ends with Relish translocating to the nucleus to induce anti-bacterial genes such as
Diptericin. The imd mutants are highly susceptible to infection by gram-negative bacteria but
possess normal anti-fungal responses (whereas the opposite is true for Toll mutants). A
receptor that specifically recognises gram-negative bacterial infection has not been identified
in the IMD pathway. Initially, 18-wheeler (a member of the Toll family) was proposed to
constitute the IMD receptor, but expression of Dipleiiein was lalei shown to be normal in
flies lacking 18-wheeler (Williams et al., 1997b; Khush et al., 2001). Further work has now
demonstrated that a member of the PGRP family, PGRP-LC, may well be the IMD receptor.
Critically, flies lacking PGRP-LC are unable to express Diptericin in response to infection
(Choe et al., 2002; Gottar et al., 2002). Thus a non-Toll related receptor appears to initiate
signalling in the IMD pathway and has contributed to a growing excitement concerning the
role PGRPs play in sensing infection within flies. There are over 15 different PGRP
members identified to date and these could be involved in sensing a variety of different
microbes in Drosophila.
1.1.5 Toll like receptors in mammals
It was a mallei of months following the discovery that Toll mediates host immunity to fungal
infections, that a mammalian homologue of Toll, Toll-Like receptor 4 (TLR 4) was
identified and shown upon over-expression to trigger the release of inflammatory mediators
(Medzhitov et al., 1997). There are now 13 TLR known to exist and they are predominantly
expressed on cell types that are likely to first encounter antigen such as phagocytic cells.
TLR 1 to 9 are expressed in both mice and humans although TLR 10 is present in mice only
as a degenerate pseudogene. TLR 11, 12 and 13 are expressed in mice but lack human
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orthologs (Medzhitov et al., 1997; Rock et al., 1998; Takeuchi et al., 1999b; Chuang and
Ulevitch, 2001; Chuang and Ulevitch, 2000; Du et al., 2000; Tabeta et al., 2004). They all
share a similar structure possessing leucine rich repeat (LRR) motifs in their extra-cellular
portions and an intracellular TIR domain (Slack et al., 2000). The extracellular regions of
TLR are composed of 19 to 25 tandem repeats of the LRR motif. Each repeat is 24 to 29
amino acids long and together forms a horseshoe-like structure. These concave structures are
thought to constitute the portion of the protein that directly binds to and so recognises
microbial components and other endogenous host ligands (Bell et al., 2003). Sequence
analysis of the TLR family demonstrates they can be divided into five subfamilies by
comparison of their amino acid sequences: TLR 2, 1, 6 and 10 form one family, TLR 9, 7, 8,
11 and 12 form another family, whilst TLR 3, 4 and 5 each lie in individual groupings - see
figure 1 (Du et al., 2000). A recent study has suggested TLR 13 is most similar to TLR 3
(Tabeta et al., 2004). TLR 1 and 6 are highly similar: they exhibit 69% identity in overall
amino acid sequence, their TIR domains are particularly conserved being 90% identical and
are located in tandem on the same chromosome - suggesting they are the product of a gene
duplication event (Takeuchi et al., 1999b). TLR 2 has two exons although the coding region
lies solely within exon 2. The TLR 9 subfamily are all encoded by two exons, with TLR 7
and 8 possessing 42.3% identity overall and 73% identity within their TIR domains and are
both located in close proximity on the X- chromosome (Chuang and Ulevitch, 2000; Du et
al., 2000). TLR 4 and 5 have 4 and 5 exons respectively, whilst TLR 3 possess five exons
with the coding sequence uniquely lying in a multitude of exons: exons 2, 3, 4 and 5. Figure
1 highlights the phylogenetic relationship of human TLR.
1.1.6 TLR play a fundamental role in the recognition and sensing of microbes
The vast majority of work studying TLR function has concentrated on the detection of
differing bacterial pathogens, with the gram-negative bacterial component
lipopolysaccharide (LPS) given particular attention. However, it is becoming increasing
clear that viruses are also subject to innate sensing by TLR. TLR responses in vivo pose a
realistic threat to viruses, as demonstrated by the presence in Vaccinia virus of three genes
that act as direct negative regulators of the TLR signalling pathway, one of which strongly
affects virulence in vivo (Bowie et al., 2000; Harte et al., 2003; DiPerna et al., 2004). Since
studies pertaining to bacterial components have been instrumental in describing TLR
function this introduction will begin by exploring the role of TLR in immune responses in













Figure 1, phylogenetic tree of known human TLRs. Based upon this analysis there
exists several groupings of TLR: i) TLR 1, 2, 6 and 10 belong to the TLR 2 grouping; ii) TLR
7, 8 and 9 belong to the TLR 9 grouping; iii) TLR 3, 4, and 5 each exist as separate members.
The sequence homology of mouse TLRs is similar albeit with three additional TLRs: TLR11
and 12 being most closely related to the TLR9 subfamily and TLR13 most closely related to































Figure 2 TLR recognise a wide variety of structurally diverse molecules. TLR
1, 2, 4, 5, 6 and 11 are expressed on the cell surface and can be recruited to phagosomes to
mediate recognition. TLR 3, 7, 8 and 9 are expressed within endosomes to which
molecules such as CpG-DNA are transported. TLR 2 works in collaboration with TLR 1
and TLR6 to mediate recognition of bacterial lipoproteins (adapted from O'Neill, 2004).
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their respective ligands, whilst Table 1 summarises in more detail the differing microbial
components that TLR have been documented to recognise to date.
1.1.7 TLR 4 recognises a variety of microbial components including
lipopolysaccharide
TLR 4 was the first mammalian member of the Toll family identified. Study of this molecule
has elucidated a significant portion of TLR biology. TLR 4 was first described in a seminal
paper that over-expressed a dominant positive TLR 4 mutant in the macrophage THP-1 cell
line resulting in the expression of several key inflammatory genes that activate the adaptive
immune system (Medzhitov et al., 1997). As such, it was the first indication that TLR were
involved in mammalian immune responses. In the following year two groups independently
demonstrated it was TLR 4 that was responsible for recognising a potent stimulator of the
immune system, LPS (Poltorak et al., 1998; Qureshi et al., 1999). Since these seminal
papers, several other members of the TLR family have been shown to be essential for the
recognition of a wide variety of microbial components. Historically, there have been two
mouse strains that were much studied due to their inability to respond to LPS, possessing a
so-called LPS hypo-responsive phenotype: the C3H/HeJ and C57BL10/ScCr strains. It was
discovered that the C3H/HeJ strain possessed a point mutation in the TLR 4 gene, with a
highly conserved proline residue being replaced by histidine. Whilst the C57BL10/ScCr
stain had a null mutation in the TLR 4 gene. Further proof of the role that TLR 4 plays in
mediating LPS-induced inflammation was demonstrated in a later study that purposefully
disrupted the TLR 4 gene in wild-type mice, resulting in the generation of the LPS hypo-
responsive phenotype (Hoshino et al., 1999).
Unlike Drosophila Toll, TLR 4 is thought by many to directly bind LPS in a complex with
CD 14 (which is thought to tether LPS molecules), and MD-2 which enhances LPS
responsiveness in cell lines and the absence of which in mice generates an LPS hypo-
responsive phenotype (Jiang et al., 2000; Da Silva et al., 2001; Nagai et al., 2002; Shimazu
et al., 1999). Like Drosophila Toll, TLR 4 recognises several endogenous ligands such as
heat shock proteins. These are secreted factors made during stress induced by a wide variety
of conditions such as heat, UV radiation and infection. They are known to induce activation
of macrophages and as such have been labelled as endogenous "danger signals" (Takeda et
al., 2003; Gallucci and Matzinger, 2001). Macrophage activation by heat shock protein 60
occurs via signalling through TLR 4, although studies have suggested that it doesn't directly
bind to the TLR (Ohashi et al., 2000; Habich et al., 2002). Indeed, the whole premise that
TLR 4 binds directly to any of its ligands, including LPS, is still a matter of debate. Several
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studies have provided convincing evidence that it is TLR 4 that provides specificity and
hence binds to LPS (Lien et al., 2000; Poltorak et al., 2000; Hajjar et al., 2002). Conversely,
others have suggested that it is MD-2 that in actuality confers the ability to recognise LPS
(Viriyakosol et al., 2001; Akashi et al., 2001). Further research is required to clarify this
important distinction.
LPS can also be delivered directly to the cytoplasm by membrane internalisation and is
recognised by Nodi an intracellular protein that like TLR 4 possesses LRR domains (Inohara
et al., 2001). This intracellular recognition protein may also be responsible for recognising
the cell-invasive pathogen Shigella flexneri (Girardin et al., 2001).
TLR 4 may also recognise a number of viral envelope glycoproteins. Viral glycoproteins
mediate virus binding and entry to host cells and as such can be sensed without the need for
viral repication or gene expression. The respiratory syncytial virus was the first virus
demonstrated to activate a member of the TLR family eliciting NK-kB activation in a TLR 4
dependent manner (Kurt-Jones et al., 2000). Further more, mice lacking TLR 4 were less
able to resist infection by this virus (Haynes et al., 2001). The mouse mammary tumour virus
has also been shown to activate immune repsones in part through TLR 4 in B cells (Rassa et
al., 2002) and cannot be effectivly cleared by TLR 4 deficient mice (Jude et al., 2003).
Importantly, in both cases each virus appears to trigger TLR 4 activation through recognition
of their envelope glycoproteins. Intriguingly, a further study has shown that the mammary
tumour virus may utilise TLR 4 along with TLR 2 on dendritic cells to aid entry by
upregulating its entry receptor CD71. As such, this finding highlights a novel viral stratergy
that utilises the host mechanisms that are designed to detect them (Burzyn et al., 2004).
1.1.8 TLR 2, 1 and 6 subfamily recognises a multitude of microbial
components
TLR 2 appears to recognise a variety of organisms and their associated components such as
lipoproteins from gram-negative bacteria, mycoplasma and spirochetes (Aliprantis et al.,
1999; Brightbill et al., 1999; Lien et al., 1999; Hirschfeld et al., 1999). Peptidoglycans and
lipopteichoic acid from gram-positive bacteria also activate TLR 2 (Schwandner et al., 1999;
Yoshimura et al., 1999; Underhill et al., 1999b; Lehner et al., 2001) as does zymosan from
yeast amongst others (Underhill et al., 1999a). Mice engineered to lack functional TLR 2
have demonstrated the necessity of this protein for protection against a variety of pathogens
including Staphylococcus aureus (Takeuchi et al., 2000) and for normal responses to
peptidoglycan (Takeuchi et al., 1999a) and lipoproteins (Takeuchi et al., 2000). TLR 2 can
also recognise atypical LPS from bacteria such as Leptospira interrogans, which is
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structurally distinct from LPS found on enterobacteria such as Escherichia coli (Werts et al.,
2001).
TLR 2 may also recognise envelope glycoproteins of viruses. The measles virus appears to
activate TLR 2 through recognition of its haemagglutinin protein, activating NF-kB and
inducing cytokine release (Bieback et al., 2002). In addition to the measles virus, some
reports have suggested components of the cytomegalovirus (CMV) may be recognised by
TLR 2. CMV is a complex Herpes virus and soluble forms of its glycoproteins activate NF-
kB and IRF3, inducing an anti-viral state in cells (Boehme et al., 2004). In a highly artificial
in vitro setting, TLR 2 (but not TLR 4) was shown to be required for HEK293 pro¬
inflammatory responses to CMV, suggesting some component of the immune response to
this virus involves recognition by TLR 2 (Compton et al., 2003). In support of TLR 2's role
in sensing Herpes infection comes a report that demonstrates Herpes Simplex virus type 1 is
recognised in vivo by TLR 2, since TLR 2 deficient mice exhibited lower serum IL-6 levels
and less pronounced immunopathology in the CNS (further discussed in section 1.2.4) (Kurt-
Jones et al., 2004).
The role that TLR 6 plays within innate immunity was analysed by introducing a dominant
negative form into the RAW264.7 macrophage cell line. This study highlighted that the
mutated TLR 6 prevented the cell line from responding to a variety of microbial components
previously identified as signalling through TLR 2. In addition, TLR 6 and 2 were shown to
co-immunoprecipitate, implying they can become spatially connected (Hajjar et al., 2001). A
further study utilised mice lacking either functional TLR 2 or 6: mice that lacked TLR 6
demonstrate a deficient response to mycoplasma lipoproteins (otherwise known as a TLR 2
ligand) although they possess a normal responses to bacterial lipoproteins (another distinct
TLR 2 ligand). Macrophages isolated from mice deficient in TLR 2 could respond to neither
molecule (Takeuchi et al., 2001). Taken together, this data suggests that TLR 6 associates
with TLR 2 and confers specific recognition between two different types of lipoprotein. TLR
1 has also been shown to associate with TLR 2 to confer specific recognition (Wyllie et al.,
2000). It is speculated that other TLR may similarly heterodimerise and so greatly expand
the possible number of microbial structures recognised by this rather finite set of recognition
receptors.
1.1.9 TLR 5 recognises bacterial flagellin
Chinese hamster ovary cells expressing TLR 5 were used in a study to demonstrate that this
receptor was responsible for recognising the potent immunogen flagellin (Hayashi et al.,
2001). Flagellin has highly conserved regions that are common to flagellins from a broad
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spectrum of gram-negative bacteria. It is this conserved region that possesses both the
immunostimulatory motif and is the region that signals through TLR 5 (Eaves-Pyles et al.,
2001). Thus the innate immune system has defined one of the few structurally related
molecules of flagellated bacteria as a pathogen-associated molecule and in doing so can
signal infection by recognising this class of pathogen through one specific receptor, TLR 5.
Interestingly, plants possess a gene called Fls2 which encodes a transmembrane receptor-like
kinase that possesses LRR motifs and has structural similarities to mammalian TLR.
Incredibly, a deficiency in FLS2 appears to confer flagellin-sensitivity to Arabidopsis
(Gomez-Gomez and Boiler, 2002). In addition to FLS2, several other plant proteins
possessing a TIR domain have been identified and appear to be involved in host responses to
pathogens (Asai et al., 2002). Hence, the TIR domain represents a truly ancient mechanism
for microbial recognition that not only spans across the animal kingdom from vertebrates to
arthropods, but also to the plant kingdom.
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Receptor Ligand Origin of Ligand References
TLR 1 Triacyl lipope.ptides Bacteria and mycobacteria (Takcuchi et al., 2002)
TLR 2 Lipoproteins/lipopeptides Various bacterial pathogens (Aliprantis et al., 1999)
Peptidoglycan Gram-positive bacteria (Takeuchi et al., 1999a)
Lipopteichoic acid Gram-positive bacteria (Schwandner et al.,
1999)
Lipoarabinomannan Mycobacteria (Means et al., 1999)
Phenol-soluble modulin Staphylococcus epidermis (Hajjar ct al., 2001)
Glycoinositolphospholipids Trypanosoma cruzi (Coelho et al., 2002)
Porins Neisseria (Massari et al., 2002)
Atypical LPS Porphyromonas ginivalis (Hirschfeld et al., 2001)
Zymosan Yeast (Underhill et al., 1999b)
Haemagglutinin Measles virus (Bieback et al., 2002)
Unknown — glycoprotein? Herpes simplex virus 1 (Kurt-Jones et al., 2004)
TLR 3 Double stranded RNA Viruses (Alexopoulou et al.,
2001)
TLR 4 LPS Gram-negative bacteria (Poltorak et al., 1998)
Fusion protein Respiratory syncytial virus (Kurt-Jones et al., 2000)
Envelope protein Mouse mammary-tumour (Rassa et al., 2002)
virus
Heat-shock protein 60 Host (Ohashi et al., 2000)
Heat-shock protein 70 Host (Vabulas et al., 2002)
Fibrinogen Host (Smiley et al., 2001)
TLR 5 Flagellin Bacteria (Hayashi et al., 2001)
TLR 6 Diacyl lipopeptides Mycoplasma (Takeuchi et al., 2001)
Lipoteichoic acid Gram-positive bacteria (Schwandner et al.,
1999)
Zymosan Yeast (Ozinsky et al., 2000)
TLR 7/8 Imidazquinoline Synthetic compounds (Hemmi et al., 2002)
Single-stranded RNA Viruses (Heil et al., 2004;
Diebold et al., 2004)
TLR 9 CpG-containing DNA Bacteria and DNA viruses (Hemmi et al., 2000;
Tabeta et al., 2004)
TLR 11 Unknown Uropathogenic bacteria (Zhang et al., 2004)
Table 1. TLR recognise a multitude of microbial compounds, some of which
are listed here. Viral interactions with TLR are highlighted
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1.1.10 TLR 3 recognises viral double stranded RNA
Double stranded RNA (dsRNA) is a strong activator of type I interferons (IFN-a and -(3) that
mediate potent anti-viral effects and stimulates the immune system. The production of type I
interferons is absolutely critical for defence against virus infections and is discussed later in
section 1.1.17. Many viruses produce dsRNA during the replication cycle either as an
essential intermediate in RNA synthesis or as a by-product generated by symmetrical
transcription of DNA virus genomes. Some of these anti-viral mechanisms are elicited by
activation of a dsRNA protein kinase R (PKR). Fibroblasts cultured from mice deficient in
PKR have impaired responses to poly(I:C), a synthetic dsRNA that possesses similar
immunogenic properties to viral dsRNA (Yang et ah, 1995; Chu et ah, 1999). Despite these
in vitro findings the IFN response is often intact upon virus infection in PKR deficient mice
(Balachandran et ah, 2000a; Levy, 2002; Abraham et ah, 1999). This suggests that
additional recognition receptors are involved in the recognition of viral dsRNA.
TLR 3 was shown to be a key dsRNA sensing molecule during host anti-viral responses in a
paper by Alexopoulou et al. (Alexopoulou et ah, 2001). HEK293 cells that are ordinarily
non-responsive to dsRNA were made responsive by transfection with TLR 3, initiating
activation of NF-kB upon dsRNA exposure, suggesting TLR 3 alone was sufficient for
dsRNA sensing. Furthermore, macrophages derived from TLR 3 deficient mice are non-
responsive to poly(I:C) and purified Lang reovirus genomic dsRNA and are unable to elicit
IFN production - suggesting TLR 3 expression is also necessary for dsRNA sensing. TLR 3
deficient mice were also resistant to shock induced by poly(I:C) treatment, suggesting TLR 3
contributes to the in vivo recognition of and responses to extracellular dsRNA (Alexopoulou
et ah, 2001). Furthermore, the effecter responses initiated by TLR 3-poly(I:C) interaction can
inhibit murine y herpes virus 68 replication in bone marrow derived cultures (Doyle et ah,
2002). A more recent study has investigated the role TLR 3 plays during Cytomegalovirus
(CMV) infection (Tabeta et ah, 2004). Mice deficient in TLR 3 possessed elevated virus
loads, and could not upregulate key inflammatory cytokines, IFN-(3 or activate natural killer
cell to the levels observed in wild-type mice infected with CMV. In addition, the activation
of Natural Killer cells was found to be significantly decreased in mice lacking TLR 3 during
CMV infection (Tabeta et ah, 2004). In this study, mice deficient in TLR 9 were also shown
to have a dramatically reduced anti-viral response (further discussed in section 1.1.11). Mice
deficient in TLR 3 exhibit markedly different immune responses to West Nile virus (WNV).
Spleen infection is more substantial and inflammatory cytokine expression is reduced in
mice lacking TLR 3 expression (Wang et ah, 2004).
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Taken together it seems highly probably that TLR 3 recognises the unique molecular pattern
of dsRNA. However, some doubts remain over the functional significance of TLR 3 during
natural infections, since the principle cell type in human and mouse blood that produces
type-1 IFNs are plasmacytoid dendritic cells (Asselin-Paturel et al., 2001; Siegal et al.,
1999), and several publications suggest TLR 3 is either absent or expressed at low levels in
these cells (Kadowaki et al., 2001a). One can speculate that PKR and TLR 3 act together or
indeed with other members of the TLR family, or that signalling through either may be
sufficient to initiate the IFN system. Unfortunately, there is little in the literature that informs
us of how PKR and TLR 3 collaborate.
The in vivo significance of TLR 3 function has been questioned in a recent report that
infected TLR 3 deficient mice with four different viruses: lymphocytic choriomeningitis
virus (LCMV), vesicular stomatitis virus (VSV), CMV and reovirus. Virus titres were
similar in TLR 3 deficient and wild type mice for all four viruses, as were T cell responses.
The ability of TLR 3 deficient mice to promote immunological memory also appeared to be
similar to wild-type mice. In addition, reovirus-associated immunopathology in the brain was
found to be similar, as were the mortality levels. Importantly, this study did not examine
whether activation of innate immunity, in particular type I IFN production, was abrogated in
TLR 3 deficient mice. Nevertheless, TLR 3 signalling does not appear to influence the
generation of effective antiviral responses for these four viruses given at these particular
doses (Edelmann et al., 2004). A separate report has shown IRF3 (a signalling molecule
downstream of TLR 3 described in section 1.1.15) deficient mice were more susceptible to
CMV infection when given, at higher doses (Hoebe et al., 2003) as were TLR 3 deficient
mice in the study by Tabeta et al. (Tabeta et al., 2004), which also described changes in
innate immune responses. In addition, several studies have shown robust type-I IFN
responses are mediated by TLR 3 signalling in vitro (Alexopoulou et al., 2001; Kulka et al.,
2004; Jiang et al., 2003) Thus, there are conditions where TLR 3 does signal in a
functionally meaningful manner. One can speculate that the in vivo functional significance of
TLR 3 signalling may be restricted to the early control of an overwhelming infection
requiring fast and strong interferon type-I responses to prevent host death (Edelmann et al.,
2004). Consequently, it has been suggested that the concentrations of dsRNA made during
"natural" infection are often not sufficient to bind to and significantly influence TLR 3
signalling when compared to the high concentrations of dsRNA used for in vitro studies
(Edelmann et al., 2004).
The subcellular location of TLR 3 differs between cell types. Fibroblast cells express TLR 3
on the cell surface whilst both immature and activated dendritic cells demonstrate TLR 3
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expression that is restricted to sub-cellular compartments (Matsumoto et al., 2003). Studies
using immature monocyte derived dendritic cells have shown TLR 3 is expressed within
intracellular vesicles and that the retention within this compartment is reliant on the specific
sequence that links the extracellular LRR domain and the cytoplasmic TIR domain (Funami
et al., 2004). Analysis has revealed that when TLR 3 is ectopically expressed within a
murine B cell line, it is found only within multivesicular bodies - a subcellular compartment
situated in the endocytic trafficking pathways (Matsumoto et al., 2003).
To summarise, several studies have suggested the activation of TLR 3 and the subsequent
secretion of IFN-a/(3 helps to establish a localised antiviral state that limits viral replication
at the site of infection. Conversely, one in vivo study has cast some doubt on whether the
concentration of viral dsRNA during "natural" infection is high enough to trigger significant
TLR 3 signalling. TLR 3 is unique from all other TLR in several ways. Firstly, the protein
lacks a critical proline residue that is conserved in all other TLR (indeed this is the mutation
that was responsible for generating the TLR 4 associated LPS hyporesponsive phenotype in
C3H/HeJ mice). Secondly, its gene is uniquely encoded by 4 exons and the complete gene
sequence is spread over 5. Thirdly, the expression of TLR 3 is maintained in certain mature
DC subsets that ordinarily down-regulate all other TLR upon maturation - see later for more
details (Muzio et al., 2000).
1.1.11 TLR 7, 8 and 9 recognise microbial nucleic acids
Bacterial and viral DNA are potent immunogens due to the presence of unmethylated CpG
motifs that are infrequent in vertebrate genomes, and represent a prototypic molecular
pattern that distinguishes a certain class of pathogen. Mice deficient in TLR 9 fail to respond
to CpG inoculates demonstrating that TLR 9 is necessary for sensing CpG motifs (Hemmi et
al., 2000). TLR 9 alone is also sufficient to confer CpG recognition in HEK293 cells (Bauer
et al., 2001). Recognition occurs in the endosome where it is expressed (Wagner, 2001;
Ahmad-Nejad et al., 2002) and not at the cell surface like ligands for TLR 1, 2 and 4 that are
actively recruited from the cell surface to phagosomes upon stimulation (Takeuchi et al.,
1999a; Ozinsky et al., 2000).
In addition to the role TLR 9 plays in sensing bacterial CpGs, this important receptor is also
critical for sensing the DNA of herpes simplex virus type 1, herpes simplex virus type 2 and
murine CMV, all of which contain genomes rich in CpG DNA motifs (Krug et al., 2004;
Tabeta et al., 2004; Lund et al., 2003). Mice with non-functional TLR 9 are highly
susceptible to CMV infection, produce low levels of IFN-a and IFN-|3, and cannot activate
natural killer cells in response to infection, unlike their wild-type counterparts. Specifically,
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CMV titres are elevated by four orders of magnitude in TLR 9 deficient mice and exhibit a
90% decrement in the amount of type I IFN produced. TLR 3 knockout mice were also
shown to exhibit deficiencies in their response to CMV infection, although not to such a
degree as observed in TLR 9 mutants. TLR 3 deficient mice exhibited a 60% decrement in
the amount of type I IFN and suffer an elevated CMV titre of three orders of magnitude.
These findings are rather surprising since the TLR 3/Trif signalling axis is independent of
the TLR 9/MyD88 signalling axis (see section 1.1.15). Nevertheless, the two pathways do
elicit the production of type I IFN in a co-dependent manner.
TLR 9 is expressed within the endoplasmic reticulum (ER) of macrophages and monocyte
derived dendritic cells and not on the cell surface. Studies using fluorescent CpG DNA show
that within minutes of exposure, CpG DNA enters monocyte derived dendritic cells via the
endosome pathway and are rapidly transported to a tubular lysosomal compartment.
Concurrent with CpG transport, TLR 9 is actively redistributed from the ER to the CpG
DNA-containing structures, which also accumulate MyD88. As such, this represent a novel
mechanism of cellular activation involving the recruitment of an immune receptor from the
ER to CpG-containing structures where signal transduction is initiated (Latz et al., 2004;
Leifer et ah, 2004).
Until two landmark papers were published simultaneously in Science, 2004, little was known
concerning the in vivo function of TLR 7 and its close relative TLR 8 - apart from their well
established roles as receptors for a family of anti-viral compounds that includes imiquimod
(Hemmi et ah, 2002). Imiquimod possesses potent anti-viral properties, owing to its ability to
induce inflammatory cytokines, especially IFN-a, and has been approved for the treatment
of genital warts caused by infection with human papillomavirus. Imiquimod and its related
compounds all have structures similar to nucleic acids and the finding that TLR 7 deficient
mice cannot respond to these compounds suggested that TLR 7 might sense viral infection
by recognising viral nucleic acids that resemble the anti-viral compounds (Hemmi et ah,
2002). This suggestion has since been verified independently by two groups showing that in
murine dendritic cells, TLR 7 recognises single stranded RNA (ssRNA) rich in uracil - such
as influenza RNA and synthetic polyU RNA. TLR 8 appears to have an analogous function
in humans (Heil et ah, 2004; Diebold et ah, 2004). The authors further suggest that viral and
cellular ssRNA can be distinguished from each other, since ssRNA released by cells to the
extracellular environment is rapidly degraded. Thus, RNA taken up by phagocytic cells
within the confines of a virus particle can be presented to TLR 7/8 with the confidence that it




To summarise, it appears likely that the TLR 9 subfamily including TLR 7, 8 and 9 may all
participate in the discrimination of microbial nucleic acid-like structures. This parallels the
situation in the TLR 2 subfamily, which discriminates between differences in bacterial
lipoproteins (Takeda et ah, 2003).
1.1.12 TLR 11 recognises uropathogenic bacteria
TLR 11 is a newly described TLR that has recently been shown to play role in sensing
bacteria that cause infections of the bladder and kidney (Zhang et al., 2004). TLR 11 was
discovered by searching the EST databases for sequences with similarity to TLR 4 and was
discovered in a mouse liver EST database. Further analysis revealed that TLR 11 was
particularly abundant in the kidney and bladder of mice. Mice generated to lack TLR 11
harboured 10,000 times as many bacteria in their kidneys compared to wild-type mice, and
could not mount pro-inflammatory responses. Interestingly, humans possess a truncated
version of TLR 11 that is almost certainly inactive. This might explain why humans are
particularly susceptible to urinary tract infections (Zhang et al., 2004; O'Neill, 2004).
1.1.13 TLR are expressed in a variety of cells that are likely to first encounter
antigen
Several studies have reported the expression patterns of TLR in several key cells of the
immune system and are summarised in table 2 and 3. Suitable antibodies that label TLR have
not been readily available, particularly for murine TLR. Thus, work that has studied TLR
expression has mostly relied on assaying RNA levels. Macrophages express most TLR
mRNAs except TLR 3 according to one report (Muzio et al., 2000), which stated that TLR 3
was only found on mature dendritic cells. Another study found human phagocytes, including
monocytes expressed all TLR mRNAs including TLR 3, albeit at low levels. B cells express
TLR 9 and 10 at very high levels and TLR 1, 3, 6, 7, 10 and RP105 at intermediate levels,
whilst T cells expressed predominantly TLR 3 and 9, although all TLR were detectable at
lower levels (Zarember and Godowski, 2002; Bourke et al., 2003). A third study determined
monocytes express high levels of TLR 2, intermediate levels of TLR 4, 5, 6 and 8, weak
levels of TLR 9 and no TLR 3, 7 and 10 (Hornung et al., 2002). Most human tissues were
shown to express at least one TLR with the spleen expressing all TLR 1-10. Regrettably,
only one sample was assayed for each respective tissue, casting some doubt over its
reliability (Zarember and Godowski, 2002). The fact that TLR 3 was readily detected in
other cell populations appears to contradict the report by Muzio et al. However, it may be
explained by the differing assays employed in each case, with the report by Zarember and
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Godowski utilising the more sensitive Taqman assay. Comparatively little work has been
undertaken on murine cells and tissues to systematically describe TLR expression.
Expression appears to be highly varied among different dendritic cell subsets and is species
specific. Human monocyte-derived dendritic cells (MDCs) express at high levels TLR 3 and
at immediate levels TLR 1, 2, 3, 4, 5, and 8. Conversely, plasmacytoid dendritic cells
(PDCs) predominantly express TLR 7 and 9 (Kadowaki et al., 2001b; Rrug et al., 2001).
Another study demonstrated both PDCs and B cells predominantly express TLR 7 and 9.
Indeed, only these cells were shown to be directly responsive to CpG motifs whilst
monocytes, natural killer cells and T cells, which expressed no TLR 7 and little TLR 9, could
not respond directly to CpG motifs. Although, co-culture of these cell types individually with
PDCs rendered them responsive to CpGs (Hornung et al., 2002). MDCs mature upon
exposure to microbial components and as they mature the expression of TLR 1, 2, 4, and 5
are lost whilst the expression of TLR 3 increases (Visintin et al., 2001). The exact cellular
expression pattern of TLR mRNAs is confused and more work is required to clarify the
matter in both human and murine systems.
Several studies have investigated the expression of TLR on other cell types that contribute to
inflammatory responses. Mast cells are important mediators of acute inflammation and
appear to express TLR 2, 4, 6 and 8 but not TLR 5 (Supajatura et al., 2001; McCurdy et al.,
2001). The expression of TLR has also been studied in epithelial cells. Epithelial cells cover
mucosal surfaces such as the respiratory tract and form a protective and continual barrier to
bacterial exposure, and yet do not generally induce an inflammatory response. However,
epithelial cells do respond if pathogenic bacteria invade into the basolateral compartment
where TLR 5 is specifically expressed (Gewirtz et al., 2001). There is little TLR 4 in the
intestine mucosa unless the host suffers from inflammatory bowel disease in which TLR 4 is
upregulated (Cario and Podolsky, 2000). Consistent with this data is the idea that
inflammatory bowel disease may result from exaggerated inflammatory responses to
commensal bacteria. Nevertheless, all the data indicate that TLR are finely regulated within
epithelial cells and generally absent unless stimulated.
1.1.14 TLR expression can be modulated by microbes and cytokines
The mechanisms behind TLR expression are not well understood. TLR expression is finely
tuned and can be altered by either exposure to microbial components, microbial invasion,
and/or cytokines. These complex interactions are summarised in tables 2 and 3.
Several studies have demonstrated that murine cells such as phagocytes can alter their TLR
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TLR 2 in macrophages whilst TLR 4 was down-regulated, both at the RNA and protein level
(Matsuguchi et al., 2000). As such, it has been suggested that this may be one mechanism by
which the phenomena of LPS tolerance is mediated (Nomura et al., 2000). Following
exposure to live Salmonella murine macrophages rapidly down regulate TLR 4 protein levels
so that by 6 hours the receptor is undetectable. Conversely, Salmonella exposure does not
alter TLR 2 expression within 6 hours, but by 24 hours is significantly elevated (Weiss et al.,
2004), suggesting TLR expression is differentially regulated over time. In addition, mice
infected with Mycobacterium avium upregulate their levels of TLR 2 in macrophages by
increasing TLR 2 promoter activity with chromatin remodelling. Concurrently, levels of
TLR 4 were found to be down-regulated (Wang et al., 2000; Wang et al., 2001; Wang et al.,
2002). Another study looked at the levels of TLR 2 in yb T cells, yb T cells are considered to
be primordial innate sensors of infection that lack the antigen receptor diversity of other T
cells. These cells upregulate TLR 2 upon infection with E.coli (Mokuno et al., 2000).
The level of TLR expression exerts an effect on the function of immune cells. Indeed, the
level of TLR expression affects macrophage responses to microbial stimuli. Macrophage
responses have been correlated with levels TLR expression by analysing macrophages
deficient in either TLR 2 or TLR 4 or both. TLR 4 ligands appear to induce an early TNF-a
response, whilst TLR 2 ligands generate a later TNF-a response. These responses correlate
with the timing of TLR expression, such that TLR 4 ligands induce a response only whilst
TLR 4 is expressed, whilst TLR 2 ligands can only induce cytokine release once TLR 2 has
been upregulated (Weiss et al., 2004). Furthermore, monocyte-derived dendritic cells
induced to upregulate TLR 7 expression have increased sensitivity to the TLR 7 ligand
imiquimod (Mohty et al., 2003). Together these data suggest that TLR expression change
can have dramatic effect on the responsiveness of macrophages to microbial stimuli.
A limited number of studies have looked at TLR expression during virus infections. One
study used Northern analysis to demonstrate an apparent upregulation of TLR 1, 2, 3 and 7
in bone-marrow derived macrophages infected with Influenza A and Sendai virus. This
upregulation was suppressed by treatment with blocking antibodies to IFN-a/(3, suggesting
that IFN mediates virus induced activation of innate immunity via modulation of TLR
expression in vitro (Miettinen et al., 2001). Human monocytes isolated from HIV-infected
patients display enhanced expression of TLR 2, although TLR 4 levels were unaffected.
Furthermore, in vitro stimulation of human monocytes with the HIV envelope proteins
triggers an increase in TLR 2 expression, supporting a possible link between HIV infection
and TLR 2 expression. Interestingly, stimulation of the TLR 2 pathway with a TLR 2-
specific agonist significantly increased viral replication along with enhanced cytokine
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production (Heggelund et al., 2004). In addition, infection of mice with mycobateria
upregulates HIV-1 expression, a phenomenon that is not observed in TLR 2 deficient mice,
suggesting innate activation of the TLR 2 pathway enhances HIV replication in vivo (Bafica
et al., 2003; Bafica et al., 2004).
Several cytokines regulate TLR expression. Colony stimulating factor 1 (CSF1) down-
regulates TLR 9 in macrophages and strongly suppresses CpG-induced production of
inflammatory cytokines (Sweet et al., 2002). Macrophage inhibitory factor (MIF) is a
cytokine that mediates inflammation and sepsis and (Bozza et al., 1999) upregulates and/or
maintains TLR 4 expression (Roger et al., 2001; Roger et al., 2003). IFN-y can prime
macrophages and phagocytes to respond to LPS and evidence suggests it is the upregulation
of TLR 4 by this cytokine that mediates this priming (Bosisio et al., 2002). The expression of
TLR 2 but not TLR 4 in macrophages can be upregulated by a series of cytokines including
IL-ip, IL -2, IL -15, IFN-|3 and TNF-a (Matsuguchi et al., 2000). Further work has shown
the expression of TLR 2 and 4 in renal epithelial cells can be induced by exposure to IFN-y
and TNF-a and so contributes to the detection of bacterial invasion in the lumen of tubules
and the induction of an inflammatory response (Wolfs et al., 2002).
A study by Doyle et al. demonstrated that IFNa/(3 signalling could induce upregulation of
TLR 3. This study utilised bone marrow-derived macrophages from mice lacking a
functional IFNa/(3 receptor and found TLR 3 expression did alter upon exposure to poly(I:C)
or LPS, which ordinarily upregulates TLR 3 expression in this cell type. The addition of
recombinant IFN-|3 caused a dose-dependent increase in TLR 3 in macrophages from wild-
type mice. This data demonstrates bone marrow derived macrophages that are cultured and
matured in vitro are capable of responding to type I IFNs by upregulating TLR 3 expression
(Doyle et al., 2003).
1.1.15 TLR signalling is complex and multi-faceted
TLR recognise a variety of differing microbial components and respond appropriately: LPS
stimulates pro-inflammatory cytokines such as TNF-a whilst viruses induce anti-viral type-I
IFNs. The intracellular signalling mechanisms that underlie this specificity are being
characterised at an increasingly rapid rate. Two main pathways have been characterised that
respond to TLR activation; one involves activation of the TLR adaptor protein MyD88
followed by NF-kB activation and consequent induction of a pro-inflammatory state; the
second involves a MyD88-independent pathway that utilises the TLR adaptor TRIF and
leads to induction of IFN-(L Indeed, it now appears that the ability of immune cells to utilise
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different combinations of TLR adaptors allows several different signalling pathways to be
initiated. Figure 3 summarises our current understanding of TLR signalling.
1.1.15.1 The MyD88-dependent pathway leads to pro-inflammatory gene
expression
Upon binding to their respective ligands. TLR undergo activation by dimerisation and
undergo conformation changes that enable the recruitment of cytosolic downstream adaptors
including myeloid differentiation factor 88 (MyD88), IL-lR-assocaited kinases (IRAKs),
transforming growth factor-activated kinase 1 (TAK1), TAK-1 binding protein (TAB1),
TAB2 and tumour necrosis factor receptor associated factor 6 (TRAF6) (Akira and Takeda,
2004).
MyD88 is a key TLR signalling molecule originally isolated as a gene induced by IL-6
differentiated macrophages (Lord et al., 1990). It possesses a death domain (DD) as its N-
terminal domain followed by a TIR domain. Myd88 can form dimers with other proteins via
both its TIR domain (for example TLR) and its DD (Myd88 homodimers). Studies have
shown that MyD88 is recruited to activated TLR as a homodimer and functions as an adaptor
linking TLR/IL-1R with downstream signalling molecules that possess DDs (Dunne et ah,
2003).
IRAKs are a family of proteins that all contain N-terminal death domains (DDs) and a
central kinase domain that phosphorylates down stream targets. IRAK4 interacts with
MyD88 and IRAKI to mediate TLR signalling. Mice with deficiencies in IRAK4
demonstrated a total lack of LPS responsiveness whilst mice deficient in IRAKI exhibited
mildly deficient LPS responses (Swantek et ah, 2000). Interestingly, humans who possess
deficiencies in IRAK4 have been identified. These patients could not respond to IL-1, IL-18
or stimulation with a multitude of TLR ligands (TLR 2, 4, 5 and 9) (Picard et ah, 2003).
TRAF6 functions as a signalling mediator for both the TNF receptor and TIR superfamily.
Upon TLR activation TRAF6 activates the NF-kB transcription factor with the use of TAK1
and two adaptor proteins TAB1 and TAB2. (Bradley and Pober, 2001; Yamaguchi et ah,
1995; Takaesu et ah, 2003). TAB1 functions to enhance TAK1 kinase activity whilst TAB2
acts to link TAK1 to TRAF6 (Takaesu et ah, 2000).
NF-kB is a member of a family of transcription factors, each of which function as homo- and
hetero-dimers. They are ordinarily sequestered in an inactive state in the cytoplasm by
molecules of the inhibitor IkB family. The activation of NF-kB is mediated by the IkB
kinase (IKK) complex, which phosphorylates the inhibitory IkB component and as such
labels it for proteasome-mediated degradation. The removal of IkB enables the now fully
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Figure 3 TLR signalling pathways. TLR can signal through at least two pathways to initiate
either pro-inflammatory cytokine or type-I EFN expression. Some data suggests TLR 9 may
activate type-I IFN expression, although the mechanism remains to be elucidated
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active NF-kB to translocate to the nucleus where it can mediate transcription of a multitude
of pro-inflammatory genes (Karin and Ben Neriah, 2000; Adachi et al., 1998; Akira and
Takeda, 2004). These interactions are illustrated in figure 3.
1.1.15.2 MyD88-independent pathways
MyD88 is an essential component of the TLR pathway that mediates responses to a wide
range of microbial components. Indeed, mice deficient in MyD88 cannot produce TNF-a or
IL-6 in response to IL-1 or microbial components recognised by TLR 2, 4, 5, 7 or 9 (Takeda
et al., 2003; Adachi et al., 1998). However, closer study of these mice revealed the existence
of a MyD88-independent pathway that also mediates signalling in response to LPS and
dsRNA (Kawai et al., 1999). Whilst most TLR utilise the MyD88-dependent pathway, a
subset of TLR responses remains intact in MyD88-deficient mice. MyD88 deficient cells
exposed to LPS induce a variety of genes, many of which are IFN-inducible, such as
glucocorticoid-attenuated response gene 16 (GARG16) and immunoresponsive gene 1
(IRG1) (Kawai et al., 2001). Conversely, cells that are deficient in TLR 4 alone cannot
induce either pro-inflammatory genes or IFN-inducible genes in response to LPS. Together
this suggests the induction of IFN-inducible genes (such as GARG16 and IRG1) in response
to LPS was possible despite the lack of MyD88 (Kawai et al., 2001). Studies have shown
that ligands for TLR 2, 5, 6, and 7 do not engage this alternative MyD88-independent
pathway (Toshchakov et al., 2002; Akira and Takeda, 2004).
The MyD88 pathway was studied in respect to DC maturation and found that maturation
induced by LPS could occur through either MyD88-dependent or -independent pathways.
However, maturation via the MyD88-independent pathway only occurs secondary to the
production of IFN-P, suggesting this pathway leads to the production of type I interferons
(Hoshino et al., 2002). Importantly, TLR 3 appears to signal through the MyD88-
independent pathway to induce IFN-P production, since MyD88 deficient cells respond
normally to poly(I:C). Thus, TLR 2, 5, and 7 signal exclusively through the MyD88-
dependent pathway, whilst TLR 3 signals exclusively through the MyD88-independent
pathway, and TLR 4 can signal through both pathways. The MyD88-independent pathway is
illustrated in both figure 3 and figure 4 and is further discussed below in section 1.1.15.4.
1.1.15.3 TLR provide specificity to innate immune responses through the
differential use of TIR-containing adaptors
The activation of different TLR results in the induction of differing patterns of gene
expression. The molecular mechanisms that underlie these differences are now, in part,
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explained by the existence of several adaptors that are used by different TLR. These adaptors
include MyD88, TIRAP (TIR domain-containing adaptor protein, also known as MyD88-
adaptor-like protein, MAL), TRIF (TIR domain-containing adaptor protein inducing factor,
also known as TICAM1) and TRAM (TRIF-related adaptor molecule, also known as
TICAM2).
TIRAP was the second TIR-containing adaptor identified after MyD88 and functions in the
MyD88-dependent pathway following activation of TLR 1, 2, 4 and 6 alone (Horng et al.,
2001; Fitzgerald et al., 2001; Yamamoto et al., 2002a).
A third TIR-containing adaptor, TRIF (also identified concurrently as a TLR 3-binding
molecule, and called TICAM1) functions in the MyD88-indpendent pathway. TRIF-deficient
mice possess impaired activation of IFN-regulatory factor 3 (IRF3), along with decreased
expression of IFN-inducible genes (Yamamoto et al., 2002b; Oshiumi et al., 2003).
Independently, a group studying the LPS-hyporesponsive phenotype Lps2 discovered Trif
was the gene responsible for both TLR 3- and TLR 4-activation of the MyD88-independent
pathway and was abrogated in the Lps2 strain (Hoebe et al., 2003). Together, these studies
demonstrated that TRIF is essential for TLR 3- and TLR 4-activation of the My88-
independent pathway, which subsequently leads to the expression of IFN-(3 and in turn the
IFN-inducible genes.
Interestingly, TRIF deficient mice have normal responses to TLR 2, 7, 5 and 9 ligands but
exhibit deficient responses to LPS signalling through TLR 4, despite normal MyD88-
pathway signalling. This suggests the induction of pro-inflammatory cytokines through TLR
4, requires signalling through the MyD88-dependent and -independent/TRIF dependent
pathways (Hoebe et al., 2003; Yamamoto et al., 2002a). By contrast, the activation of the
MyD88-dependent pathway alone is sufficient to induce cytokine expression in response to
activation of TLR 2, 5, 7 or 9 - none of which activate the MyD88-independent/TRIF
dependent pathway. It is not known why TLR 4-mediated responses requires both MyD88-
dependent and -independent pathways to induce cytokine expression. Perhaps this represents
an extra mechanism by which the host protects itself against lethal cytokine excess that
occurs during septic shock.
Finally, further database searches revealed the existence of another TIR containing adaptor,
TRAM. TRAM appears to function in conjunction with TRIF and TLR 4, but does not
associate with TLR 3, to mediate expression of IFN-inducible genes through the MyD88-
independent pathway (Yamamoto et al., 2003). Figure 3 and 4 illustrates the differential use
of the TIR-containing adaptors by TLR.
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1.1.15.4 The antiviral MyD88-independent/TRIF dependent pathway involves
IRF3 and NF-kB
Expression of IFN-(3 and hence all the IFN-inducible genes requires activation of IRF3 and
NF-kB, as described in figure 4 (Yoneyama et ah, 1998). IRF3 is expressed constitutively
and is phosphorylated upon virus infection at its C-terminal regulatory domain by two IKK-
related proteins: IKK-e and TBK1 (Sharma et ah, 2003; Fitzgerald et ah, 2003).
Phosphorylation enables dimerisation and consequent translocation to the nucleus where it
activates transcription of type I IFNs. Once secreted, type I IFNs can signal in an autocrine
fashion to activate the expression of IFN-inducible genes (including IFN itself) via Janus
Kinase/STAT pathways and further enhance IFN expression (Taniguchi and Takaoka, 2002).
Stimulation with LPS can also induce IFN-|3 production via TLR 4-mediated IRF3 activation
in a Myd88-independent manner. However, the activation of IRF3 through TLR 3 is more
rapid and potent than that triggered through TLR 4 signalling. Indeed, TLR 3 signalling
initiates a more pronounced phosphorylation of IRF3 than TLR 4 signalling. These findings
may explain why TLR 3 ligands trigger a more sustained release of IFN-(3 (Doyle et ah,
2003; Servant et ah, 2003; Akira and Takeda, 2004).
Transcriptional activation of the IFN-/3 gene appears to require activation of both IRF3 and
NF-. B (figure 4). TRIF can mediate activation of NF-kB through its C- or N-terminal
domains, whilst TRIF can only activate IRF3 through its N-terminal domain (Yamamoto et
ah, 2002b). TRAF6 interacts with TRIF, thus allowing TRIF to activate NF-kB
independently of MyD88 (Sato et ah, 2003). As stated above IRF3 is activated by TBK1,
which associates with the N-terminal of TRIF. Thus, the N-terminal region of TRIF directly
associates with TRAF6 and TBK1, leading to activation of NF-kB and the IRF3 gene
respectively. The C-terminal of TRIF can also activate NF-kB via an interaction with the
receptor-interacting protein 1 (RIP1) (Meylan et ah, 2004).
To summarise, TLR 3-mediated IFN-P expression occurs as a consequence of two pathways
that diverge from its TIR domain: one that triggers NF-kB via a TRIF/TRAF6 interaction;
and one pathway that activates IRF3 through the kinase activity of TBK1 and IKK-e. Figure
4 illustrates these findings diagrammatically.
The response of dendritic cells (DC) to CpG motifs is less well understood. TLR 9 activation
also leads to the induction of type-I IFN synthesis. CpG motifs activate IFN-a expression in
human PDCs, which predominantly express TLR 7 and 9 (Krug et ah, 2001; Krug et ah,
2003) and in other murine DC subsets (Hemmi et ah, 2003). Type-I IFN expression is not
inducible in MyD88 deficient cells, suggesting that the TLR 9/MyD88-dependent pathway
30
Figure 4, TLR 3 signalling activates both IRF3 and NF-kB through a MyD88-
independent manner. Activated TLR 3 can associate with TRIF through the binding of their
common TIR domains. The localisation of TRIF to the plasma membrane allows RIP, TRAF6 and
TBK1 to associate. RIP and TRAF6 act to free NF-kB of its inhibitory component, whilst TBK1
activates IRF3. Activation of these transcription factors induces their translocation to the nucleus
where upon they induce production of IFN-p. IFN-(3 acts in a paracrine and autocrine fashion to
further upregulate type-I IFN and initiates a potent anti-viral response.
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is essential for cellular responses to CpG motifs found in viruses and bacteria (Hemmi et al.,
2003).
1.1.15.5 Negative regulation of TLR signalling
It is perhaps not surprising that animals have developed mechanisms for modulating TLR-
responses following activation - since excessive production of cytokines can lead to lethal
systemic disorders such as septic shock (Akira and Takeda, 2004). In macrophages following
LPS-mediated activation, levels of IRAK-M increase in the cytoplasm. This IRAK family
member prevents the dissociation of the IRAKI-IRAK4 complex from MyD88, thus
inhibiting the TLR signalling pathway (Kobayashi et al., 2002). In addition, the expression
of SOCS1 is induced following LPS and CpG exposure in macrophages (Dalpke et al.,
2001). Ectopic expression of this gene in macrophages prevents LPS induced NF-. B
activation, implying it directly down regulates TLR-signalling pathways, perhaps via its
ability to bind to IRAKI (Nakagawa et al., 2002). Mice deficient in either IRAK-M or
SOCS1 are both hypersensitive to LPS and produce excessive quantities of cytokines.
MyD88s is an alternatively spliced variant of MyD88 that lacks a domain critical for the
recruitment of IRAK4. Expression of MyD88s is induced in macrophages following LPS
exposure and is thought to down-regulate TLR signalling by directly competing with MyD88
(Burns et al., 2003). More recently, membrane-bound orphan receptors that contain
cytoplasmic TIR domains (called SIGRR and ST2) have been identified. Mice deficient in
these molecules are hyper sensitive to LPS (Wald et al., 2003).
Given the central role TLR play in sensing infection and activating immune responses it is
not surprising that infectious agents have evolved mechanisms to inhibit TLR signalling. The
Vaccinia is a complex poxvirus that expresses homologues of proteins encoded by the host
immune system such as secreted decoys for cytokines. This virus also encodes proteins that
inhibit TLR signalling including A46R and A52R, which act as dominant negative inhibitors
in the TLR pathway and decrease NF-kB activation and cytokine release (Bowie et al., 2000;
Harte et al., 2003). Furthermore, the poxvirus protein NIL is amongst the strongest
determents of vaccinia virulence and functions to inhibit IRF3 and NF-kB so that IFN-P
production is curtailed (Bartlett et al., 2002; DiPerna et al., 2004)
Both host- and microbe-derived inhibitory proteins are examples of molecules that
negatively regulate the TLR pathway by their association with downstream adaptors of the
TLR pathway. These studies suggest there are multiple mechanisms that exist for dampening
down the responses that are activated by TLR signalling.
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To summarise, the mechanisms that mediate TLR signalling are being rapidly elucidated.
TIR-containing adaptors such as MyD88, TIRAP, TRIF and TRAM have crucial roles to
play in the TLR pathway, providing specificity to the response generated by individual TLR.
There is still much to discover; for example how differing viruses generate differing immune
responses is still to be determined, with much of the current literature focussed on the
mechanisms that mediate TLR responses to bacterial products.
1.1.16 Modulation of immune responses by TLR
1.1.16.1 TLR signalling primes dendritic cells to modulate T cell activation
Although long considered as non-specific, innate immune responses may be crucial in the
transmission of appropriate information to the immune cells that are involved in acquired
immunity. Indeed, recognition of infection by TLR triggers activation of not only innate
immunity but also adaptive immunity. Most signals that initiate adaptive immune responses
are provided by dendritic cells (DCs), a cell type that resides in the periphery, has a high
capacity to endocytose and functions to detect the first signs of infection. DCs are readily
activated by various TLR ligands such as; LPS, CpG DNA, peptidoglycan, lipoproteins and
cell walls ofMycobacteria, which initiates their maturation (Flemmi et al., 2000; Tsuji et al.,
2000; Hertz et al., 2001; Kaisho et al., 2001). As DCs mature their cell surface receptors are
rapidly internalised and new receptors expressed so that they can migrate to and enter the
lymph nodes. DCs also respond to TLR ligands by expressing a variety of cytokines that
modulate T cell responses, losing their ability to endocytose and expressing key co-
stimulatory molecules. Upon entry to lymph nodes the matured DCs can activate resident T
cells by presenting antigen in the context of their MHC-II receptors to naive T cells and so
initiate an antigen specific immune response (Banchereau and Steinman, 1998; Reis e Sousa,
2001; Reis e Sousa, 2004).
The ability of DCs to steer the adaptive immune response down either a Thl-dominant
response verses a Th2-dominant one has been suggested by a number of studies. This work
suggests the type of TLR ligand recognised by DCs could drive distinct DC responses that in
turn drive distinct adaptive immune response. Myd88 deficient mice immunised with an
antigen (Ag) along with complete Freund's adjuvant (CFA) exhibit deficiencies in; the
production of the Thl cytokine IFN-y, the activation of CD4 T cells and the production of
Ag-specific IgG2a, all of which suggest the Thl response is compromised in these mice.
(Schnare et al., 2001; Kaisho et al., 2002). Furthermore, Thl immune responses otherwise
provoked by a protozoan parasite in wild-type mice, are abolished in mice lacking Myd88
33
Chapter 1 Introduction
(Jankovic et al., 2002). Taken together, it would seem that the Myd88-dependent signalling
pathway primarily initiates Thl immune responses.
Further evidence for the role TLR play in specifying the type of adaptive response comes
from work that suggests activation of TLR 4 or TLR 9 initiates production of IL-12. This
cytokine along with IFN-y primes T cells to initiate a Thl dominated response whilst IL-4
and IL-10 are characteristically produced during a Th2 response (Rissoan et al., 1999; Liu et
al., 2001; Liu, 2001). Using LPS as a TLR 4 ligand and PGN as TLR 2 ligand, Re and
Strominger showed that monocyte- derived DCs preferentially expressed IL-12 (Thl
response) or IL-10 (Th2 response) when stimulated through TLR 4 or TLR 2 respectively
(Re and Strominger, 2001). A further more comprehensive study confirmed this finding
using murine cells; LPS, peptidoglycan and zymosan trigger distinct programs of innate
cytokine production in mice (Qi et al., 2003). The three microbial TLR activators were
shown to be inherently different in their abilities to induce IL-10 and IL-12 production.
Overall the results show LPS was a much stronger IL-12 inducer but weaker IL-10 stimulator
than the TLR 2 ligands peptidoglycan and zymosan, which primarily stimulated T cells to
express IL-10 and IL-4. The authors conclude that their results reveal that LPS,
peptidoglycan, and zymosan differentially condition DCs to prime Th effecter phenotypes,
suggesting that distinct microbial TLR agonists can be a cue that DCs sense in order to
differentially direct Th effecter development (Qi et al., 2003). Together this data suggests
TLR signalling in DCs are involved in determining the balance of Thl / Th2 responses - an
important finding considering the massive impact these responses have on the course of
immune responses.
1.1.16.2 TLR signalling can directly result in microbial killing
TLR appear to be directly involved in the induction of antimicrobial activity. In Drosophila,
the Toll pathway leads to the synthesis of antimicrobial peptides. The power of these
antimicrobials have been demonstrated by a study that found a single anti-microbial peptide
is sufficient to rescue the susceptibility of Spatzle/IMD double mutant flies to microbial
infection (Tzou et al., 2002). These peptides have been well-characterised and as such
represents a conserved and evolutionary ancient mechanism to kill microbes (Zasloff, 2002).
In mammals, the best-described analogues of these antimicrobial peptides are the (3-
defensins. These peptides are made at the very front line of defence between pathogen and
host in several kinds of epithelial cell; in the gastro-intestinal and respiratory tracts, and the
skin (Zasloff, 2002). In addition, the paneth cells at the base of the crypts of the GI tracts
secrete a-defensins in response to LPS or bacterial challenge (Lehrer and Ganz, 2002).
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Stimulation of a lung epithelial cells with lipoproteins led to TLR-2 mediated induction of (3-
defensin-2 (Birchler et al., 2001). Together, these findings indicate that TLR are likely to
mediate the secretion of antimicrobial peptides, hence regulating the direct killing of
micrdrganisms at the epithelial interface between host and the environment.
In addition, TLR 2 signalling in macrophages can directly lead to microbial killing by
inducing nitric oxide (NO)-dependent and independent killing of intracellular Mycobacteria
(Thoma-Uszynski et ah, 2001), whilst TLR 2 and TLR 4 deficient macrophages cannot kill
phagocytosed Salmonella to the same extent as wild type cells (Weiss et ah, 2004).
Another mechanism by which TLR may directly result in the killing of microbes is via the
induction of apoptosis. Macrophages infected with invasive bacteria or viruses undergo
apoptosis and in doing so may limit the spread of the pathogen (Zychlinsky et ah, 1992;
Allsopp and Fazakerley, 2000). Exposure of several differing kinds of microbial components
to macrophages and epithelial cells can induce apoptosis such as LPS and lipoproteins.
Macrophages lacking TLR 2 have a reduced capacity to enter into apoptosis upon exposure
to lipoproteins, suggesting TLR may have a role to play in this phenomenon (Aliprantis et
ah, 1999).
1.1.17 Interferons mediate a potent anti-viral response
The interferon (IFN) response is a potent anti-viral tool that is used effectively by the host to
rapidly suppress virus replication upon infection. Indeed, the effectiveness of the IFN
response has led to many viruses developing mechanisms that work against either the
production or actions of IFNs. It has even been suggested that all viruses must inhibit the
IFN response in some shape or form if virus replication is to occur at all in vivo. Moreover
the degree of virulence that a particular strain possesses may well be party based on its
ability to circumvent the IFN response (Goodbourn et ah, 2000).
The IFNs are a family of multifunctional secreted proteins that are categorised into two
groups: type I IFNs are produced in direct response to virus infection and consist of the
products of the IFN-a multigene family, which are predominantly expressed by leukocytes
and the product of the IFN-|3 gene that is expressed by most cell types. In contrast, type II
IFN consists of only IFN-y that is expressed by activated T cells and natural killer (NK) cells
during adaptive immune responses to viral infection (Goodbourn et ah, 2000). As such the
type I IFNs can be considered an innate immune response and will be discussed here.
The importance of type I IFNs has been exemplified by studies that utilise mice engineered
to lack a functional receptor for type I IFNs, termed the IFN-a(3-Receptor. These mice
cannot respond to IFN and hence cannot mediate any of its potent effects. As such, these
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mice cannot mount effective immune responses to a wide variety of viruses and die soon
after infection (Muller et al., 1994; Fiette et al., 1995; Hwang et al., 1995; Rousseau et al.,
1995; van den Broek et al., 1995; Mrkic et al., 1998; Grieder and Vogel, 1999). Type I IFNs
initiate a wide variety of mechanisms that can be grouped into three main strategies to resist
viral infection: 1.) IFNs stimulate an anti-viral state in target cells whereby the replication of
virus is blocked or impaired due to the synthesis of a number of enzymes that interfere with
both cellular and viral processes; 2.) IFNs can slow the growth of target cells and/or make
them susceptible to apoptosis; 3.) IFNs can have piofound iimiiuiio-iiiodulatatory effects and
stimulate adaptive immune responses (reviewed in:(Goodbourn et al., 2000)).
IFN-|3 is the first IFN induced directly by viral infection and is followed by IFN-a4
expression. Once these two IFNs are expressed, autocrine and paracrine mechanisms result
in the synthesis of interferon regulatory factor 7 (IRF7) that in turn initiates the production of
more type-I IFN family members (Erlandsson et al., 1998; Au et al., 1998; Marie et al.,
1998; Sato et al., 1998). The initial activator of IFN-|3 expression is intracellular dsRNA
(Jacobs and Langland, 1996), which signals through TLR 3 and PKR depending on the cell
type (Alexopoulou et al., 2001; Boehme and Compton, 2004), and is rapidly released to the
extracellular environment. Binding of IFN-a/p to its receptor on the surface of cells initiates
its biological activities by bringing together the two major sub-units IFNAR1 and IFNAR2
to form an active dimer that signals through a Jak/STAT pathway (Mogensen et al., 1999).
Activated STAT hetrodimers translocate to the nucleus where they bind to a consensus
sequence upstream of all IFN-inducible genes called the ISRE and initiate gene expression
(Shuai et al., 1994; Veals et al., 1992).
A considerable amount of research has focused on the pivotal roles that the dsRNA-
dependent protein kinase R (PKR) and the 2'-5' oligoadenylate synthetases (OAS) play in
the anti-viral response, both of which are upregulated by IFN-a/p signalling (Figure 5).
Activated PKR has a multitude of actions involved in the control of transcription and
translation, although it is ordinarily inactive in the cytoplasm (Meurs et al., 1990). Binding
of dsRNA unmasks a catalytic domain enabling a variety of functions including:
phosphorylation of the translation initiation factor eIF2 which in turn inhibits recycling of
initiating factors and hence translation (Meurs et al., 1992); participation in signalling
cascades such as NF-kB activation and STAT1 activation (Wong et al., 1997); and finally in
the initiation of apoptosis (Tanaka et al., 1998).
The OAS system constitutes a group of enzymes whose expression is induced by IFNs and
whose activity is triggered by dsRNA. OAS enzymes catalyse the synthesis of ATP
oligomers in the unusual 2'5'conformation (Kerr and Brown, 1978). These 2'5'ATP
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oligomers bind to and activate the endonuclease RNase L, which mediates the cleavage of
single-stranded mRNA (both cellular and viral) thereby inhibiting protein synthesis. RNase
L tends to be activated in the immediate "vicinity" of the activator (dsRNA), ensuring viral
transcripts are preferentially destroyed over cellular mRNA(Nilsen and Baglioni, 1979).
In addition to PKR and OAS, the IFN-inducible Mx proteins interfere with RNA virus
replication, particularly that of the negative stranded RNA viruses such as those in the
Bunyaviridae (Frese et al., 1996), Mx proteins have GTPase activity and probably inhibit the
trafficking or activity of viral polymerases (Stranden et al., 1993). Importantly, additional
uncharacterised anti-viral effects of IFN must exist, since mice triply deficient in PKR,
RNase L and Mxl can still successfully resist some virus infections (Zhou et al., 1999).
IFNs can also inhibit cell growth and change a cell's propensity to initiate apoptosis by a
variety of mechanisms. For example, IFNs upregulate the level of the cyclin-dependent
kinase inhibitor p21, which plays a crucial role in the progression of the cell cycle from G1
into the S phase (Subramaniam et al., 1998; Sangfelt et al., 1999). IFN goes further than cell
arrest and triggers apoptosis by various routes, including PKR and OAS associated activity,
but also more directly by inducing the expression of the inactive precursors for caspasel,
caspase 3 and caspase 8 (Figure 5) (Chin et al., 1997; Subramaniam et al., 1998;
Balachandran et al., 2000b).
Finally, IFN-a/p production also has potent immunomodulatory effects. IFN-a/|3 is
produced constitutively at low levels by plasmacytoid dendritic cells which represent the
main producers of IFN following virus infection. Upon infection these cells can produce
large amounts of IFN that have systemic effects (Siegal et al., 1999). Once secreted, IFN-a/p
has the ability to upregulate a cell's ability to present internal antigens to leukocytes in the
context of MHC-I molecules and thereby promote CD8+ T cell responses (Goodbourn et al.,
2000). In addition, IFN-a/p enhances the cytotoxicity of NK cells by upregulating levels of
perforins and inducing IL-15 production by macrophages that promotes NK proliferation
(Kaser et al., 1999; Fawaz et al., 1999). IFN-a is an important cytokine for the generation of
protective T-cell mediated immune responses to viruses, either directly or by maintaining the
survival of T cells once activated (Sun et al., 1998; Marrack et al., 1999).
Type I IFNs provide the host with a powerful tool for restricting viral replication and spread
at sites of viral infection in a rapid and potent manner. Thus, it is not surprising that viruses
have evolved mechanisms to counteract the IFN-a/p response. Indeed, there is a plethora of
examples in the literature of viruses that either inhibit IFN production or interfere with IFN
signalling. Many viruses attempt to minimise IFN-a/p production by sequestering the main
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activator of the IFN system, dsRNA. For example, the reovirus major capsid protein a3
binds dsRNA (Lloyd and Shatkin, 1992), as does the aA protein of the avian reovirus
(Martinez-Costas et al., 2000). Importantly, differences in reovirus virulence have been
linked to differences in the ability of a3 protein to sequester dsRNA - suggesting IFN
suppression by this route is instrumental in the determination of virulence (Bergeron et al.,
1998). In addition to reoviruses, several other viruses attempt to hide their dsRNA by
expressing dsRNA-binding protein such as the NS1 protein of influenza virus (Lu et al.,
1995), the E3L protein vaccinia virus (Chang et al., 1992) and products of the nsP3 gene of
porcine rotaviruses (Langland et al., 1994). Further examples of IFN-a/|3 suppression come
from; the African swine fever virus which encodes a homologue of IkB that inhibits NF-kB
mediated induction of IFN-p (Powell et al., 1996); the human papillomavirus type 16 which
expresses an inhibitor of IRF-3 that ordinarily mediates IFN-a/p production (Ronco et al.,
1998); several poxviruses that encode soluble IFN-a/(3 receptor homologues that bind and
sequester IFNs, thereby blocking their biological activity (Symons et al., 1995); whilst
human cytomegalovirus disrupts IFN signalling by decreasing levels of key members of the
signalling cascade downstream of the IFN-a/(l-R (Miller et al., 1998). In addition to these
few examples are a multitude of examples whereby viruses interrupt IFN-a/(3 detection,
signalling, and its functions directly; these are beyond the scope of this introduction but are
well reviewed by Goodbourn et al. (Goodbourn et al., 2000).
1.2 The CNS is a highly complex tissue possessing a specialised immune
environment
The CNS is the most complex organ in the mammalian body. It possesses a vast number of
neurones that interconnect to form the most intricate cellular network known to science. This
organ is also one of the most vital; many neuronal nuclei and circuits cannot be replaced if
damaged or lost. Neurones are sensitive to various forms of assault, be it physical, chemical,
inflammatory or infective and are protected by a variety of mechanisms. The blood-brain-
barrier (BBB) acts to separate the organ from the blood, whilst glial cells act to support
neuronal function, aid recovery from insult and guide CNS immune responses. Due to the
consequences of CNS damage there exists a variety of mechanisms that prevent unnecessary
or inadvertent immune activation.
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1.2.1 The blood-brain-barrier (BBB) protects the brain
The BBB constitutes an important barrier that prevents the passage of cells and many
proteins into the CNS from the systemic circulation. This cellular barrier is composed of
endothelial cells that adhere tightly to each other and are surrounded on the tissue side by a
circle of astrocytic processes, whilst vascular cells express few adhesion molecules for
circulating leukocytes to bind. Epithelial cells found in other organs are not joined tightly in
this way and ordinarily allow a whole host of proteins, aqueous compounds and mobile cells
to pass around them. In comparison, the tight barrier in the brain prevents proteins, most
non-lipid soluble compounds and mobile cells such as lymphocytes, dendritic cells and
monocytes from entering. This barrier is essential for the exclusion of most pathogens, non-
endogenous substances, and hormones, and acts to maintain a steady environment for
neurones whose non-renewable nature requires special protection. The CNS has long been
considered to be immunoprivileged due the absence of key components of the immune
system and a lymphatic system. Unlike other tissues, patrolling lymphocytes and dendritic
cells, which are the typical cellular sensors of microbes, cannot be found in the resting CNS.
Indeed, the tissue architecture is unique in that it lacks lymphatics (Hickey et al., 1991;
Pachter et ah, 2003). In addition, levels of complement are undetectable as are antibodies
and MHC expression. (Kakinuma et ah, 1998; Paul et ah, 2003; Halevy et ah, 1994; Lustig et
ah, 1992).
Immune responses in the CNS are tightly controlled. Microglia are kept in a quiescent state
by CD200-CD200R neuronal interactions (Hoek et ah, 2000), whilst astrocytes contribute to
immune suppression by expressing the immunosuppressant cytokine TGF-|3 along with
neurotrophins such as brain-derived neurotrophic factor (BDNF) and nerve growth factor
(NGF), all of which encourage microglial quiescence, suppress T cells and deactivate any
infiltrating antigen-presenting cells that manage to pass the BBB (Gordon et ah, 1998; Hailer
et ah, 1998). The few T cells that enter the resting brain become anergic and undergo
apoptosis or leave through an as yet uncharacterised mechanism (Hickey et ah, 1991; Piccio
et ah, 2002). In addition, plasmacytoid DCs the main producers of type-I IFN following
virus infection are also not observed in the CNS, suggesting alternative mechanism must
exist to regulate immune responses in the CNS.
Importantly, the BBB can be compromised during times of trauma, ischaemia, pressure,
inflammation and infection, allowing an infiltrate of leukocytes and serum proteins (Cotran,
2004). During viral encephalitis a flood of mononuclear cells enters the brain along with
antibodies that can neutralise virus and label virus and infected cells for clearance (Pachter et
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al., 2003; Amor et al., 1996; Morris et al., 1997). Whilst virally infected cells in the
periphery are eliminated by the immune system there is relatively little cytolytic clearance in
the CNS, suggesting there are alternative mechanisms for CNS viral clearance (Griffin,
2003; Levine et al., 1991). Fundamentally, it has remained puzzling how infection is sensed
and how immune responses are co-ordinated within a tissue that lacks such critical
components of the immune system.
1.2.2 Microglia are resident facultative phagocytes of the CNS
The long-standing tenet that the CNS is an immunologically privileged site has undergone
considerable revision with the notion that microglia have immune functions. Microglia
express several key immunologically related receptors including complement receptors
(Moller et al., 1997), Fc receptors (Peress et al., 1993), scavenger receptors (Husemann et
al., 2002), cytokine receptors for IL-1, IL-2, IL-3, IL-4, IL-6, IL-10, IL-12, IL-13, IL-15, EL-
18, IFN-y, IFN-a/p and many chemokines (Hanisch, 2002). Ex vivo microglia isolated from
the uninfected brain express the co-stimulatory molecules B7-2, ICAM-1 and CD40 and can
be induced to express high levels of MHC-II molecules, suggesting they have a capacity to
interact with and stimulate T-cells (Carson et al., 1998). Accordingly, microglia are thought
to play a pivotal role during CNS immune responses and have been described as the resident
antigen-presenting cell of the CNS, although in the resting CNS remain in a quiescent state
until activated by injury or infection (Streit, 2002).
The function, integrity and survival of neurones are dependent on the presence of large
numbers of glial cells under normal and pathological conditions. Indeed, microglia can be
considered a hybrid between leukocytes and glial cells; they function to both provide
protection and support to neurones, and as sentinels for infection. Microglial activation has
been consistently associated with neuropathology in a variety of neurological diseases, from
trauma and infection to chronic disease such as prion disease and Alzheimer's disease (AD)
(Streit, 2002; Rezaie and Lantos, 2001; Eikelenboom et al., 2002). Microglia are exquisitely
sensitive to their environment and can become activated even without obvious neuronal
pathology (Raivich et al., 1999). Indeed, they are activated early in the response to infection
or injury and are major players in both innate and adaptive immune CNS responses (Raivich
et al., 1999; Benveniste et al., 2001).
There has been much debate over the ontogeny and function of microglial cells, since they
are often confused with circulating monocyte-derived macrophages that occasionally migrate
into the CNS (Streit et al., 1999). It is now generally accepted that microglia originate during
embryogenesis from mesodermal cells, probably of the haematopoietic lineage (Cuadros and
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Navascues, 1998; Cuadros and Navascues, 2001), which after invasion into the CNS rapidly
proliferate to form a vast pool of self-propagating, professional phagocytes based on their
characteristic expression of F4/80 antigen, FcR and Mac-1 (Streit, 2002). Bone marrow
chimera studies in adult mice show that only a small proportion of microglia enclosed by the
BBB are derived from circulating bone marrow precursors. Conversely, cells with a
morphology similar to that of microglia that populate the perivascular tissue alongside the
blood brain barrier are derived from circulating monocytes and are unlikely to be
functionally analogous to the resident CNS microglia (Hickey and Kimura, 1988).
In adults, resident microglia are a stable population of cells with low levels of cell division,
whose numbers can also receive occasional addition from perivascular macrophages.
Infiltrating perivascular macrophages can be distinguished by their relatively high expression
of CD45. The perivascular CD45hlgh macrophages are effective antigen presenting cells and
stimulate T cell proliferation. Conversely CD45low microglia isolated from the resting brain
fail to present antigen effectively and cause T cell anergy in vitro unless activated with IFN-
y, or microbial components such as LPS (Aloisi et al., 2000; Ford et ah, 1995). However,
microglia isolated from brains infected with Theiler's murine encephalomyelitis virus
(TMEV) express all the necessary markers for antigen presentation and can effectively
activate T cells to produce IFN-y ex vivo. TMEV initiates a chronic demyelinating disease
characterised by inflammatory lesions of demyelination. Microglia isolated from infected
mice express a multitude of pro-inflammatory cytokines and iNOS at levels equivalent to
those produced by invading macrophages (Mack et ah, 2003). Cultured microglia infected
with TMEV express high levels of IFN-a/p, pro-inflammatory cytokines and several
chemokines such as MlP-la and readily activate T cells. Microglia stimulated with LPS,
peptidoglycan and CpG motifs also express inflammatory mediators (Olson and Miller,
2004). Microglia isolated from the brains of mice exhibiting demyelination initiated by
experimental allergic encephalitis (EAE) are also able to effectively present both exogenous
and endogenous antigens to T cells (Juedes and Ruddle, 2001). Together these studies inform
that microglia promote T cell anergy in the resting brain, whilst in the infected and inflamed
brain are effective T cell activators and mediators of inflammation. The mechanism that
switches microglia between these two states is uncharacterised; although one can
hypothesise that microglia possess an innate ability to sense infection or damage without
prior priming by IFN-y or other inflammatory mediators.
The activation of microglia in the virus-infected brain can be associated with a concurrent
increase in neurological damage. This finding has been well characterised in human
immunodeficiency virus (HIV) associated dementia (HAD), in which microglia have been
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linked to neurodegeneration. The brains of HAD patients exhibit wide spread glial activation
and loss of neurones that manifests clinically as a progressive chronic dementia with
cognitive and motor dysfunction (Perry and Marotta, 1987). The predominant mechanism of
HAD neuropathogenesis appears to involve the response of infiltrating macrophages and
resident microglia. Microglia can be stimulated by infection with HIV itself, by interaction
with viral proteins or by immune stimulation in response to factors secreted from adjacent
infected cells (Garden et al., 2002). Microglia constitute the major infected cell type in the
CNS and compelling evidence suggests that microglial infection occurs before the onset of
AIDS and is sufficient to promote CNS pathology even when therapeutic intervention
controls HIV infection in the periphery (Major et al., 2000). The topographical distribution
of apoptotic neurones is closely associated with markers of microglial activation (Adle-
Biassette et al., 1999). Furthermore, in HAD patients elevated levels of pro-inflammatory
cytokines such as TNF-a (Sippy et al., 1995), iNOS activity (Zhao et al., 2001) and
excitatory amino acids, all of which are neurotoxic, are evident (Giulian et al., 1996). In
primate models neurobehavioral abnormalities associated with infection progress more
rapidly in animals exhibiting greater microglial activation, suggesting that the release of
inflammatory mediators from infected microglia may be the cause the of neurologic
dysfunction (Berman et al., 1999; Garden et al., 2002).
Studies that have investigated other CNS virus infections have also suggested microglia
promote inflammation. Infection of microglia with coronavirus increased NO production
(Edwards et al., 2000), whilst infection of a glial cell line with the measles virus led to
increased expression of MHC-I (Aloisi et al., 2000). Microglia persistently infected with
TMEV directly upregulate cytokines involved in innate immunity (such as IL-6 and IFN-a)
along with MHC-II, IL-12 and co-stimulatory molecules B7-1, B7-2 and ICAM-1, enabling
effective presentation of antigen to T-cells (Olson et al., 2001).
Whilst resident microglia have the potential to become highly phagocytic, resting microglia
in the uninfected CNS are unlikely to be involved in phagocytic activity. When rats were
injected with a marker of phagocytic activity (fluoro-gold), only the perivascular microglia,
but not the resident microglia, were labelled (Pennell and Streit, 1998). However, separate in
vivo studies using the fluoro-gold marker have shown resident microglia to be engaged in
high levels of phagocytosis during neurodegeneration of the optic nerves (Thanos et al.,
1994) and within cortical lesions (Sorensen et al., 1996). Hence, perivascular microglia are
the only constitutive macrophages present within the brain. Resident microglia can be
considered facultative phagocytes - ordinarily quiescent but, when called upon, are capable
of ingesting vast quantities of material. When activated in the adult CNS, microglia
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transform from a process bearing (ramified) morphology to a rounded macrophage-like
morphology and ingest dying cells. Conversely, mild neuronal injuries cause microglia to
adopt a reactive so-called hyper-ramified state which ensheaths regenerating neurons and
appear to help in the process of recovery (Barron et al., 1990; Streit et ah, 1999). Microglia
are widely cultured for research purposes as primary cell cultures and as immortalized
amoeboid cell lines. Purification and culturing techniques tend to activate microglia and
these cells possess a rounded morphology and an almost constitutive capacity to phagocytose
particles in vitro (Hayes et ah, 1988).
Whilst microglia are capable of sensing microbial components, they can also be activated
indirectly through neuronal/glial dialogue. Damaged neurones can communicate to both
microglia and astrocytes by expressing the CNS-specific chemokine fractalkine, which is a
neuronal membrane bound factor that is rapidly cleaved following neuronal damage
(Neumann et ah, 1997; Harrison et ah, 1998; Rappert et ah, 2002; Chapman et ah, 2000).
Collectively, these studies have demonstrated that activated microglia can be major
producers of cytokines, chemokines, and other neurotoxic compounds, arc active phagocytes
and can stimulate T-cells. However, the extent of their participation in the initiation and
progression of CNS inflammation and microbial sensing remains to be determined. Indeed,
the relative contribution microglia make to CNS inflammation compared to astrocytes and
infiltrating macrophages is an active topic of debate (Streit, 2002; Liberto et ah, 2004).
1.2.3 Astrocytes are a major glial cell type with a multitude of roles
Astrocytes are dynamic cells that maintain the homeostasis of the normal CNS and can play
a pro-activate role during immune responses. Astrocytes express numerous receptors that
enable them to respond to virtually all known neuroactive compounds, including;
neurotransmitters, neuropeptides, cytokines, growth factors and toxins. Astrocytes not only
play a role in neuronal support and signal processing, but also function as sentinels for CNS
damage and infection. Astrocytes are also critical for the establishment and maintenance of
the BBB through interactions with endothelial cells. Upon perturbation of the CNS
homeostatic environment, astrocytes become activated; increasing their metabolic activity,
increasing in size (hypertrophy) and number (hyperplasia) and help promote angiogenesis,
remyelination, neuronal survival and restoration of the BBB. Activation is associated with an
increased production of the intermediate filaments such as glial fibrillary acidic protein
(GFAP) (Krum and Rosenstein, 1998; Albrecht et ah, 2003; Dreyfus, 1998; Janzer and Raff,
1987; Liberto et ah, 2004). During immune responses "reactive" astrocytes exacerbate tissue
damage via the release of pro-inflammatory cytokines, reactive oxygen species and NO that
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inhibits neurite outgrowth and kills oligodendrocytes (Liberto et al., 2004). However,
microglia produce far higher levels of these cell damaging intermediates and cytokines than
astrocytes - and it is therefore questionable to what extent astrocytes contribute to the
initiation and perpetuation of immune responses and the pathogenic mechanism that mediate
CNS damage during infection and injury (Liberto et al., 2004).
1.2.4 TLR expression and function in the CNS remains largely uncharacterised
Our knowledge of TLR has rapidly expanded over a relatively short period of time and little
attention has been given to their expression and function in neuronal tissue. Since monocytes
possess a broad repertoire of TLR expression and microglia have some functional
similarities to these cells, it may speculated that microglia will express TLR, although since
microglia are not derived from circulating monocytes this assumption is far from certain.
Microglia in culture are capable of responding to a variety of pathogens and their
components such as LPS and CpG-DNA (Olson and Miller, 2004; Dalpke et al., 2002),
suggesting they possess a mechanism for microbial sensing. Similarly, astrocytes are also
activated by LPS and CpG-DNA and express cytokines (Lee et al., 2004). Despite the
participation of glial cells in CNS immune responses there exists little in the literature to
inform us of TLR expression and function in these important cells. Whether innate
recognition is conferred by glial expression of TLR or by inter-glial, inter-leukocyte and/or
neuronal-glial dialogue is uncertain. Some recent work has begun to address these questions.
The CNS exhibits a well-organised innate immune reaction to systemic bacterial infection
and cerebral injury. Intravenous injection of LPS initiates severe endotoxaemia that alters the
BBB and causes severe neurological damage. Studies have shown the circumventricular
organs, which lie within the brain but lack a BBB constitutively express CD14 and TLR 4, as
determined by in situ hybridisation. Circulating LPS rapidly upregulates CD14 and TLR 4
within the circumventricular organs, followed by a massive upregulation of TNF-a and a
subsequent upregulation of TLR 2, TLR 4 and CD14 in microglia across the parenchyma
(Lacroix et al., 1998; Laflamme and Rivest, 2001; Laflamme et al., 2001). The activation of
parenchymal microglia during endotoxaemia is associated with a robust induction of genes
that encode cytokines, chemokines and proteins of the complement system and leads to
severe neurological dysfunction (Brochu et al., 1999; Nadeau and Rivest, 2000; Thibeault et
al., 2001). TLR 4 deficient mice do not exhibit inflammatory CNS responses to LPS, whilst
TLR 2 deficient mice do respond to LPS stimulation but fail to elicit such a profound
cytokine response - suggesting TLR 2 cooperates with TLR 4 in the CNS to mediate
maximal cytokine release (Laflamme et al., 2003). Work in rats has shown that LPS
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exposure sensitises the brain to ischaemic injury and alters TLR 4 expression (Eklind et al.,
2001), whilst work investigating LPS-induced injury of oligodendrocytes in mice has
documented a pro-active role for TLR 4 expressing microglia (Lehnardt et al., 2002;
Lehnardt et al., 2003). Interestingly, work studying a mouse model of multiple sclerosis
(EAE) observed an increase in CNS TLR 2 mRNA in association with CNS pathology and
the induction of inflammatory molecules (Zekki et al., 2002). In addition, an increase in
human TLR 3 and 4 expression is observed around inflamed blood vessels in multiple
sclerosis (Bsibsi et al., 2002).
In addition, work studying a mouse model of motor neurone disease suggests activation of
innate immunity in the brain exacerbates neurodegeneration. Transgenic mice that possess a
mutant form of super oxide dismutase 1 (which is responsible for 20% of all human familial
forms of the disease), exhibit motor axon degeneration. These mice exhibit elevated levels of
TLR 2 as the CNS degenerates and is an example of innate immune activation that occurs
without microbial stimulus, suggesting innate immunity is activated by endogenously-
derived mediators in addition to microbial components. Motor neurone disease progression
is also enhanced upon chronic LPS stimulation and TLR 2 upregulation closely associates
with disease severity. In this model, despite a robust inflammatory response, there is no
evidence of lymphocyte activation or other acquired immune responses (Nguyen et al.,
2004). In addition to LPS, CpG-DNA is a potent inducer of neuronal injury. CpG-DNA is
not directly toxic to neurones in culture but does initiate neuronal damage in mixed
neurone/glial cultures and in hippocampal slice cultures, suggesting CpG-DNA signals
through glial TLR 9 to initiate production of various neurotoxic molecules such as NO and
TNF-a (Iliev et al., 2004). Together this work suggests the CNS expresses functional TLR
and further highlights the detrimental effects of innate immune responses to CNS cells and
tissue architecture.
Microglia cultured from post-mortem human brain samples express all TLR 1 -9 as measured
by RT-PCR (end product, semi-quantitative PCR). TLR 2 and 3 is also detected in astrocytes
and oligodendrocyte cultures, although since these represent primary cultures, microglial
contamination cannot be excluded. The level of TLR from human to human varies
considerably, however a perceived increase in TLR expression is observed in cultures
derived from donors with neurodegeneration. In addition, TLR 3 and 4 protein expression is
highly variable from cell to cell within a culture and is predominantly intracellular for
microglia and extracellular for astrocytes (Bsibsi et al., 2002).
A recent report has ascertained TLR levels in murine microglia cultures by quantitative RT-
PCR. This work showed microglia express mRNA for TLR 1-9 and that microglia recognise
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a variety of bacterial and virus-associated molecules. Upon stimulation with LPS,
peptidoglycan, poly(I:C) or TMEV infection; cytokine and chemokines are upregulated and
TLR expression levels altered. In addition, stimulation with TLR ligands upregulates
microglial expression of MHC-II and co-stimulatory molecules, enabling microglia to
efficiently present antigens to T cells (Olson and Miller, 2004). Microglial innate immune
responses to Staphylococcus aureus have also been characterised. Cultured N9 microglia
respond to S.aureus by expressing a variety of pro-inflammatory cytokines (Kielian et al.,
2002). The expression of TLR 1, 2 and 6 along with CD14 is enhanced upon in vitro culture
with S aureus as determined by semi-quantitative PCR and FACS analysis, which may serve
to augment microglial activation in situ during CNS infection. In addition, astrocyte cultures
from TLR 2 deficient mice exhibit reduced cytokine responses to S. aureus and particularly
to peptidoglycan. This suggests that S.aureus is indeed sensed by glial cells and that this
recognition is conferred by TLR 2, as is the case for macrophages in the periphery (Esen et
ah, 2004; Yoshimura et ah, 1999).
Primary cultures of murine astrocytes express constitutive levels of TLR 2, 4, 5 and 9 as
determined by RT-PCR and are upregulated following stimulation with various PAMPs
(end-product analysis, semi-quantitative; TLR 1, 3, 6, 7 and 8 were not assayed). Following
PAMP stimulation astroglial NF-kB translocates to the nucleus and IL-6 is expressed,
suggesting that TLR signalling occurs in astrocytes (Bowman et ah, 2003). In this report
protein expression didn't accurately replicate the authors finding for TLR 2 upregulation in
response to flagellin. Furthermore, the semi-quantitative PCR technique was not well
described and no data was given to demonstrate the quantitative nature of the assay - such as
a standard curve or diluting assay (Bowman et ah, 2003). Questions must remain over the
validity of the RT-PCR data from the Bowman et al. papers since the quantitative nature was
not clearly substantiated. There is a clear need for these issues to be further explored using
the more robust quantitative approach of quantitative PCR.
For certain virus infections, mice deficient in specific TLR appear to be protected from
immune-mediated pathology but are more susceptible to higher CNS virus titres. HSV-1
infected TLR 2 deficient mice suffer higher virus titres but importantly exhibit decreased
levels of CNS mononuclear infiltrates, chemokines and serum IL-6, and are resistant to lethal
HSV-1 challenge. This would suggest decreased mortality and inflammation is achieved at
the expense of a concurrent decrease in an ability to clear the virus. A deficiency in TLR 4
does not alter the kinetics of HSV-1 infection. These results suggest that TLR 2-mediated
cytokine responses to HSV-1 are responsible for a portion of the morbidity and pathology
associated with HSV-1 infection (Kurt-Jones et al., 2004). In addition, TLR 3 deficient mice
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exhibit significantly reduced levels of CNS inflammation and pathology upon infection with
WNV (Wang et ah, 2004).
In summary, these reports suggest cultured CNS cells express functional TLR, although TLR
expression in the resting and virally infected CNS remains to be characterised. Preliminary
studies suggest murine glia express TLR in vitro, although this is yet to be confirmed in vivo.
TLR expression is complex and is little understood, especially in the immunospecialised
context of the CNS, and yet deficiencies in TLR result in dramatically altered susceptibility
to CNS infection in the case of TLR 2 and 3. There is clear requirement for a more detailed
and systematic analysis of TLR expression in the CNS.
1.3 Viral encephalitis and neurotropic viruses
The clearance of virus from the CNS requires a finely balanced response that successfully
eliminates the virus without damaging essential non-renewable cells such as neurones.
Fortunately, viral infections of the CNS are relatively uncommon but once initiated are
potentially devastating to the individual. The CNS is particularly susceptible to persistent
viral infections; a combination of the relative inaccessibility of this tissue to
leukocytes/serum proteins and the longevity /non-renewable nature of neurones.
1.3.1 Viral encephalitis is disease of high morbidity and mortality
Viral encephalitis is an inflammatory disease in which viral infection of the CNS often leads
to death or severe neurological defects. The most characteristic histological features include,
perivascular and parenchymal mononuclear cell infiltrates, glial cell activation, and
neuronophagia. A multitude of viruses can cause encephalitis from complex DNA viruses
such as the HSV-1, to simple RNA viruses such as Semliki-Forest virus (SFV). In particular,
there are several positive-stranded RNA viruses that cause encephalitis front the Toguviridut
and Flaviviridae that share several phenotypic and life-cycle characteristics. Representatives
of these two genera have a worldwide distribution, are almost exclusively transmitted to their
vertebrate hosts via an arthropod vector and exhibit a broad range of pathogenicity in
humans and animals (Strauss and Strauss, 1994; Solomon, 2004). Ordinarily, human
infection is incidental to the natural transmission cycle, which is propagated by wild or
domesticated animal populations. However, auxiliary mosquito-borne human-to-human
transmission can be apparent during epidemics of infection. Little can be done for patients
suffering from viral encephalitis apart from basic supportive treatments. Mortality is high
and most survivors are left with severe neurological sequelae (Cotran, 2004). A better
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understanding of the pathogenic mechanisms at play in viral encephalitis would undoubtedly
better inform our understanding of these devastating conditions and enable the development
of therapeutic strategies to combat these diseases.
1.3.2 Alphaviruses are neuroinvasive and infect a wide range of animals
Alphaviruses are positive stranded RNA viruses of the Togaviridae family. There are 23
alphaviruses that are known to cause human illness, which present principally as CNS
infections or as a syndrome of febrile illness and rash (Tsai, 2002). Phylogenetic analysis
suggests these viruses arose in the New World with subsequent introductions into the Old
World (Strauss and Strauss, 1994). They can only be transmitted naturally by arthropods,
primarily mosquitoes, the specificity of which is determined by the vector's ability to
support viral replication in midgut cells, enable dissemination within the arthropod and
exhibit infection of the salivary glands (Tsai, 2002). Natural infections can be observed in a
broad range of animals including birds, mammals, reptiles and amphibians, although only
those hosts that develop elevated blood viremia (>103'5/ml) for several days, contribute to
further viral transmission. Uniquely, horses appear to be particularly susceptible to infection
with alphaviruses and can contribute to amplification of viral levels and facilitate
transmission to other hosts in the immediate area such as humans. The range of animals that
can be infected with alphaviruses is broad; laboratory infection of mice, hamsters, guinea
pigs, rats, rabbits, and non-human primates with encephalitogenic alphaviruses can all result
in the host developing encephalitis (Strauss and Strauss, 1994; Tsai, 2002).
1.3.3 Alphavirus pathogenesis
Following natural infection virus-infected saliva is deposited in extravascular tissue whilst
the mosquito feeds. Similarly, experimental infection with a needle results in local viral
replication that results in Langerhan cell activation, drainage to the local lymph nodes and
consequent activation of the adaptive immune system. Viral replication in the tissues results
in a brief blood viremia, which is severely curtailed by the host's potent interferon response
and then neutralised by antibodies. Alphaviruses can be efficiently neuroinvasive since
viremia is rapidly followed by a CNS infection that passes across the blood-brain-barrier via
infection of the cerebral vascular endothelial cells. In rare cases alphaviruses can enter the
CNS by tracking along peripheral nerves to the olfactory bulb following intra-nasal
infection. CNS pathology reflects both viral and immunopathogenic mechanisms that result
from the expression of cytokines, interferons and other immune mediators such as NO,
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which are important in balancing viral clearance with immune-mediated damage
(Fazakerley, 2002; Tsai, 2002).
In both humans and mice, an age-dependent susceptibility of infants to alphavirus
encephalitis is observed epidemiologically, a phenomenon that may be due to either the
changing susceptibility of neurones to undergo virus-induced apoptosis as they mature or the
changing nature of neuronal circuitry and metabolism as the CNS develops and ages (Griffin
et al., 1994; Allsopp and Fazakerley, 2000). The production of immunoglobulins appears to
be protective and mediates viral clearance from peripheral tissues, the blood and brain
(Griffin and Hardwick, 1997). Whilst it is not understood exactly how antibody mediates
protection functions, studies using Sindbis virus have shown antibodies reactive to the viral
E2 glycoprotein are critical for viral clearance and prevent the release of budding virus
(Griffin et al., 2001).
1.3.4 Several alphaviruses impact upon human health and economically
important animals
Eastern equine encephalitis (EEE) virus was first isolated in 1933 in North America and
results in a severe, often lethal CNS infection in humans. EEE also infects bird populations
and has resulted in several devastating outbreaks in commercial pheasant, turkey, partridge
and emu flocks. The virus is distributed across wide areas of North and South America
although human infection is concentrated in costal areas on the Atlantic seaboard and
directly correlates with the geographic distribution of its mosquito vector Culiseia melunuru,
primarily in freshwater swampland. Fortunately, infection of humans are rare averaging 5 to
10 cases each year in the USA (Tsai, 2002). Western equine encephalitis (WEE) virus
infects humans, horses and bird populations in the western USA, parts of Canada and South
America. Whilst infection rates were relatively high in the 1960's, the disease is now very
rare with only 4 cases reported between the years 1987 and 1998 in the USA (Tsai, 2002). In
contrast Venezuelan equine encephalitis (VEE) virus is a disease of exceptionally high
mortality (up to 40% in some cases) and occurs sporadically as epidemics of infection in
conjunction with epizootic transmission among horses. These epidemics have been recorded
to affect tens of thousands of humans and hundreds of thousands of equine cases; primarily
in Venezuela, Colombia and Central America (Rivas et al., 1997; Tsai, 2002). Horses appear
to be excellent amplifying hosts exhibiting particularly high viremia that facilitate rapid
animal-to-animal transmission by a variety of mosquito vectors (Rivas et al., 1997). In
addition to the alphaviruses that cause encephalitis, there are several genus members that do
not cause encephalitis such as the Chikungunya virus and O'nyong-nyong viruses, which
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cause repeated epidemics of infection throughout the tropics and produce haemorrhagic
symptoms followed by severe joint pains that can last many years post infection in humans
(Deller, Jr. and Russell, 1968; Tsai, 2002).
1.3.5 Flavivirus infections are a major public health concern
Several viruses of the Flaviviridae cause encephalitis in humans across the world. Like
alphaviruses, they can be transmitted by arthropod vectors and result in high viremia
followed by CNS invasion. Japanese Encephalitis virus causes up to 50,000 cases each year
in south-east Asia, one third of which are fatal and of those that survive, half have serious
neurological sequelae. Children and the elderly appear to be particularly susceptible to CNS
infection. The West Nile virus has received much publicity in the past few years due to its
rapid spread across the USA, decimating certain wild bird populations and resulting in over
6,000 cases of human encephalitis in 2003/2004 alone. In continental Europe, tick-borne
encephalitis continues to be a public health concern (Solomon, 2004). Clearly there is an
urgent need to elucidate pathogenic mechanisms and develop therapies for these diseases.
1.3.6 Semliki Forest virus (SFV) is an experimental model of viral
encephalitis
1.3.6.1 SFV is a member of the alphavirus genus of Togaviridae
Like all members of the Togaviridae family, SFV is a small icosahedral virus that possesses
a positive stranded RNA genome of approximately 11Kb that possesses a 5' cap and is
polyadenylated. SFV possesses an icosahedral capsid and is enveloped by a lipid bilayer
(hence the name Togaviridae coming from the Latin "Toga" meaning "cloaked"). SFV
occurs naturally in Africa where it infects horses, humans and its mosquito vector (Aedes
aegypti) from whence it was originally isolated in the Semliki forest of Uganda (Mathiot et
al., 1990; Smithburn and Haddow, 1944). Since its identification 60 years ago it has been
extensively used in the laboratory. There are a variety of strains with differing levels of
virulence and include the prototype L10 strain and SFV4 strain that invariably result in fatal
fulminant panencephalitis upon introduction to the mouse host. As such, they have been
classified as being virulent strains (Pusztai et al., 1971; Glasgow et al., 1991; Santagati et al.,
1995). Several avirulent strains have also been used extensively in the laboratory, such as the
A7(74) strain that results in a mild, transient encephalitis that upon viral clearance results in
a chronic demyelinating disease that mimics several characteristics of human demyelinating
diseases such as Multiple Sclerosis (Fazakerley and Walker, 2003; Fazakerley, 2004).
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The RNA genome of SFV is infectious upon transfection into cultured cells as is the RNA
from in vitro transcribed cDNA plasmids that encode the genome. These properties have
been exploited to rapidly generate mutants and are the basis for the SFV vector system that is
used extensively for recombinant expression in eukaryotic cells, and which has much
promise for use as transient gene therapy and in vaccine technologies (Berglund et al., 1996;
Fleeton et al., 2001; Morris-Downes et al., 2001; Atkins et al., 1999).
1.3.6.2 SFV replication
Upon entry to the cytoplasm, the RNA genome of SFV can act directly as a message RNA.
Replication of the genome is via a negative strand intermediate that gives rise to a full-length
genomic RNA copy and a subgenomic message that represents the 3' third of the genomic
RNA. The subgenomic RNA species encodes the structural genes of SFV; the capsid protein
C, followed by the envelope glycoproteins E2, E3 and El. The full-length genomic RNA
species encodes from 5' to 3' four non-structural proteins termed nsPl, nsP2, nsP3 and nsP4
that are involved in viral RNA replication, followed by the structural genes listed above. The
presence of a particularly potent sub-genomic promoter, located immediately upstream of the
structural genes, leads to the synthesis of many sub-genomic RNA copies, such that during
the course of infection the sub-genomic species out-numbers the full length RNA species.
This leads to many copies of structural proteins per copy of RNA genome during the
assembly of mature virus (Strauss and Strauss, 1994; Lemm et al., 1994).
The cellular receptor by which SFV binds to is yet to be elucidated, although limited data has
suggested MHC-I molecules (Helenius et al., 1978). It is known that the virus enters the cell
via the endosomal route (Marsh et al., 1984). Fusion of endosome with lysosomal creates a
highly acidic environment that alters the conformation of the El glycoprotein, triggering the
fusion of viral and endosomal membranes (Kielian and Helenius, 1985; Omar and Koblet,
1988; Wahlberg and Garoff, 1992). Upon fusion, the capsid is liberated into the cytoplasm
and RNA synthesis begins in association with smooth membrane structures termed
cytopathic vacuoles (Grimley et al., 1968; Grimley and Friedman, 1970). Complexes of
capsid and viral RNA migrate to underlie the plasma membrane and viral budding occurs
(Pathak and Webb, 1978).
1.3.6.3 Entry of SFV into the host
The natural transmission of the virus is via its mosquito vector, which directly transfers virus
into venous blood and extravascular tissue. Experimentally, several routes of inoculation
have been used to study SFV pathogenesis (Bradish et al., 1971; Bradish et al., 1975).
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Following intraperitoneal inoculation the virus replicates in peripheral muscles - including
the skeletal, cardiac and smooth muscle (Amor et al., 1996; Pusztai et ah, 1971). Viral
replication is exceptionally rapid producing a high titre viremia within 24 hours that peaks at
48 hours and is rapidly cleared by innate immune mechanisms that are yet to be
characterised along with neutralising IgM antibodies (Fazakerley et ah, 1993; Pusztai et ah,
1971). All strains of SFV are neuroinvasive and readily cross the BBB by infecting the
cerebral endothelial cells to initiate foci of perivascular CNS infection (Fazakerley et ah,
1993; Soilu-Flanninen et ah, 1994).
SFV can also be directly inoculated into the brain that results in a more extensive CNS
infection; the white matter tracts are particularly susceptible to infection via this route.
Alternatively, SFV can be introduced to the CNS via intra-nasal inoculation in which the
virus directly infects the olfactory neurones that terminate in the nasal passage. Virus then
spreads along the olfactory nerves to infect the olfactory bulbs in the brain (Kaluza et ah,
1987; Oliver and Fazakerley, 1998). SFV can readily infect certain neuronal populations and
oligodendrocytes, although astrocytes tend to be refractory to infection as determined by
immunostaining of infected brain (Balluz et ah, 1993; Amor and Webb, 1988; Atkins et ah,
1999).
1.3.6.4 Productive and restricted replication
Virulent strains such as SFV4 and L10 can spread rapidly across the brain from the initial
perivascular sites of infection. Accordingly, mice infected with virulent strains develop
fulminant panencephalitis, and die three to four days post infection (Fazakerley et ah, 1993).
Conversely, the dynamics of infection with avirulent strains such as A7(74) varies
dramatically with the age of the host. Neonates cannot contain viral spread within the CNS
and develop panencephalitis that leads to death within 48 hours. Fascinatingly, once mice
have matured to 14 days of age they can successfully restrict the spread of the SFV A7(74)
to the initial sites of perivascular CNS infection. This finding was dramatically illustrated in
a study that showed 100% of infected mice aged 12 days died upon infection with A7(74),
whilst 100% of infected mice aged 14 days survived infection with the same batch of virus
(Fleming, 1977; Oliver and Fazakerley, 1998). Age-related mortality appears to be a
fundamental characteristic of many viral encephalitides in both animals and humans. For
example, Japanese Encephalitis exhibits a mortality that is far higher in young children
(Solomon, 2004).
Several key studies have suggested the maturity of the adaptive immune system has little to
do with these dramatic age-related differences, since adult mice completely lacking T cells
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or mice lacking both B or T cells, and hence not capable of mounting adaptive immune
responses, do not succumb to fatal panencephalitis upon infection with avirulent strains
(Amor et al., 1996; Fazakerley and Webb, 1987c; Fazakerley et al., 1993). Rather it appears
to be the maturity of the neurones and the state of neuronal connectivity in the developing
mouse brain that determines whether avirulent SFV strains can spread across the brain.
Indeed, it appears that the propensity for neurones to facilitate viral replication and release
new virus alters as they mature and their connections with their surrounding neurones
changes. Interestingly, these studies also highlight that the propensity for neurones to
undergo viral-induced apoptosis changes as neurones mature, such that adult neurones are
refractory to apoptosis upon infection. Many cells of the periphery upon infection undergo
"altruistic" cell suicide- a phenomenon widely believed to be an evolutionary ancient
strategy of multi-cellular organisms to limit viral infection. Neurones appear to be an
exception to this rule exhibiting a rather "selfish" failure to undergo apoptosis, presumably
due to their irreplaceable nature (Allsopp et al., 1998; Allsopp and Fazakerley, 2000; Oliver
and Fazakerley, 1998; Oliver et al., 1997). The role that the adaptive immune response plays
in limiting viral spread in the CNS of neonates is of little consequence since the mice die
before any meaningful response can be initiated. There have been no studies that have
addressed the role that the innate immune system may play or whether its maturity changes
upon development.
The ability of virulent SFV strains to spread across brain is little understood. SFV4 infection
spreads across the brain within two to three days, occurring before a naive adaptive immune
system can respond. Putatively, the ability of SFV4 to spread across the brain may be due to
either or both circumvention of the host innate immune response, along with an ability to
replicate in mature neurones that the A7(74) strain lacks.
The genetic loci that determine the virulence of differing SFV strains remains only partly
characterised. In common with several other alphaviruses, mutations introduced into viral
glycoproteins alter virulence. Viral glycoproteins are a fundamental constituent of the mature
virus and mediate binding to host cells and fusion with host membranes. Chimeric SFV4
engineered to express the E2 glycoprotein from the avirulent A7(74) strain is apathogenic
upon infection into mice, suggesting the avirulent nature of A7(74) is partially conferred by
RNA sequence of the E2 gene. Single amino acid changes in the structural proteins can also
attenuate the virus in vivo (Santagati et al., 1995). However, further work has cast some
doubt on these studies, suggesting that the attenuation of viral pathogenicity in these studies
is due to the incompatibility of differing spike proteins that when recombined from differing
strains affects functionality. Indeed, when all the structural genes of SFV4 were completely
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replaced with those from A7(74), the recombined virus was still lethal and highly virulent
(Tuittila et al., 2000). Thus, it is unclear what contribution the structural genes of SFV make
towards virulence. Conversely, work has demonstrated that the non-structural genes have a
curial role in determining virulence (Tuittila et al., 2000). Successive mutations in the nsP3
gene of SFV cumulatively affect neurovirulence (Tuittila and Hinkkanen, 2003). In addition,
work has suggested that variations in nsP2 sequence may alter virulence. nsP2 is involved at
a number of critical stages of viral replication. Uniquely, nsP2 possesses a nuclear
localisation signal that mediates translocation to the nucleus; suggesting nsP2 may possess
additional roles besides its roles in RNA replication (which occurs solely in the cytoplasm).
When this gene is mutated at a single codon in the translocation signal, nsP2 is confined to
the cytoplasm and does not enter the nucleus (Fazakerley et al., 2002; Rikkonen, 1996).
Critically, this mutant is less virulent in vivo, exhibiting lower viral titres and limited spread
throughout the brain compared to the wild-type SFV4 strain. Thus, minor alterations to the
primary amino acid sequence of the replicase genes can have a considerable effect on in vivo
virulence (Fazakerley et al., 2002). Studies that have utilised Sindbis virus (a close relative
of SFV in the alphavirus family), have also shown non-structural proteins can contribute to
differing levels virulence (Heise et al., 2000). The mechanism of this virulence is yet to be
characterised, although virus with nsP2 mutations differentially modulate the host's
interferon response. This work demonstrated that mutated nsP2 induces far more type I IFN
upon infection, along with more pronounced activation of 170 IFN-inducible genes
suggesting wild-type nsP2 most likely acts by decreasing IFN production and thus
minimising virus visibility to the host (Frolova et al., 2002).
1.3.6.5 Immune responses to SFV
Immunocompetent Balb/c mice clear avirulent strains of SFV from the blood within 3 days
and from the brain within 8 days after intraperitoneal infection (as measured by plaque assay
that measures infectious virus only) (Fazakerley et al., 1993; Suckling et al., 1978). Limited
work using RT-PCR has demonstrated viral genes can be detected several weeks post
infection in the brain, although this remains to be confirmed (Donnelly et al., 1997). Levels
of neutralising IgM antibodies are detected in the blood within the first few days post
infection, followed by the production of IgG2a antibodies and finally a slow IgGl antibody
production that persists for several weeks (Fazakerley et al., 1993). The blood brain barrier
becomes leaky between day 4 and 10 post infection, permitting the passage of
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immunoglobulins and leukocytes into the brain, with inflammation peaking at day 7 post
infection (Parsons and Webb, 1982; Soilu-Hanninen et ah, 1994).
Adult mice that lack T cells (nu/nu) can also survive an infection with the avirulent A7(74)
strain without developing panencephalitis. As in fully immunocompetent animals, levels of
neutralising IgM antibody rise within the first few days, however IgG antibodies can not be
detected since the lack of T-cells prevents class switching in B cells. These mice clear blood
viremia as normal and the systemic infection is controlled - presumably due to the potent
anti-viral effects of interferon and the production of IgM antibodies that bind to and
neutralise blood-borne virus. However, these mice cannot clear infectious virus from the
brain and exhibit a life-long persistent CNS infection that appears to be otherwise sub¬
clinical (Amor et al., 1996; Fazakerley and Webb, 1987c). Adult mice that lack both T cells
and B cells (Scid) can also survive infection with A7(74) for several weeks and like nu/nu
mice, do not develop panencephalitis. These mice can produce neither cell-mediated immune
responses nor neutralising IgM antibodies. Scid mice cannot clear infectious virus from
either the blood or brain and eventually die, most probably from systemic infection rather
than a neurological cause. Adoptive transfer studies with infected Scid mice have
demonstrated that introduction of serum from infected nu/nu can mediate clearance of blood
viremia, demonstrating that IgM is sufficient to clear blood viremia (Amor et al., 1996;
Suckling et al., 1982). Transfer of serum from immunocompetent Balb/c mice, which
produce both IgG and IgM antibodies, to infected Scid mice clears the majority of infection
from both the periphery and the CNS, however some infectious virus remains, suggesting
that cell-mediated responses are necessary for complete CNS clearance (Amor et al., 1996).
Primarily, these studies inform us of the differential roles that antibodies have in clearing
virus in immunocompetent mice. Secondarily, they reaffirm the potency of the innate IFN
response, which protects the mouse for so long from succumbing to viral overload in the
absence of an adaptive immune response.
Interestingly, immunocompetent mice develop lesions of inflammatory demyelination
throughout the oligodendrocyte-rich white matter tracts of the brain (Kelly et al., 1982;
Suckling et al., 1978). Neither nu/nu nor Scid mice develop demyelination despite the
persistence of virus, suggesting that an adaptive immune system is critical for both clearance
of CNS virus and for the development of SFV-induced demyelination (Amor et al., 1996).
Further studies have highlighted the critical role that T cells play during SFV-induced
demyelination. Experiments in which mice are immunosuppressed by either total body
irradiation, cyclosporin, cyclophosphamide or cycloleucine all demonstrate T cell responses
are pathogenic and are required to generate lesion of demyelination (Amor and Webb, 1987;
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Fazakerley and Webb, 1987c; Fazakerley and Webb, 1987b; Fazakerley and Webb, 1987a;
Fazakerley et al., 1993). In addition, experiments in which CD8+ cells were depleted with
the use of monoclonal antibodies demonstrated that cytotoxic T cells were responsible for
mediating demyelination, whilst depletion of CD4+ T cells greatly reduced CNS
inflammation but not demyelination (Subak-Sharpe et al., 1993).
Several cytokines characteristic of a pro-inflammatory response can be readily detected
within the CNS 7 days post infection, including; IL-lcx, IL-1|3, IL-3, -6, -10 and TNF-a
(Morris et al., 1997). The cytokine profile along with the initial production of IgG2a
followed by a slow IgGl response both suggest that a Thl T cell response is initiated upon
SFV infection and is followed by a Th2 immune response (Fazakerley, 2004).
Cellular immune responses during SFV infection have also been characterised; 4 days post
infection onwards one can observe infiltrating mononuclear and perivascular cells, with the
influx peaking at day 7 post infection (Parsons and Webb, 1982; Morris et al., 1997). The
areas of SFV infection and cellular infiltrate coincide as does the activation of microglia and
astrocytes. These glial cells can be found to upregulate their MHC-II expression so that it
becomes detectable by immunocytochemistry. Otherwise little is known concerning the role
microglia and astrocytes play during SFV pathogenesis. In response to infection, endothelial
cells upregulate adhesion molecules, such as VCAM1 so that blood-borne leukocytes can
enter the CNS (Morris et al., 1997; Soilu-Hanninen et al., 1997). The majority of infiltrating
cells appear to be MHC-II negative and primarily constitute CD8+ T cells, although some B
cells can also be found (Amor et al., 1996; Morris et al., 1997).
Remarkably, there are few studies that have studied the innate immune responses of viral
encephalitis and SFV is no exception. Levels of type-I IFNs parallel viremia following
intraperitoneal infection of SFV and mice engineered to lack a functional IFNa/p receptor all
die within 48 hours post infection (Bradish et al., 1975; Muller et al., 1994; Fazakerley et al.,
2002). The course of death in these animals appears to be extraneural with wide-spread
infection of peripheral organs, most notably the exocrine pancreas (Fazakerley, 2004).
Intracerebral inoculation of virus results in a widespread infection of oligodendrocytes,
meningeal and ependymal cells (infection of the latter two cell-types rarely is observed in
wild-type mice). Interestingly, the limited infection of neurones remains a feature of SFV
infection in IFNR deficient mice, indicating the restricted replication of avirulent SFV in
mature neurones is independent of type-I interferon responses (Fazakerley, 2004). The extent
to which each differing sub type of IFN is induced and the roles they play resisting viral
replication remains to be determined. There are no publications relating to how CNS cells
sense SFV infection and whether Toll-like Receptors are involved in SFV recognition. In
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fact, it is not clear whether TLR are expressed in the resting mouse brain. Fundamentally, it
is not clear how the CNS senses virus or others infections, or how immune responses are
initiated and implemented.
1.3.7.5 Summary: SFV as a model for viral encephalitis
SFV is closely related to several viruses that impact upon human and animal health, such as
eastern, western and Venezuelan equine encephalitis viruses. The pattern of disease and
mechanisms of pathology are analogous to diseases caused by several flaviviruses that
greatly impact on human health, such as Japanese Encephalitis virus. Thus, studying the
pathogenesis of SFV better informs our understanding of not only SFV but also of several
clinically relevant viruses that cause encephalitis in humans. Studies on SFV pathogenesis
also help us to better understand the more fundamental interactions between neurotropic
viruses, the CNS and the immune system - interactions that are likely to be fundamental to a
multitude of encephalitides. Laboratory infection of mice with SFV provides one model
system to address the many unexplained puzzles of viral encephalitis.
1.4 Amyloid-related diseases
Amyloid is a term used widely to describe an aggregation of insoluble matter that can be
visualized under standard histopathological examination. It commonly manifests as an
amorphous extracellular substance that, with progressive accumulation is associated with
atrophy in adjacent cells. The phrase, coined by pathologists in the early half of the 20th
century is now, in the molecular era, known to describe a whole variety of protein aggregates
whose subunits can differ widely in their composition. Common features of amyloid are its
high content of cross (3-pleated sheet folded proteins, its non-branching fibrils of indefinite
length as seen under electron microscopy and its almost absolute association with pathology.
The role of amyloid has been implicated in a whole variety of diseases from type II diabetes
to conditions of neurodegeneration such as Creutzfeldt-Jakob disease (CJD) and Alzheimer's
disease, although the exact cellular and molecular mechanisms that underlie this involvement
are not well characterized (Cotran, 2004).
1.4.1 The Prion diseases
The deposition of abnormally folded protein in a pathological setting has been much studied
in the context of neurodegeneration, especially in respect to the prion diseases and in
Alzheimer Disease. Prion diseases (also referred to as transmissible spongiform
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encephalopathies) are rare, invariably fatal neurodegenerative diseases of animals and
humans. They present as a highly heterogeneous group of disease that can be divided into
three groups: familial, acquired and sporadic (Rrown e,t al., 1994). Familial prion diseases
are all associated with inheritance of an abnormal form of the Prion Protein (PrP) gene.
Prion diseases can also be acquired via contact with infectious tissue that has originated from
a diseased animal. However, the majority of cases in humans are still classified as sporadic
with the cause of these devastating diseases still a mystery. In the past few years the
awareness of prion disease has been heightened with the appearance of bovine spongiform
encephalopathy and its highly probable ability to spread to humans as variant CJD via the
consumption of BSE -infected meat (Bruce et al., 1997). Current modelling suggests that the
total number of new variant CJD cases could be anything between 600 and 136,000
depending on the incubation period of the disease agent (Ghani et al., 2000).
Prion diseases have several distinguishing characteristics." primarily they represent a group of
uniquely transmissible amyloid-related diseases; additionally they all share a pathology that
presents as a spongiform degeneration of the brain under histopathological examination.
Accompanying this is the appearance of activated glial cells and the concurrent formation of
abnormal aggregates that primarily consist of an aberrant, protease-resistant form of PrP
known as PrPSc. High levels of neuronal apoptosis are a salient feature of prion diseases and
often lead to gross atrophy of the brain, with extreme pathology centred around PrPSc
deposition (Masters and Richardson, Jr., 1978). The clear association of PrPSc deposition
with pathology has lead to the hypothesis that the presence of PrPSc is responsible for the
pathogenic effects of prion diseases (Prusiner, 1998).
The cellular form of PrP (PrPc) is protease sensitive and is found expressed as a GPI-linked
cell surface protein of unknown function. PrPSc is generated in a post-translational process
as PrPc transforms into PrPSc. Both PrPc and PrPSc possess identical primary structures, the
critical difference between them being the three-dimensional folding of their amino acid
chains. PrPc is mostly alpha helical in structure whilst PrPSc appears to have a high
composition of (3-pleated sheets, giving PrPSc an ability to form large polymeric aggregates
(Riek et al., 1996). To explain these puzzling infectious diseases, Pruisner proposed a
protein-only prion hypothesis whereby an infecting PrPSc molecule binds to it's cellular
counterpart PrPc and converts it into a conformation identical to that of the infecting PrPSc
molecule - a process that does not require the presence of a genome on the part of the
pathogen (Prusiner, 1998).
The physiological function of PrPc is not known although PrP is not essential for viability, as
knockout mice appear to be fertile and healthy. However, cultured neurons from these mice
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do appear to be far more susceptible to oxidative damage (Milhavet et al., 2000). The
expression of PrP is an absolute requirement for susceptibility to prion diseases, which has
led to speculation that either PrP is the critical component of the etiological agent, since no
PrPc is available for conversion, or that PrPc acts as a receptor for the agent (Weissmann,
1999). Interestingly, it appears that transgenic mice that express low levels of PrPc appear to
be more tolerant to PrPSc infection (Fischer et al., 1996). Conversely mice over expressing
PrPc require very little PrPSc before clinical symptoms appear (Bueler et al., 1994). However,
it should be noted that the expression of PrPcis clearly not the only factor that determines the
susceptibility of cells to undergo PrPSc-induced cell death. The Purkinje neurons of the
cerebellum strongly express PrPc and yet are comparatively resistant to cell death, whilst
other neuronal populations with similar PrPc expression levels are severely affected
(Kretzschmar et al., 1986). Additionally, non-CNS PrPc expressing cells such as follicular
dendritic cells or peripheral neurons exposed to PrPSc during the course of an infection, do
not suffer from obvious degeneration (Mabbott and Bruce, 2001). Nevertheless, Prion
diseases represent an amyloid-related disease whose CNS-centred pathology seems to rest on
the presence of abnormal polymeric PrPSc molecules.
Prion diseases characteristically exhibit an absence of immune responses. Indeed,
conceivably it may be that the inability of the host to respond and clear Prl^ infection is
directly attributable to the absence of an immune response (Mabbott and Bruce, 2001).
Disease progression is unaffected in mice lacking T cells or B cells, whilst mice engineered
to express antibodies specific to PrP fail to propagate infection, suggesting the initiation of
an adaptive immune response can halt and even prevent disease (Heppner et al., 2001)
Despite the lack of an adaptive immune response, glial cells become highly activated -
particularly towards terminal disease (see section 1.4.3). The absence of an immune response
to prions suggests they lack the immunogenicity to activate adaptive immune responses.
When mice are exposed to CpG-DNA as a prophylaxis post scrapie infection, the incubation
time is extended by 40%, and even longer following repeated CpG-DNA inoculation. This
rather surprising finding is most likely due to activation of TLR 9 signalling in cells of the
innate immune system such as macrophages that conceivably upregulate antigen presentation
and initiate a limited adaptive immune response that delays disease progression (Sethi et al.,
2002). This interesting possibility is not unlikely since the ability of CpG-DNA to induce
resistance against other diseases has been demonstrated in mice (Zimmermann et al., 1998).
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1.4.2 Alzheimer's disease (AD) and the amyloid cascade hypothesis
AD is a progressive dementing neurological illness that affects hundreds of thousands of
predominately elderly people in the developed world and hence is one of the largest areas of
pharmaceutical research. Similar to prion diseases the deposition of amyloid fibrils appears
to be central to pathology, although AD appears to be non-transmissible upon inoculation in
animal models. The major hallmark of AD pathology is the presence of senile plaques - a
tangled focus of inflammatory cells that centres on an aggregation of abnormal (3-amyloid.
The amyloid cascade hypothesis states that the inappropriate cleavage of the Amyloid
Precursor Protein results in the production of pathogenic amyloid fibrils (as reviewed by:
(Selkoe, 1999)). These fibrils are proposed to be intrinsically neurotoxic, causing a cascade
of changes within a neuron that leads to its eventual destruction (Hardy and Higgins, 1992).
In addition, the identification of activated microglia within AD plaques, coupled with the
presence of numerous inflammatory proteins suggests that inflammation is an integral part of
the neurodegeneration. It has been proposed that the continued presence of (3-amyloid
plaques persistently activates microglia; a process that results in chronic "inflammation"
(Meda et al., 1995; Benveniste et ah, 2001). Consequently, it has been suggested that the
activation of microglia may play a key role in the pathogenesis of this amyloid related
disease.
1.4.3 The role of microglia during neurodegeneration
Central to research within the field of prion diseases is the question of whether the toxicity of
the PrPSc is due to the gain or loss of function of PrPSc. The primary mechanism by which
PrPSc asserts its pathogenic effects is yet to be fully elucidated, however it is probably a
combination of two mechanisms. The gain of function hypothesis states that as P rP converts
to the PrPSc form, it gains the ability to be directly or indirectly toxic to cells. Alternatively,
the conversion of the physiological PrPc to its non-functional counterpart will impart an
induced knockout phenotype to an infected cell that could feasibly affect its survival (Giese
and Kretzschmar, 2001). The microglial cell appears to be a central component of these
pathogenic mechanisms by contributing to neuronal death following PrPSc infection, whilst
the action of microglia in AD has also been tightly coupled to that of neurodegeneration
(Minagar et al., 2002). Microglia are activated in all known cases of prion disease and in
numerous other neurodegenerative conditions. Critically, it now appears that microglial
activation is not only strictly associated with neurodegeneration (and hence PrPSc deposition)
(Williams et al., 1994), but precedes neuronal death, as originally demonstrated in the
hippocampus of mice infected with the 301V strain of BSE (Williams et al., 1997a).
61
Chapter 1 Introduction
Additionally, a large time course study using three different strains of scrapie demonstrated
microglial activation occurred early during the incubation period, with activation clearly
occurring before significant neuronal apoptosis and prior to the onset of clinical symptoms in
all the models studied (Giese et al., 1998).
Convincing in vitro evidence suggests that for the toxicity of prion fragments to be fully
realized, microglia must be present in CNS cultures. Brown et al. showed that pre-treatment
of primary neuronal/glial cultures with L-leucine methyl ester (LLME) effectively removes
all microglia from cultures and attenuates PrPSc toxicity. Further addition of untreated
microglia restores the toxicity of PrPSc and high levels of neuronal apoptosis occurr. More
recently another group has further elucidated the killing of prion-damaged neurones by
microglia and shown that microglia-mediated killing is cell-mediated and requires cell-to-
cell contact (Brown et al., 1996; Bate et al., 2001; Bate et al., 2002).
Taken together the above observations support the idea that microglial activation and its
association with amyloid-induced pathology appears to be similar in several diseases of
neurodegeneration, irrespective of differences in aetiology, or composition of amyloid.
1.4.4. The role of PRR in the recognition of altered self
A growing consensus is emerging that PRR not only recognize the unique molecular patterns
associated with microrganisms, but also unique molecular patterns that are generated in a
variety of homeostatic and disease processes. Scavenger receptors and CD14 are well
characterised as receptors for both bacterial components and apoptotic cells (Savill et al.,
2002). The process of apoptosis involves the expression of several novel markers, such as
phosphatidylserine, that label cells as dying. Thus, receptors that recognise both non-self also
recognise the altered self of apoptotic cells.
PRR may also have a role to play in the pathogenesis of atherosclerosis. This disease process
involves the accumulation of oxidised low-density lipoprotein in blood vessels that attracts
and activates immune cells, primarily macrophages. Atherosclerotic lesion progression has
been shown to depend on persistent, chronic inflammation in the artery wall and this
inflammatory reaction leads to increased thickening of vasculature that can eventually
precipitate blockage of the vessel. MyD88 and TLR 4 deficient mice demonstrate a reduction
in atherosclerosis through a decrease in macrophage recruitment to the artery wall and
associated reduced chemokine, cytokine and prostaglandin levels (Bjorkbacka et al., 2004;
Michelsen et al., 2004), whilst TLR expression was significantly upregulated in
atherosclerotic plaques in humans (Edfeldt et al., 2002). Thus, the presence of an altered
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form of a host protein, oxidised low-density lipoprotein, engages a pro-inflammatory
signaling cascade that is also engaged by microbial pathogens.
The initial stimulus that activates microglia in TSE is likely to be the abnormal form of the
prion protein, PrPSc. In the prion infected brain, PrPSc can be found as polymers of repeating
units in the form of amyloid fibrils (Wille et al., 2002). Potentially these abnormal repeating
patterns may be recognised by PRR such as TLR and trigger a response more appropriate for
defence against pathogens than endogenously derived protein, be they infections in the case
of TSE, or non-infections as in the case of AD. Surprisingly antibodies that have been raised
against DNA also recognise PrPSc (but not PrPc), suggesting DNA and PrPSc share a repeat
motif that may be recognised by TLR in addition to antibodies (Zou et al., 2004). Several
studies have suggested PRR are involved in the recognition of amyloid and the pathogenesis
of neurodegeneration; CD14 binds |3-amyloid and is upregulated in mouse models of AD
(Fassbender et al., 2004), whilst microglia deficient in CD14 cannot kill neurones through |3-
amyloid induced inflammation (Bate et al., 2004); and mice deficient in CD36 have marked
reductions in the recruitment of microglia following (3-amyloid injections and secrete lower
levels of neurotoxic, inflammatory mediators (El Khoury et al., 2003). Together this suggests





Toll-like receptors are a family of pattern recognition receptors that recognise a broad
spectrum of microbial components. Expression of these receptors confers the ability to
innately sense infection and initiate differential signalling cascades that are specific to the
pathogen type. The resting brain is separated from the systemic circulation by the blood
brain barrier and has no obvious immune process. Lymphocytes, dendritic cells and other
leukocytes are absent, whilst the expression of MHC, complement and other immunological
molecules are almost non-existent. Despite the apparent immunoprivileged environment,
immune responses can be generated. Glial cells have been proposed to fulfil some immune
function in the CNS. They are activated in numerous disease states in vivo and by microbial
components in vitro. The mechanisms by which glia are activated continue to be
characterised. There has been a substantial amount of interest and research in TLR function
in the past few years, although there has been comparably little in respect to TLR in the
brain. TLR expression continues to be characterised in cultured neural cells although TLR
expression in the CNS is yet to be studied. It is highly likely that glia express TLR along
with other PRR. Microglia are the principal phagocyte of the CNS, can express high levels of
cytokines and activate adaptive immune responses, although they are not analogous to tissue
macrophages found in other organs. Astrocytes may contribute to CNS immune responses
through the production of pro-inflammatory mediators and interferon in addition to their
roles as support cells to neurones. It is highly likely that the expression of TLR on both cell
types provides one mechanism by which these intriguing cells are activated. TLR signalling
in the infected CNS would trigger inflammatory processes and synergise adaptive immune
responses. SFV is efficiently neuroinvasive and initiates encephalitis. Viral encephalitis
results in substantial morbidity and mortality in humans and animals, and underlines the
sensitivity of the CNS to immune processes and inflammatory reactions. The role that
microglia play in the initiation and perturbation of inflammation is yet to be fully defined,
although the expression of TLR and associated inflammatory responses to virus by glia
would further emphasise the pro-active role glia has in this process. In addition, it is likely
that any TLR expression change during viral infection will reflect the nature of the infections
agent and those TLR involved in recognition of virus are likely to be upregulated.
The level of TLR expression imparts differing sensitivity to microbial components. It is
highly likely that glia dynamically regulate TLR in an appropriate and specific manner.
Macrophages down regulate TLR 4 upon exposure to LPS and become refractory to further
stimulation by endotoxin. Similarly, glial cells are likely to respond to microbial challenge
by altering TLR expression. The mechanisms that regulate TLR expression are little
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understood. Conceivably, direct binding of microbial components to cell surface receptors
may signal to alter TLR expression. In addition, cytokines and interferon may by themselves
further augment TLR expression in an autocrine and paracrine manner. It is likely that during
the specific case of virus infection, interferon signalling will alter TLR expression.
The expression of TLR in the brain has implications for both infectious disease and diseases
of chronic neurodegeneration. Glia become activated in the degenerating brain and are
closely associated with neuronal damage. It is possible that glia are activated by TLR in
numerous disease states including prion disease. Glia upregulate several makers of innate
immune activation in the prion infected CNS and it is likely that some TLR are also
upregulated. In addition to their substantiated role in recognising non-self, PRRs (including
TLR) may also function to recognise altered-self, such as oxidised LDL in atherosclerosis
and the abnormal repeating patterns of amyloid in disorders of neurodegeneration. The exact
nature of the infectious agent in prion disease is still a matter of debate; nevertheless it is
likely that infection of mice with scrapie will result in changes in TLR as a consequenos of
CNS infection and homeostatic perturbation. In addition, there is a distinct possibility that
microglia and other phagocytes utilise PPR to recognize the repeating patterns of amyloid
fibrils. It is conceivable that microglia aberrantly recognize amyloid fibrils as a pathogen
associated molecular pattern and respond accordingly. The binding properties of PRR are
fairly plastic so that they can bind common "molecular signatures" which vary among
different species within a given class of microrganism and endogenous ligands. Thus a
particular PRR may be able to bind and become activated to both an exogenous pathogen
and an endogenous, aberrantly folded protein. Indeed, TLR2 is capable of recognising a vast
range of different patterns (see table 1), whilst TLR4 can recognise both LPS - an exogenous
molecular pattern, and the endogenous Heat Shock Protein 60 protein, whilst another PRR,
CD14, can bind both LPS and the unique molecular patterns exposed on the surface of
apoptotic cells. The molecular patterns of amyloid fibrils are unlikely to have been a major
selective pressure during evolution of the immune system and there would have been little
chance for the development of tolerance, since the unique repeating pattern of PrPSc or of (3-
amyloid is one that is generally only present once reproductive age has passed.
Microarrays and quantitative real time PCR (QPCR) are sophisticated methodologies that
permit analysis of gene expression. It is likely that these expression technologies will
provide useful in characterising glial and CNS responses to infection and stimulation, with
particular emphasis on TLR expression.
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1.6 Aims and objectives
This thesis aims to characterise the innate capability of glia and CNS tissue to recognise
infection. This will be undertaken by studying the expression profile of PRR, particularly
TLR, using microarray and QPCR technology.
To achieve this aim a series of objectives have been identified:
1.) To design, validate and utilise a novel custom microarray to assay levels of gene
transcripts on microglia involved in innate immune responses, and will involve;
• assaying all known PRR, a panel of cytokines, chemokine and stress-associated
gene transcripts
• designing suitable probes for microarray analysis and array layout
• determining experimental procedures for generating optimal microarray signal
• optimising the ability of the microarray platform to generate reproducible signals
and minimise variation
• validating the ability of the microarray to discern changes in gene expression
• determining gene transcript changes in microglia stimulated with a classical
innate immune stimulus, LPS and upon infection with SFV
2.) To design a reliable and sensitive QPCR protocol for assaying gene expression;
• to determine the expression of all known murine TLR
• to determine expression of several key pro-inflammatory cytokines and IFN
3.) To grow cultures of neural cells and determine TLR expression:
• at rest
• following stimulation with LPS
• following infection with SFV
4.) To determine the extent of TLR expression in vivo and specifically:
• whether TLR are expressed in the resting/uninfected brain
• whether TLR are expressed in the virus infected brain
• whether TLR expression alters during the course of infection, whether this
requires T-cell infiltration and whether this is specific and appropriate to the
pathogen
• whether a functional IFN system is required for TLR expression changes
• whether CNS TLR expression is modulated during the course of prion infection
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2 Materials and methods
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2.1.1 Cell culture
N9 microglia and N2a neurobalstoma cells were a kind gift from Alun Williams (Institute of
Comparative Medicine, Department of Veterinary Pathology, Glasgow University
Veterinary School, Bearsden Road, Glasgow). N9 cells express typical markers of resting
mouse microglia and have been extensively used as representatives of primary mouse
microglial cells (Ferrari et ah, 1996; Meda et ah, 1995; Righi et al., 1989). N9 cells were
grown in RPMI supplemented with 5% heat-inactivated foetal calf serum, 2 mM glutamine,
100 units/ml penicillin and 100 pg/ml streptomycin at 37°C/5%C02. The N2a cell line was
established by R.J. Klebe and F.H. Ruddle from a spontaneous tumour of a strain A albino
mouse (Olmsted et ah, 1970) and was grown in DMEM supplemented with 5% heat-
inactivated foetal calf serum, 2 mM glutamine, 100 units/ml penicillin and 100 pg/ml
streptomycin at 37°C/5%C02.
J774.1 macrophages are an immortalised cell line and were grown in RPMI supplemented
with 10% heat-inactivated foetal calf serum, 2 mM glutamine, 100 units/ml penicillin and
100 pg/ml streptomycin at 370C/5%CO2.
Primary astrocyte cultures were grown from neonatal mouse brain by a modification of an
established protocol to generate mature cells that were analogous to their in vivo counterparts
in the adult brain (Juurlink and Flertz, 1985). These cultures were generated in collaboration
with Claire Cotterill, Centre for Infectious Disease, University of Edinburgh, UK. Briefly, P2
mouse brains (CBA crossed with C57B1/6) were harvested and meninges removed. The
cortex and cerebellum were cut finely, cells dissociated with enzymatic digestion in papain
and DNAse I for 1 hour at 37°C, and triturated through a 19 and 21 gauge needle. Resulting
brain homogenates were grown for 11 days in DMEM with 10% horse serum, 2mM
glutamine and 25 pg/ml gentamycin. Following shaking to remove microglia (200 rpm for 1
hour) and oligodendrocyte precursors (350 rpm for 18 hours), the primarily astrocyte culture
was further purified by growing for 7 days in DMEM with 20% foetal calf serum to
differentiate remaining oligodendrocyte precursors to type 2 astrocytes, and out grow non-
dividing contaminating cells. Astrocyte cultures were finally grown for a further 6 days in
DMEM 10% FCS with 0.2 mM dibutyryl cyclic adenosine monophophate (dbcAMP) to
differentiate astrocytes and kill any remaining contaminating microglia. Purity of the
cultures was determined by immuncytochemical staining for glial fibrillary acidic protein
(GFAP) - a well-defined marker of astrocytes (Eng, 1985) and CDllb a marker of the most
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likely contaminating cell, microglia. QPCR was undertaken on cultures to confirm the
presence GFAP at the mRNA level.
2.1.2 Virus stocks
The SFV 4 and A7(74) strains used in this study were grown by Lucy Breakwell (a PhD
student in the laboratory). Both stains were grown in confluent BHK-21 cells maintained in
Glasgow's modified Eagles medium (GMEM), supplemented with 10% foetal calf serum,
200 mM L-glutamine, penicillin and streptomycin at 37°C, 4% C02. BHK-21 cells were
infected with a MOI of 0.01 and incubated for 22 hours. Infectious supernatant from these
cells were harvested, clarified at 1000 g for 20 minutes and stored at-80°C.
2.2 Immunocytochemistry
Primary astrocyte cultures were transferred to 8-well chamber slides (Nunc) and grown for 6
days with 0.2 mM dbcAMP added to medium. 5 x 104 cells were seeded per well.
Slides were taken from then incubator and the cells were immediately washed twice for five
minutes each in PBS and then fixed using 4% paraformaldehyde in PBS for 15 minutes.
Following two additional 5 minute washes, cells were permeabilised using 0.1% TritonX-
100 in PBS for 15 minutes and washed four times in PBS to remove detergent. Prior to
application of antibodies, the cells were blocked using 10% normal goat serum (NGS) in
PBS for one hour at room temperature. Anti-GFAP (goat polyclonal, Chemicom) at 1:100 in
10% NGS/PBS, or anti CDllb:FITC at 1:10 in 10% NGS (Serotec, UK), or control antibodies
were added to cells for one hour at room temperature. Cells were subjected to 3 five-minute
washes with PBS. CD lib stained cells were fixed again in paraformaldehyde, washed once
more, covered with aqueous Dako fluorescent mounting medium (Dako), cover slipped and
sealed. GFAP labelled and control labelled cells were incubated with 1:100 rabbit polyclonal
anti-goat IgG conjugated to FITC in 10% NGS/PBS, for one hour at room temperature. Cells
were subjected to two further 5-minute washes, fixed again in paraformaldehyde, mounted
and sealed for microscopy.
2.3 Stimulation of N9 cells with Lipopolysaccharide (LPS) and phorbol 12-
myristate 13-acetate (PMA)
Cells were seeded into T25 flasks and allowed to grow for 24 hours at which point cells were
90% confluent (4xl06 cells per flask). Cells were stimulated with the addition of either LPS
(E.coli 055:B5, Sigma) 100 ng/ml or PMA (Sigma) to 10 ng/ml. Following incubations of
various lengths (see results section), media supernatants were collected for IU6 ELISA
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assay, whilst attached cells were washed in Versene EDTA solution and detached from the
plastic using 0.25% trypsin. Following quenching of trypsin with addition of 10 ml RPMI
with 5% FCS, cells were pelleted at 600 g for 5 minutes to pellet cells and then washed in
PBS, re-pelleted and either suspended in RNAlater (Sigma) or immediately lysed in RFT
buffer (Qiagen) for RNA extraction (see section 2.10.2 for more details).
RNA was used for microarray hybridisations (section 2.11) and QPCR analysis (section
2.12).
2.4 IL-6 ELISA assay
Supernatants from LPS and PMA stimulated cells were assayed for their IL-6 content using
an in house ELISA developed and undertaken by Clive Bate (Institute of Comparative
Medicine, Department of Veterinary Pathology, Glasgow University Veterinary School,
Bearsden Road, Glasgow).
2.5 Infection of N9 cells with SFV4
Cells were seeded into T-80 flasks at 2xl06 cells per flask and left to grow for 14 hours until
50% confluent. Cells were infected with SFV4 at a Multiplicity of Infection (MOI) of 0.5 in
5 ml media - to obtain infection of only a small fraction of the total cells. Flasks were well
shaken every 10 minutes for one hour to ensure even distribution of virus and then left to
incubate at 37°C/5% C02. Four uninfected flasks were immediately harvested for RNA,
whilst two uninfected flasks were assayed for Caspase 3 activity (section 2.8 for more
details). Six flasks of infected cells (four for RNA and two for caspase assay) were then
harvested at each of the following time-points: 3, 12 and 24 hours post infection. Cell pellets
included both attached cells and cells that had detached during the time of incubation with
virus. Cell pellets destined for RNA extraction were immediately lysed and RNA extracted,
whilst pellets destined for caspase assay were lysed and frozen for later analysis.
2.6 Infection with SFV4 and LPS stimulation of N2a cells
Cells were seeded at 1x10s cells per T-80 flask and left to grow for 18 hours. Cells were
either infected with SFV4 at a MOI of 0.5 in 5 ml media, so that only a small fraction of the
total cells were infected. Flasks were well shaken every 10 minutes for one hour to ensure
even distribution of virus and then left to incubate at 37°C/5% C02. Other flasks of N2a cells
were stimulated concurrently with LPS at 100 ng/ml and harvested as above (section 2.3) at
0, 3 and 12 hours post infection/stimulation.
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2.7 Infection with SFV4 and LPS stimulation of astrocyte primary cultures
Astrocytes were seeded to T-25 flasks and incubated for 6 days in dbcAMP (see above for
exact culturing conditions) and either infected with SFV4 at an MOI of 5 in 5 ml media.
Flasks were well shaken every 10 minutes for one hour to ensure even distribution of virus
and then left to incubate at 37°C/5% C02. Other flasks of astrocytes were stimulated
concurrently with LPS at 100 ng/ml. Cells were harvested as above (see section 2.3) at 12
hours post stimulation with LPS and 20 hours post infection with SFV4. Three flasks of
uninfected and three flasks of infected cells were also assayed for caspase 3 activity.
2.8 Caspase 3 assay of cell pellets
Cell pellets were assayed for caspase 3 activity using the caspase 3 assay kit (Sigma) that
utilises the unique activity of caspase 3 to cleave the substrate Acetyl-Asp-Glu-Val-Asp p-
nitroanilide (Ac-DEVD-pNA), to release the colourimetric compound p-Nitroaniline (pNA).
Cell pellets of 2xl06 cells were lysed for 20 minutes on ice in 40 pi lysis buffer (50 mM
HEPES, pH7.4, 5 mM CHAPS, 5 mM DTT) and the resulting homogenate spun for 20
minutes at 17 000 g/4°C. Supernatants were immediately assayed or frozen at -80°C for
storage. Caspase activity of supernatants were assayed in 96-well clear plastic plates: 5 pi
supernatant was added to 85 pi Assay buffer (20 mM HEPES, pH7.4, 0.1% CHAPS, 5 mM
DTT, 2 mM EDTA) and 10 pi substrate (2 mM). Additionally, the specificity of each assay
was confirmed by incubating 5 pi supernatant, 75 pi Assay Buffer and 10 pi caspase specific
inhibitor Acetyl-Asp-Glu-Val-Asp-aldehyde (Ac-DEVD-CHO). Assay mixtures were
incubated in the dark for at least 90 minutes, along with p-NA standards of known
concentration diluted in assay buffer, and the absorbance of each well was measured at 405
nm. Concentrations were calculated using the molar absoptivity of emM = 10.5. Each
supernatant was assayed in duplicate, along with two assays per sample containing inhibitor.
To determine the level of specific caspase 3 activity, the amount of non-specific conversion
undertaken in the presence of the caspase 3 inhibitor was subtracted from the those wells
lacking inhibitor to reveal the level specific caspase 3 activity. To act as a positive control,
each cell line was induced into apoptosis using Staurosporin (Sigma) at 1 pg/ml for four
hours and the resulting cell pellet assayed concurrent with other samples.
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2.9 Infection of mice with SFV, sampling and tissue processing
All animal experiments were approved by the University of Edinburgh ethical review
committee and were carried out under the authority of a UK Home Office Animal Licence
using defined clinical end-points representative of lethal virulent infection. Mice were
housed in environmentally enriched boxes and were kept under specific pathogen free
conditions.
2.9.1 Intra-peritoneal inoculation
Mice were inoculated via the intra-peritoneal route so that inoculation could occur without
direct damage to the brain. Mice were inoculated with either SFV A7(74), 0.1 ml containing
5 x 103 PFU (stock 50,000 PFU / ml) in PBSA or were inoculated PBSA alone to act as
controls.
2.9.2 Intra-cerebral inoculation
Mice were inoculated via the intra-cerebral route so that a large amount of virus would enter
the brain directly (compared to inoculation via the intra-peritoneal route).
Mice were temporally anaesthetised with halothane and a 0.02 ml inoculum of either lxlO3
pfu of SFV A7(74), lxlO3 pfu of SFV 4, or PBSA alone was given intra-cerebrally.
N.B. all animal work was undertaken with assistance of Amanda Boyd who undertook all
steps that required a Home Office personal animal licence.
2.9.3 Sampling of brain tissue from mice following infection
Mice were terminally anaesthetised with a halothaneroxygen mix and intracardially perfused
with sterile PBS. Once anaesthetised, the thoracic cavity was opened and the right atrium of
the heart was cut. The left ventricle was cannulated using a needle and >8ml of PBS was
carefully and slowly administered until the liver and lungs gained a pale colour indicative of
blood clearance. The extent of perfusion of the brain was scored using an arbitrary scale of 1
(no perfusion) to 10 (perfect perfusion). The brain was removed and bisected laterally down
the midline. One half of the brain was immediately placed in RNAlater (Sigma) for gene
expression analysis. The other half of the brain were either fixed in PLP for 4hours at 4°C
and passed through graded sucrose solutions of 12%, 16% and finally 18% in PBS (two,
twenty minute incubations in each solution) for future use in immunocytochemistry on
frozen (cryostat cut) sections or fixed in 4% phosphate buffered formal saline and sent to the
histology service for paraffin embedding and sectioning.
2.10 RNA extraction
Total RNA was extracted from samples using the RNeasy Mini kit (Qiagen, Crawley, UK).
This process is based on the ability of silica-gel-based membranes to selectively bind RNA
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above 200 bases in length. This process partially enriches for mRNA since the majority of
5S rRNA and tRNAs are selectively excluded. Proteins, lipids and DNA do not bind to these
columns (see www.qiagen.co.uk for more details).
2.10.1 RNA purification from brain and spleen
RNA was extracted from tissue samples using the RNeasy Mini kit as per manufacture's
instructions with the alterations indicated below. Briefly, tissues were removed from RNA
Later and 80 mg tissue homogenised in a cooled glass homogeniser (2 ml), mixed with 1.6
ml RLT buffer (containing |3-Mercaptoethanol at 10 pi per ml RLT and guanidine
thiocyanate) and passed through a 19 gauge needle twenty times. The resulting homogenate
was either frozen or mixed with an equal volume of 70% ethanol (molecular grade) to alter
binding properties of RNA and loaded on to two RNeasy columns per 80 mg sample (40 mg
of tissue per column). Columns were washed once with RW1 buffer (containing ethanol) and
contaminating DNA digested using on-column digestion with DNAsel (Qiagen) for 15
minutes. Following two more washes with RW1 buffer and RPE buffer (constitutes 95%
ethanol), RNA was eluted in 30 pi RNase free water and the integrity and concentrations of
the RNA was determined using an Agilent 2100 Bioanalyser (Agilent Technologies,
Edinburgh, UK) as per manufacture's instructions. Briefly, 1.5 pi of RNA was heated to
70°C for 2 minutes and cooled on ice for at least 5 minutes. Meanwhile, the RNA Agilent
chip was prepared by loading gel and markers as per manufacture's instructions. Each chip
was loaded with up to twelve 1 pi samples of total RNA. Concentrations were determined by
comparison to RNA ladder (150 ng) and integrity determined with visualisation of the 18S
and 28S ribosomal bands/peaks and lack of small, degraded RNA fragments (see figure 6).
2.10.2 RNA purification from cell cultures
Total RNA was extracted from cultured cells using the RNeasy Protect Mini kit (Qiagen) as
per manufacture's instructions. Briefly, cell pellets of not more than lxlO7 were either lysed
immediately after harvesting or following preservation in RNA later, were pelleted by
centrifugation at 4000 g for 10 minutes, re-suspended in RLT lysis buffer, loaded onto
RNeasy columns and contaminating DNA digested using on-column digestion (Qiagen).
RNA was eluted in RNase free water and the integrity and concentration determined by the




RNA conc. = 263ng/ul
rRNA ratio (28S/18S) = 2.22
Figure 6, Agilent Bioanalyser
was used to determine the
quality of RNA. (A) The Agilent
produces a gel-like image that
shows the two major rRNA bands,
28S and 18S (arrows). An RNA
ladder than represents 150 ng RNA
can be seen on the far left lane. (B)
Each sample can be visualised as an
electropherogram. This sample is an
excellent example of RNA that is
not degraded. The 5S (at 29seconds)
is just visible along with the 18S and
28S peaks. There is no evidence of
degraded RNA (base line is flat). In
some tissues the 28S peak has
around twice the RNA content of
the 18S peak. The 28S species is
highly susceptible to degradation -
hence any degradation of the RNA
sample can be seen as a reduction of
the 28S:18S ratio. (C) This
electropherogram highlights a
partially degraded RNA sample.
Notice the 28S peak is reduced and
degraded RNA is visible as rise in
the base line. (D) This
electropherogram highlights a
degraded RNA sample. Notice the
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2.11 Microarray fabrication, preparation, cDNA labelling and hybridisation
2.11.1 Probe design and array fabrication
Customised DNA arrays were fabricated by The Scottish Centre for Genomic Technology
and Informatics (ScGTI), Edinburgh, UK. Each array contained 282 50-mer long probes
complementary to 161 genes printed in triplicate and 10 SpotReport probes (Stratagene,
SpotReport™) printed ten times each. Probes were dissolved in 3 X SSC buffer and arrayed
onto either poly-L-lysine-coated glass slides or Corning-Gap ™ glass slides, using a
Microgrid II arrayer (Genomic Solutions).
Prior to printing glass slides were coated in poly-L-lysine using the following method. Slides
were first washed in 0.5 M NaOH dissolved in a 60% ethanokwater mixture for 2 hours on a
rotating platform. Slides were thoroughly washed in distilled water to remove all traces of
NaOH and ethanol before a 1 hour incubation with 0.1 M poly-L-lysine in 10% PBS. Slides
were then submerged in distilled water five time, spun dry for 5 minutes at 500 rpm and
heated in an oven at 45°C for 15 minutes. Slides were stored in desiccators at room
temperature until used. Alternatively slides from Coring Gap were purchased ready for
printing and did not require poly-L-lysine coating.
To determine the success of each print-run a representative microarray was hybridised to
SpotCheck, a Cy-3 labelled random 9-mer solution (Genetix). 20 . 1 of Spot Check was
denatured at 95°C for 5 minutes, followed by cooling on ice for 5 minutes then applied to the
array surface (arrays had been prepared and blocked as described in section 2.11.4). The
SpotCheck solution was allowed to hybridise for 20 minutes in the dark at room temperature
and then subjected to the following stringency washes in 250 ml glass baths with vigorous
stirring; IX SSC/0.2% SDS for 5 minutes, 0.1X SSC/0.2% SDS for 5 minutes and 0.1X SSC
for 5 minutes. Slides were then spun dry at 1000 rpm for 1 minute and read using an
Affymetrix 418 scanner.
Quality controlled microarrays were stored in desiccators at room temperature prior to use.
For more detailed description of array design see results section 3.1. All probe sequences are
listed in appendix 2.
2.11.2 Spiking of total RNA with SpotReport™
25 pg of purified RNA was spiked with 0.2 ng mRNA (Stratagene SpotReport™), carried in
10 ng/pl of yeast transcription RNA buffer. RNA was precipitated by the addition of 0.5
volumes ammonium acetate (7.5 M) and 2.5 volumes 100% ethanol and incubated at -80°C
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overnight. Samples were centrifuged at 12,000 g for 25 minutes at 4°C. The resulting pellet
was washed twice in 80% ethanol at 12,000 g for 5 minutes at 4°C. The pellet was then re-
suspended in 9 pi of DEPC-treated water and stored at -80°C. For more detailed description
see results section 3.1.
2.11.3 cDNA Synthesis from total RNA for microarray analysis
cDNA was synthesis by reverse transcription (RT) was undertaken using one of two
methods. The first method involved a custom based approach using individual reagents and
did not rely on any commercially available kits designed specifically for microarray labelling
reactions. Briefly, 25 pg of RNA was incubated with 2 pg Oligo-dT at 70°C for 10 minutes
to denature RNA, followed by 5 minutes incubation on ice. An RT master mix was made
containing per reaction; 6 pi 5X Buffer (Superscript II), 3 pi DTT (0.1 M), 0.6 pi dNTP
mix (25 mM each, except dCTP which was 15 mM), 3 pi Cy3-dCTP (1 mM) and 2 pi
Superscript II reverse transcriptase (Invitrogen). 14.6 pi of master mix was added to each
RNA sample and incubated for 2 hours at 42°C. Resulting cDNA samples were incubated
with 15 pi 0.1 M NaOH at 70°C for 10 minutes, followed by the addition of 15 pi of 0.1 M
HC1 to neutralise and 0.5 pi Tris-HCl (pH 7.5) for buffering. Labelled cDNA was mixed
with 20 pg COT-1 human DNA (Invitrogen, Life Technologies) to buffer labelled cDNA for
subsequent purification steps and reduce non-specific binding of DNA to the microarray
surface. YM-30 microfiltration columns (Amicon) were used wash once in 500 pi and then
to reduce the final volume of labelled cDNA to < 8 pi. YM-30 columns enable all molecules
below 30,000 MW to pass through along with water during centrifugation at 4000 g.
Samples were immediately processed for hybridisation to the microarray (see section
2.11.5).
Alternatively, cDNA was synthesised from total RNA using the FluoroScript™ cDNA
Labelling System (Invitrogen, Life Technologies). Briefly 25 pg of total RNA was
incubated with 0.5 pg of Oligo-dT at 70°C for 5 minutes to denature RNA, followed by 5
minutes incubation on ice. RT master-mixture was made containing per reaction; 4 pi 5X
Fluoroscript™ buffer, 2 pi DTT (0.1 M), 1 pi dNTP mix (0.5 mM each, except dCTP which
was 0.3 mM), 2 pi Cy3-dCTP (1 mM) and 1 pi Fluoroscript™ (15 U/pl). 11 pi of the
resulting master mixture was added to the denatured RNA to give a total volume of 20 pi.
The resulting RT mixture was incubated at 50°C for 1 hour. The reaction was stopped by the
addition of 2 pi of 200 mM EDTA. Resulting cDNA samples were incubated with 15 pi 0.1
M NaOH at 70°C for 10 minutes, followed by the addition of 15 pi of 0.1 M HC1 to
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neutralise and 0.5 pi Tris-HCl (pH 7.5) for buffering. Labelled cDNA was mixed with 20 pg
COT-1 human DNA (Invitrogen, Life Technologies) to buffer labelled cDNA for subsequent
purification steps and reduce non-specific binding of DNA to the microarray surface. Excess
Cy3-dCTP label was removed from cDNA by elution through S.N.A.P™ columns as per
manufacturer's instructions (Invitrogen, Life Technologies). YM-30 microfiltration columns
(Amicon) were used to reduce the final volume of labelled cDNA to < 15 pi. Thus, a YM-30
column further purifies the labelled cDNA and concentrates it. Samples were immediately
processed for hybridisation to the microarray (see section 2.11.5).
2.11.4 Microarray slide preparation
Microarray slides were prepared for hybridisation to labelled cDNA with a methodology
similar to that previously described (Ebrahimi et al., 2003). Oligonucleotide probes were
firstly cross-linked to Corning-Gap ™, poly-lysine coated slides under UV light (3000 units).
The array of probes can be visualised whilst the surface is dry, however following re¬
hydration the probes can no longer be seen without the naked eye. Hence, prior to
rehydration the array area was demarcated using a diamond pen to scratch the surface
surrounding the array. Arrays were re-hydrated in a humidity chamber containing 3X SSC
for 5 minutes at room-temperature and then placed on a hotplate at 70°C for 10 minutes.
Following incubation, slides were repeatedly submerged in a 170 mM succinic anhydride/N-
methyl-2-pyrrolidinone solution buffered by a borate at a final concentration of 40 mM
vigorously for seven submersions. Following a further 15 minutes with vigorous stirring,
slides were submerged in s 95°C milliQ water for 2 minutes followed by submersion in
absolute alcohol and spun dry at 1000 rpm for 1 min.
2.11.5 Hybridisation protocol
Labelled target cDNA samples from section 2.12.3 were immediately mixed with 3.46 pi
20X SSC, 0.58 pi 10% SDS and appropriate volume of nuclease-free water to give a final
volume of 20 pi. The resulting hybridisation mixture was incubated at 100°C for 2 minutes
followed by incubation at 37°C for 30 minutes. Samples were spun for two minutes to
remove any precipitates, volume adjusted to 20 pi if necessary and added to the array surface
by application to the underside of a 22 mm x 25 mm LifterSlip (Merck) cover slip that
distributes an equal volume of cDNA across the array. Arrays were placed in a humidified
chamber, sealed and incubated at 57°C overnight in the dark. The next day microarrays
received the following stringency washes in 250 ml glass baths with vigorous stirring; IX
SSC/0.2% SDS for 5 minutes, 0.1X SSC/0.2% SDS for 5 minutes and 0.1X SSC for 5
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minutes. Slides were then spun dry at 1000 rpm for 1 minute and read using an Affymetrix
418 scanner.
2.11.6 Microarray Analysis
Image quantification was carried out in a similar way as described previously (Forster et al.,
2003). Probe signal and background signal was determined using QuantarrayTm
(PerkinElmer, Boston, USA). To normalise signal intensity across the array slide, arrays
were intra-normalised using SpotReport™ Oligo Array Validation System (Statagene, La
Jolla, CA, USA). For a particular array the average median of negative control probes + 2
times standard deviations were used to calculate background signal. Probes producing a
signal at or lower than background levels were considered below the threshold of detection.
Arrays were then inter-normalised by comparing the 75th percentile of 30 housekeeping
probe signals of each array. The median value of each probe spot (printed in triplicate) was
selected to represent each probe for a particular array. Selecting the median in this way
prevents probes that produce erroneous exceptionally high signals from contributing to the
data (Forster et al., 2003). The signal of each probe was converted to a log base2 value for
comparison between arrays. More detail on the analysis of array data can be found in results
chapter 3.1.
2.12 Quantitative polymerase chain reaction (QPCR)
2.12.1 Reverse transcription of RNA for Quantitative Polymerase Chain
Reaction
cDNA was synthesised from total RNA by reverse transcription (RT) using Superscript II. 5
pg of RNA was mixed with 0.5 pg oligo-dT primer, dNTPs (0.5 mM each final), denatured
at 65°C for 5 minutes and placed on ice for 5 minutes. An RT master mix was made up to
contain per reaction; 5 pi 5X buffer, 2 pi 0.1 M DTT, 0.5 pi RNAsin (RNase inhibitor). 6.5
pi of master mix was added to each denatured RNA sample and incubated for 2 minutes at
42°C. 50 units of Superscript II was added and incubated for 60 minutes at 42 °C followed by
a 15-minute inactivation step at 70°C.
Samples were diluted either 1 in 5 or lin 10 in nuclease free water and used as template for
QPCR. Samples that were to be directly compared within a quantitative PCR were reverse
transcribed using the same master mix to avoid inter-day and inter mixture variability in




A set of "inner" primers were designed for use in the quantitative PCR machine (Rotorgene
3000, Corbett Research, Australia) and an "outer" set of primers were designed for creating
PCR products to act as standard templates. All primers were designed using Primer3
software (available online @: http://www.broad.mit.edU/cgi-bin/primer/primer3_www.cgi/l
and verified for low spontaneity to form duplexes and hairpin loops using 01igo6 software
(Molecular Biology Insights, CO, USA).
Primer specification:
between 18 and 20 base-pair (bp) in length
between 45 and 55% GC content (50% optimal)
Max self complementarity: 2
Max 3'self complementarity: 1
Outer primers were allowed to possess higher self complementarity
levels if the software could not suggest suitable primers using the above
criteria
BLAST analysis (http://www.ncbi.nlm.nih.gOv/BLAST/l was used to
ensure primer sequences were specific to gene of interest alone
Both sets of primers were tested for specificity by undertaking a standard PCR using cDNA
substrate sourced from either resting or infected brain RNA. PCR products were separated
using electrophoresis through an agarose gel (2%) and visualised using ethidium bromide.
PCR primers were deemed suitable for QPCR if single, clear and distinct bands of the
correct predicted size were found on the gel, indicating PCR specificity. The presence of
multiple bands or smears on the gel implied primers would not be suitable for QPCR. PCR
products were also visualised using the Agilent Bioanalyser as per manufacturer's
instructions. All primer sequences can be found in table 4.
2.12.3 Generation of DNA standards for QPCR
The generation of a standard curve is essential for quantifying the levels of the gene of
interest in the test samples. A standard DNA template for each gene assayed was generated
by taking the PCR product generated using the outer primers, purifying the PCR product on
a PCR purification column as per manufacturer's instructions (Qiagen) and diluting this
product to generate serial dilutions. Each dilution was a factor of 10 more dilute than the
previous. Each of these dilutions was used as a template for a QPCR using the inner primers
for amplification. The ability of the QPCR platform to discern that the template is present at
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Gene Genbank Innerl Inner2 PCR product size
5 TO 3' 5 'TO 3' (bp)
TLR1 NM 030682 TACAGTTCCTGGGGTTGAGC TAGTGCTGACGGACACATCC 216
TLR2 NM 011905 CGTTGTTCCCTGTGTTGCT AAAGTGGTTGTCGCCTGCT 119
TLR3 NM 126166 TTGCGTTGCGAAGTGAAG TAAAAAGAGCGAGGGGACAG 406
TLR4 NM 021297 TTCACCTCTGCCTTCACTACA GGGACTTCTCAACCTTCTCAA 225
TLR5 NM 016928 CAGGATGTTGGCTGGTTTCT CGGATAAAGCGTGGAGAGTT 169
TLR6 NM_011604 ATGGCACAGCGGACTTACTT ATGAGAGCCCAGGTTGACAG 170
TLR7 NM 133211 GCTGTGTGGTTTGTCTGGTG CCCCTTTATCTTTGCTTTCC 270
TLR8 NM 133212 GACTTCATCCACATCCCAAA TCCCAATCCCTCTCCTCTAA 156
TLR9 NM 031178 GAAAGCATCAACCACACCAA ACAAGTCCACAAAGCGAAGG 304
TLR13 NM_205820 CTGTCTTCACCAACGGGATT CAAGTCGGCACCATTCACT 131
CathepsinD* NM 009983 GCTGTTCTGTTCTGTGGTTC TTCTGTCCTCTTCTTGCTCCTTC 326
GAPDH* NM 001001303 AACTCCCACTCTTCCACCTT GCCCCTCCTGTTATTATGG 269
GFAP* NM 010277 GAAAACCGCATCACCATTCC CGCATCTCCACAGTCTTTACC 128
IL-6 NM_031168 TTCCATCCAGTTGCCTTCTT ATTTCCACGATTTCCCAGAG 171
IL-1 alpha* NM 010554 GATGTCCAACTTCACCTTCA ACAAACTTCTGCCTGACGA 228
IL-1 beta* NM 008361 GTGTAATGAAAGACGGCACA AGAAACAGTCCAGCCCATAC 269
INF-alpha4 NM_010504 AGGACAGGAAGGATTTTGGA GCTGCTGATGGAGGTCATT 186
IFN-beta** NM_010510 CACAGCCCTCTCCATCAACT GCATCTTCTCCGTCATCTCC 152
TNF-alpha* NM_013693 CCCTTTACTCTGACCCCTTT AACCTGACCACTCTCCCTTT 260
SFV E1*** X74491 CGCATCACCTTCTTTTGTG CCAGACCACCCGAGATTTT 173
Beta-actin NM_007393 CGTTGACATCCGTAAAGACC CTGGAAGGTGGACAGTGAG 202
Table 4A, sequences for primers used in QPCR reactions. Primers are referred to as the "inner"
primers.
Gene Genbank Outerl Outer2 PCR product size
5' TO 3' 5' TO 3' (bp)
TLR1 NM 030682 CCTTTGATGCCCTGCCTAT ATGCCAAACTATCTGGAGGA 436
TLR2 NM 011905 GCTGAAAACACTCCCAGATG GCCAGTCAACCAGGATTTG 211
TLR3 NM 126166 CCAACTCAGAAGATTACCACCT GGGATGTGAAGCAAGTGAAA 849
TLR4 NM 021297 ACAGCAGAGGAGAAAGCATC TCCCATTCCAGGTAGGTGTT 393
TLR5 NM 016928 GCCTGTAACTTCTCCCAAGG ATTCTCATCGTGGTGGTGGT 535
TLR6 NM 011604 TCATCTTGCTGGAACCCATT CAGGTAGGAACTGAAAACCACA 262
TLR7 NM 133211 CIGAGGI 11 1 IGAGGG IAIGC CTGTATGCTCTGGGAAAGGTT 844
TLR8 NM 133212 GIG 1 1 1 IAGIGGGAIG 1 1 IGG TTTCTTGCTCTGGTTTATGCTC 269
TLR9 NM 031178 GGTTCCAAGGTCTGGTCAAC GCATCATCTGCCTCTTCAGG 423
TLR13 NM 205820 AATGGCACAAAACGGAGAAAG AGAAAAGTGGCTGCTGGTGA 432
CathepsinD* NM 009983 TAGTGTTGCTGGACCCTTG GGGGGAGGI ICAIAGI 1 1 1 392
GAPDH* NM 001001303 TGTCTCCTGCGACTTCAA TGCAGCGAACTTTATTGATG 341
GFAP* NM 010277 CCAGTTACCAGGAGGCACTT TCACATCACCACGTCCTTG 338
IL-6 NM 031168 TCCAGAAACCGCTATGAAGT CTCCAGAAGACCAGAGGAAA 370
IL-1 alpha* NM 010554 TCCTGACTTGTTTGAAGACC TAGTTTGGTTGAGGGAATCA 425
IL-1 beta* NM 008361 GCAACGACAAAATACCTGTG GCCGAGGACTAAGGAGTGT 412
INF-alpha4 NM 010504 TGGCTAGGCTCTGTGCTTTC GGAGGTTCCTGCATCACAC 385
TNF-alpha* NM 013693 GTGAAGGGAATGGGTGTTC TGGAAAGGTCTGAAGGTAGG 370
Beta-actin NM 007393 GTACTCCTGTTGCTGATCC GTACTCCTGCTTGCTGATCC 272
Table 4B, sequences for primers used to generate DNA templates standards. Primers are
referred to as the "outer" primers as the PCR product encompasses the sequence to which the
"inner" primers bind. NB There are no outer primers for SFV E1 of IFN-. as a plasmid containing
the gene sequences was used as a DNA standard for these QPCRs.
* primers designed by Alan Brown
** primers designed by Lucy Breakwell
*** primers designed by Rennos Fragkoudis
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differing levels in the serial dilutions indicates the range and sensitivity of the quantification
process. The use of standards also permits relative and absolute quantification of unknown
transcript levels in samples.
The absolute amount of each standard was determined by analysing the mass of each PCR
product using the Agilent Bioanalyser (Agilent Technologies). Copies of each transcript
were then calculated using the following formulas with (3-actin given as an example:
(3-actin PCR product was 278 bp in size and had a concentration of 7.035xlCFsg per pi.
Copies of molecule per mole = 6.023xl023 (Avagadro's constant)
Average molecular weight for double stranded nucleotide = 660 Daltons
Molecular weight of double stranded DNA = 660 Daltons * PCR product length
= 660 * 278 bp
= 183,480 Daltons
Copies DNA per pi = (6.023 x 1023 * mass per pi) / Molecular weight DNA
= (6.023 x 1023 * 7.035xl0"8) / 183,480 Daltons
= 2.309 x 1011 copies per pi
2.12.4 Quantitative PCR assay
The PCR mixture (total volume 20 pi) contained; 2 pi 10X PCR buffer, 2.8 pi MgCl2 (25
mM). 0.4 pi dNTP mix (10 mM each), 2 pi cDNA, 0.4 pi of each primer (50 pmol/pl), 0.15
pi FastStart Taq polymerase (Roche Applied Science, Germany), 0.7 pi SYBR (BioGene
Ltd.) and 11.15 pi nuclease free water. Following a hot start at 95°C for 10 minutes to
activate the hot-start Taq polymerase, an amplification cycle was carried out for 40 cycles at
the following temperatures; 95°C for 30 seconds, 62°C for 20 seconds, 72°C for 20 seconds
on a RotorGene 3000 (Corbet Research, Australia). Fluorescence was measure at the end of
each 72°C step. At the end of the PCR a melt curve analysis was performed as per
manufacturers instruction: measuring fluorescence during a incremental increase in
temperature from 65°C to 94°C. A serial dilution of PCR fragments containing template of
interest was also assayed concurrently to convert cycle number of exponential amplification
to copies of template of interest (Brown et al., 2003).
Alternatively, QPCR was undertaken with a Roche LightCyler™, utilising the LightCyler-
FastStart DNA Master SYBR Green I mix (Roche Applied Science, Germany). Briefly, the
fast start Taq master mix was prepared as per manufacturers instructions and MgCl2 added to
a final concentration of 4 mM. 2 pi of cDNA (diluted 1 in 10) was added to 18 pi master-
mix and placed in the LightCycler and heated as follows: 95°C denaturation for 10 minutes
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followed by 40 cycles of: 94°C for 10 seconds, 62°C for 5 seconds and 72°C for 10 seconds.
Melt curve analysis was undertaken by measuring fluorescence from 65°C to 95°C.
2.12.5 Normalisation of cDNA samples
To allow effective comparison of gene levels between samples, normalisation of cDNA
levels was undertaken. The amount of cDNA between samples can inadvertently be varied
by multiple factors including: variation introduced during RNA extraction, differential RNA
degradation, the amount of RNA used in the reverse transcription reaction and the reaction
efficiency of the reverse transcription. This variation was reduced by; 1.) Using exactly 5 pg
of non-degraded total RNA (as determined by Agilent Bioanalyser) - hence in effect
normalising to levels of 18S rRNA; 2.) All samples that were directly compared within a
quantitative PCR were reverse transcribed using the same master mix to avoid inter-day and
inter mixture variability in reverse transcriptase activity; and 3.) Housekeeping genes were
used to normalise samples as described previously (Brown et ah, 2003; Vandesompele et ah,
2002; Suzuki et ah, 2000). Housekeeping genes are those genes that are required for cell
metabolism, are expressed in all cells and have no role to play in cell differentiation (Suzuki
et ah, 2000). One can assume that the levels of all housekeeping cDNA will be varied in
proportion to one another and genes transcripts of interest.
Levels of two housekeeping genes (|3-actin and/or GAPDH) were assayed via QPCR to
determine the level of cDNA present within a specific sample (an example of the
normalisation process is given in Table 5). (3-actin is a major cytoplasmic structural protein
whilst GAPDH is an important glycolytic enzyme that catalyses the oxidative
phosphorylation of glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate. (3-actin was
primarily used as a control, since a review of the literature has reported the expression of this
gene to be more reliable than other commonly used controls- particularly for in vivo work
(Suzuki et ah, 2000). Each sample was allocated a ratio of its (3-actin /GAPDH content in
relation to the 75th percentile of (3-actin /GAPDH levels of all samples assayed. This ratio
was subsequently used to normalise the levels of genes of interest (see table 5 for an
example).
In actuality, any sample whose housekeeping genes varied by more than a factor of 2 from
the 75th percentile, were disqualified and excluded from the analysis due to error that can be
introduced by such large scale alteration of the raw data.
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A B C D E
Sample Name Assayed level Level of house Ratio to 75th Normalised level of
of gene X keeping gene Percentile gene X
(copies/fxl) (copies/pl) (column C/71.25) (column B/D)
LPS1 10 40 0.561 18
LPS2 50 200 2.807 18
LPS3 12 45 0.632 19
LPS4 10 10 0.14 71
LPS5 8 40 0.561 14
75th percentile 71.25
Table 5 An example of normalisation using a housekeeping gene to determine
levels of "gene X". Notice that pre-normalised levels indicate that sample LPS2 has a
high value of 50 copies of gene X and that sample LPS4 has a low value of just 10 copies
(column B). Once the cDNA levels have been lioimalised the lesults demonstrate the level of
gene X in sample LPS2 was in fact quite low compared to the majority of the samples. This
was because the amount of cDNA present in this sample was high. Conversely, the level of
gene X in sample 4 appears low in pre-normalised levels although in actuality the level is
much higher - since there was only a small amount of cDNA in this sample. The 75th
percentile of housekeeping gene copy number is determined and used as a reference since
this value unlike other measures, such as the mean average, are affected little by outliers that
may skew the result in a particular direction. A ratio is then determined for each sample and
in doing so measures the difference of each sample from the 75th percentile. Levels of gene
X can then be alteied on the assumption that the latio of housekeeping gene to gene X is
uniform.
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Chapter 3. The development of a custom microarray that assays the
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Chapter 3 Microarray development
3.1.1 Introduction
Microarrays enable the collection of gene expression data for a large number of genes in a
single experiment. Each microarray contains features (spots) representing hundreds to
thousands of genes that are surveyed in an assay in which a sample representing the mRNA
expressed in the cell of interest are labelled with a distinguishable marker and allowed to
hybridise to features on the array. The microarray platform assumes that the relative amount
of hybridisation for each of the labelled extracts for each feature represents the relative
population of the corresponding mRNA species in the experimental sample. Microarrays
have successfully been used to identify novel gene expression pattern in many scientific
fields of interest. They have been particularly useful in identify putative mechanisms of
disease processes where little was previously known. Microarrays can discern new trends
and identify patterns of gene expression that can lead to new hypothesis of cellular function
and pathogenesis; both in vitro such as the actions of glucocorticoids on immune cells
(Galon et al., 2002); and in vivo such as the complex interactions that occur during scrapie
neuropathogenesis (Brown et al., 2004). However, the cost of commercial microarrays is
prohibitively expensive and makes their use inappropriate for extensive research work.
Here, a custom glass slide DNA oligonucleotide microarray platform has been developed
that is relatively inexpensive. Probes complementary to a variety of genes of interest were
designed and arrayed onto a glass slide. RNA from the cells of interest was used to generate
first-strand cDNA labelled with the spectrally distinguishable fluorescent dye Cy3 and
hybridised to the microarray. The arrays were scanned following hybridisation and
independent grey-scale images were generated for control and test samples as 16-bit Tagged
Image File Format (TIFF) files. These images were analysed to identify spots and measure
the relative fluorescent intensities of each spot. Once each spot was identified and measured,
signal intensities were normalised to effectively compare within, and between arrays. The
whole process of designing and developing a reliable microarray platform required
considerable time and resources and is described here.
3.1.2 Objectives
To design and develop a microarray platform:
1. That possesses probes that function under the same conditions of hybridisation:
a. probes must be, as a population, thermodynamically homogenous
b. probes must be refractory to secondary structure formation
2. With optimised hybridisation conditions
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3. That produces a strong, specific, detectable signal that is consistent across the array
surface
4. That demonstartes little inter-array variation i.e. replicate arrays produce a
consistent signal
To undertake these objectives a custom microarray was designed and validated with the help
and guidance of several members of the Scottish Centre for Genomic Technology and
Informatics (ScGTI), including Douglas Roy, Klemens Vierlinger, Marie Craigon, Thorsten
Forster and Peter Ghazal.
3.2 Design of microarray
3.2.1 Choice of target genes
The microarray platform was designed with the aim to primarily characterise pattern
recognition receptor (PRR) expression and the first task was to define a list of specific genes
to be assayed. The exact definition of a PRR is somewhat vague and so a variety of genes
were included. All TLR and TLR-like proteins (such as Rpl05 and Nodi) were included
along with several lectins that bind microbial associated sugars (such as CD14), secreted
PRRs (such as Mannose Binding Lectin 1), scavenger receptors that bind both exogenous
and endogenous proteins (such as SR-AI), the peptidoglycan recognition protein (PGRP)
family, the N-formyl peptide receptors and other putative PRRs including the triggering
receptor expressed on myeloid cells (TREM) family. Several other genes that have putative
functions such as the PrPSc receptor were included in the list (such as complement receptor 1
and PrP itself) (Mabbott and Bruce, 2001). Genes that function to recognise the unique
molecular patterns of apoptotic cells, such as the phosphatidylserine receptor and the
integrins were also included in the list since these apoptotic cell associated molecular
patterns (ACAMPs) may be recognised in a fashion analogous to pathogen associated
molecular patterns (PAMPs) (Gregory, 2000). It is advantageous to characterise the
inflammatory state of immune cells along with PRR expression, since one can discern trends
in PRR expression in the context of other markers of innate immune activation. Thus, in
addition to PRRs the microarray was also designed to assay a multitude of key genes
involved in the process of inflammation and stress-associated responses including; several
key pro-inflammatory cytokines (such as TNF-a), anti-viral mediators (such as IFN-(3)
several chemokines (such as MlP-la) and a variety of genes that either mediate stress
responses or are induced as a reaction to conditions of cellular stress (such as nitric oxide
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synthase (Nos), superoxide dismutase (SOD), cylco-oxygenases (COX) and heat shock
protein 25 (Hsp25)). In addition to these genes, termed "genes of interest", a variety of
positive and negative controls were chosen. The number of control probes included on the
microarray was sufficiently high to allow effective statistical analysis. The positive controls
represent genes that are constitutively expressed within all murine cells and whose presence
is mandatory for cell survival - genes that are often referred to as housekeeping genes. A
total of 15 housekeeping genes were chosen, some which are highly expressed (such as (3-
actin) and housekeeping genes that are generally expressed at lower levels (such as glycogen
synthase kinase-3(3) (Warrington et al., 2000). The reasons for including probes that
recognise housekeeping genes are two fold - demonstration that the microarray platform
adequately detects gene expression in each sample and demonstration of the sensitivity of the
platform to detect transcripts present at differing levels. Finally, several genes with no
homology to known mammalian genes were identified so that probes could be generated on
the assumption that they recognise no known murine gene products. These probes were
referred to as the "negative controls" and included genes such as celA from Ruminous
flavefaciens and ChlorophyllA-B binding protein 7 from Arabidopsis thaliana.
3.2.2 Design of oligonucleotide probes
Microarrays can differ in the type of DNA arrayed across the surface. There are cDNA
arrays where PCR products are typically used as probes for array spots, and oligo arrays
where the spots are made of oligonucleotides. PCR products offer the advantage of
amplification so that limited template DNA and clone banks can be spotted multiple times
after amplification from a single source plate. However, reliance on amplification means that
there are a number of precautions needed to prevent contamination and the sequence is
typically 400 to 1000 bp long. Conversely oligonucleotides are purchased at high expense
and can only be used for a limited number of print runs before more oligonucleotides have to
be purchased.
Oligonucleotides are typically used in the range of 25 to 80 bp, and are generated
synthetically in a form ready for spotting. They are less prone to the problems of
contamination and can be produced quickly, without resources and time being spent on
extensive cDNA library work and sequencing. Importantly, unlike PCR spots
oligonucleotides can be designed to; minimise cross hybridisation with other genes; have
lower secondary structures; and have similar hybridisation efficiencies at a given
temperature. Therefore, with careful design oligonucleotide spots are more likely to
hybridise at a similar efficiency. In comparison, PCR spotted arrays demonstrate higher
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variation in the efficiency of hybridisation between individual spots. Also, oligonucleotides
are better able to distinguish between highly related genes such as the TLR, unlike PCR
spots that due to their size are likely to bind all members of a closely related gene family.
(Lockhart et ah, 1996; Kane et ah, 2000).
Oligonucleotide probes were designed using 01igo6 software to suggest possible
hybridisation probes complementary to cDNA from mRNA transcripts. From the list of
probes suggested by the software for an individual gene, two were selected as probe
sequences based on a variety of criteria. These criteria were based on the predicted
thermodynamics of the probe, its probability of forming unwanted secondary structures, its
hybridisation target on the cDNA sequence and its specificity. Probes that possess stable
secondary structures may not bind to their target sequence with sufficient strength at
hybridisation temperatures. The 01igo6 software can predict the spontaneity of probes to
form duplexes and hairpin loops and this was used to exclude certain probes. A well-
functioning microarray possesses probes that exhibit similar thermodynamic properties,
since each probe has to hybridise to its target sequence under the same hybridisation
conditions such as temperature and salt concentration. Indeed, populations of probes with
homogenous thermodynamic characteristics are more likely to generate a measurable signal
within the dynamic range of a given microarray platform (Kane et al., 2000).
Consequently, the probes were chosen to have the following characteristics:
Tm between 87°C and 94°C (90°C optimal)
AG between -84 and -96 kcal/mol (the more negative the AG value the
stronger the binding between probe and complementary cDNA strand)
AG of predicted hairpin structures above -1.5 kcal/mol (the more negative
the AG value the more stable the hairpin loop)
Tm of predicted hairpin structures must not exceed 45°C (20°C to 30°C
optimal)
AG of predicted probe duplexes must be above -10 kcal/mol
probes must bind as close to the 5' polyT tail of the cDNA as possible
without compromising above criteria. Each gene must have one probe that
binds within 600 bp of the 5' polyT tail
all probes must not possess a stretch of 16 or more contiguous bases that are
complementary to any known mouse mRNA sequence (other than target
sequence)
The location on the cDNA sequence to which the probe binds was highly restricted. This was
due to several factors including the limitations of the cDNA synthesis reaction. The process
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of converting mRNA to cDNA that incorporates Cy-dye labeled nucleotides was highly
inefficient, which means longer cDNA strands were synthesized in low amounts. This means
the cDNA representing the 3'end of the mRNA were greatly enriched and very few cDNA
representing the entire mRNA transcript were produced. For this reason probes were
designed to bind close to the 5' polyT tail. Another advantage of designing probes that bind
to the 5' polyT tail is that this region represents the 3' untranslated region of the mRNA.
These sequences tend to be more gene-specific and decrease the probability of cross-
hybridisation to other gene transcripts.
Any probe sequence is likely to be complementary to non-target sequences for a stretch of
nucleotides. Studies have shown that 50-mer probes that possess 16 or more contiguous
bases that are complementary to a given labeled cDNA will bind and contribute to the spot
signal (Kane et al., 2000). This characteristic is a particular problem for microarrays, which
by their nature are 1-dimensional (unlike Northern gels that are 2 dimensional). Hence, all
probes were BLAST searched to determine the extent of their specificity. Any probes that
possessed 16 or more contiguous bases to other murine sequences were excluded, an event
that happened frequently. On average for every final probe selected, four were excluded on
the basis of their cross-complementarity to other murine transcripts.
Due to the strict criteria for probe design, not all specifications could be met for some
probes. In these cases a hierarchy of criteria was chosen for probe specification. It was
decided that the thermodynamic homogeneity of the probe population was more important
than an individual probes theoretical ability to form secondary structures. Thus, the Tm and
AG value of each probe was most critical, whilst the ability of the probe to form duplexes, its
ability to bind to 16 or more contiguous bases of other murine transcripts and the probes site
of complementarity to within 600bp of mRNA 3' end, was considered dispensable if no
probes could be designed with all specifications met. For example, if no "perfect" probe
could be designed then a probe with duplex formation would be preferable over a probe that
exhibited divergent Tm/AG values. The ability of the probe to form a duplex was considered
a low priority, since duplex formation is unlikely on glass microarrays due to the low
probability of substrate-bound probes to form duplexes. The characteristics of the probes are
shown in figure 7 and are described in detail in appendices 2 to 6.
Originally 75 mer probes were designed - however, these 75 mer probes were frequently
found to contain stretches of contiguous oligonucleotides complementary to more than one
gene and appeared to represent common nucleotide motifs. To avoid this, 50 mer probes
were used. Smaller probes result in a lower signal upon hybridisation. However, because of
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Figure 7, characteristics of oligonucleotide probes. (A) The predicted Tm of each probe, almost all of which
are between 88 and 94°C, and the majority of which are between 89 and 92°C. Those probes that lie outside this
narrow range represent a gene sequence that generates few probe sequences that match the strict criteria outlined in
section 3.2.2. Each gene has at least one probe that possess a Tm between 89 and 92°C. (B) The predicted Tm of the
most likely hairpin secondary structure, all of which are below 45°C and are unlikely to occur at hybridisation
temperatures. (C) Distance of probe binding site from the 5' poiyT tail of the cDNA. Each gene has at least one probe
that binds within 600 bp of the cDNA 5' end and most genes have both probes binding within this region
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common motif. Additionally, 50 mer probes were cheaper to synthesise (a significant point)
and underwent more sophisticated quality control by the manufacturer (MALDI-TOF mass
spectrometry), which was not possible for 75mer probes.
3.2.3 50-mer probes were arrayed randomly across the glass surface
As discussed above, two probes for each gene of interest were designed. These probes along
with probes complementary to housekeeping genes (positive controls) and genes of non-
animal origin (negative controls) were given an arbitrary number generated at random by
Excel™ (Microsoft Office 2000) and this was used to rank all probes such that there was no
user-influenced order to their ranking. The probes were then arrayed onto the glass substrate
according to this order by Klemens Vierlinger at the Scottish Center for Genomic
Technology and Informatics (ScGTI) using a MicroGrid II arrayer (Genomic solutions). It
was important to randomly distribute the probes across the array since this reduces the
possibility of hybridisation error skewing the results. For example, if there was a defect in a
particular hybridisation for a certain area of the array surface and two probes complementary
for the same gene were arrayed side-by-side in this area, then both probes would give
erroneous signals. Conversely, if the two probes are arrayed in different areas of the array
surface then this is unlikely to happen. Likewise if one area of the array possessed all probes
complementary for housekeeping genes and this area hybridised less well, then this would
give an erroneous signal for all the positive controls. Randomly distributed positive controls
are less likely to be influenced as a population in this way.
The randomly ordered probes were arrayed as four sub-arrays. Each sub-array contained a
particular probe printed in triplicate. Figure 8 demonstrates the layout of the array. The
rationale for printing each probe in triplicate was two-fold. Firstly, printing in triplicate
allowed more reliable data to be produced from the array. Following hybridisation to a
labeled cDNA substrate the signal from each "spot" or "element" was measured. The value
of each triplicate repeat was compared and from these three values the median was used for
further analysis and the others discarded (more details on data analysis are discussed below).
By undertaking this screening, almost all outliers (those elements that give erroneous signals
due to hybridisation defects) were excluded and a fair representative of the probe's signal
was obtained. Figure 22 demonstrates how this decreased variation in the probe signal
(Forster et al., 2003). Secondly, printing probes in triplicate enables the user to undertake
more sophisticated quality control of each hybridisation. Theoretically, an ideally printed
microarray that undergoes an ideal hybridisation should give the same signal for a particular
probe that is printed multiple times across the array i.e. a perfect hybridisation is one in
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Chapter 3 Microarray development
which a specific probe will give exactly the same signal wherever it is placed on the array.
However, in practice the strength of a signal for a particular probe can alter across the array
surface due to a variety of reasons brought about by in perfect probe printing, array blocking
and hybridisation. To determine whether the signal for a specific probe changes, the user has
to simply compare the values of the triplicates and any deviation in signal will be detected
and if warranted the data for that hybridisation can be discarded.
Along with probes the array was spotted with buffer alone. The rationale for the inclusion of
buffer spots was two-fold. Firstly they were used as a measure of background signal.
Secondly, the buffer spots were used to evaluate the quality of the microarray printing
process. During the printing process, the printing pins pick up DNA from a source plate and
print the DNA onto the microarray slides at pre-defined coordinates. The printing pins then
move to a wash solution where the DNA is removed from the pins before the next DNA
probe is collected. This process is repeated until the microarray printing is complete. If the
DNA is not completely removed from the printing pins at the wash station, any DNA
remaining on the pins will be combined with and printed with the next probe, producing
spots printed with combined DNA (a process referred to as DNA carryover). Evidence of
carryover can be found by detecting hybridisation signal from one or more of the buffer
spots. Figure 9B shows a close up of one sub-array and demonstrates that buffer spots did
not generate any signal suggesting that DNA carryover did not occur.
3.2.4 cDNA transcripts were labeled using a single dye
Labelling all samples with a single dye has multiple advantages when compared to dual
labelling with both Cy-3 and Cy-5. Dual labelling involves labelling a reference/control
sample with Cy-3 and the test sample with Cy-5 and hybridising both cDNA populations
onto the same array. Conversely, a labelling technique that relies on using just one Cy dye
requires undertaking separate hybridisations for each sample. Dual labelling is advantageous
if one wants to undertake a simple comparison between two samples e.g. control and test
sample - mainly because one doesn't have to undertake inter-array comparison. However,
single dye labelling is an almost pre-requisite for credible comparisons between multiple
samples e.g. control, test 1, test 2, test 3, test 4 etc.
Undertaking multiple inter-array comparisons when using the dual-labelling method requires
sophisticated data analysis, because all the data exists as ratios whilst single-dye
hybridisations rely on absolute normalised data sets. The generation of ratios means the
value of specific data points is lost, and this increases the complexity of data analysis. For
example, if a dual labelled experiment suggested that a gene expression level was up by two-
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fold, it would not be possible to tell whether this resulted from the gene expression changing
from an arbitrary value of 2 to 4, or from 2000 to 4000. The latter change of 2000 to 4000
might be a significant result whilst the former might mean little. To undertake even simple
inter-array analysis using the dual dye labelling method requires two steps of normalisation:
one, to normalise between the two dyes on each chip (Lowess normalisation) and two, to
normalise between the chips themselves. To undertake inter-array comparison using the
single dye labelling method requires only one more simple process of normalisation -
between the arrays themselves. This has the added advantage that the comparisons can be
more complex and thorough (Forster et ah, 2003).
There are also some other minor problems with dual labeling that make it an unfavorable
choice. The two Cy dyes have differing levels of fluorescence intensities, stabilities and
levels of "quenching" - all of which complicate the data analysis. The scanning process
involves subjecting the microarray to bursts of intense light. Consequently, the relative
fluorescent signal from the Cy-5 dye decreases substantially in comparison to the more
stable Cy-3 signal following repeated scanning. Normal daylight exposure can also
dramatically reduce the fluorescence of Cy-5. The process of image capture involves
multiple scans and because of the differing dye stabilities the primary scan can have a
different ratio to that of the last scan. In addition, scans of the same hybridisation at a later
date after exposure to daylight are likely to produce erroneous ratios. This factor is an
important one since it is the ratio of Cy3 to Cy5 that is measured in these hybridisations
(rather than absolute levels that are measured in single-labeled hybridisations). The
commercial Affymetrix ™ chip system used widely for assaying genome wide expression
profiles also uses a single-dye labeling system, suggesting this is the best method (Forster et
al., 2003).
Inter-array comparison has been considered difficult because reproducibility between arrays
can be prone to error. This partly explains why dual labeling has been the more popular
option to date. The production quality of microarray chips now enables effective inter-array
comparison. The fact that most microarray experiments have utilised dual labeled
microarrays should not be seen as a vindication of that method but rather as a sign that array
technology has limited researchers approach until now.
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3.3 Development and optimisation of microarray
3.3.1 Optimisation of hybridisation temperature
The first step in optimising hybridisation conditions was the optimisation of hybridisation
temperature. The thermodynamics of DNA-to-DNA binding state that longer probes remain
bound at higher temperatures than shorter probes. Secondly, as the temperature of
hybridisation increases for a given probe of a given length, the percentage of probe bound to
its labelled complementary cDNA sequences decreases, which results in a lower signal on
the microarray (i.e. the amount of bound cDNA is inversely proportional to the temperature).
Non-specific binding of a given probe to a random labelled cDNA also occurs, albeit at
lower temperatures than specific sequences. Thus, the ideal hybridisation temperature is low
enough to allow sufficient binding of probe to its specific cDNA sequence but high enough
to prevent non-specific binding. Previous work at the ScGTI using 75-mer probes has shown
65°C to be an ideal temperature whilst Affymetrix gene chips, which use 25-mer probes, are
hybridised at 45°C. Since the array designed here utilised 50-mer probes it is highly likely a
suitable temperature would exist somewhere between 45°C and 65°C. An experiment was
undertaken in which labelled cDNA was hybridised to the array at a variety of temperatures
from 50°C to 67°C. The ideal temperature is one in which positive control probes generate
the highest possible signal without causing negative control probes to generate significant
signal from non-specific binding. The J774.1 macrophage cell line was grown until semi-
confluent, RNA extracted and its quality assayed using the Agilent bioanalyser. The J774.1
macrophage line was used since this cell line is known to express a multitude of PRR, such
as CD 14 and all housekeeping genes. The RNA was used to make labelled cDNA using
Superscript II, mixed into one pool and hybridised to the arrays. Any variations in signal
were thus due to hybridisation efficiency and not the quality of the cDNA. The temperature
of each hybridisation oven was checked using an alcohol-based thermometer and a
thermocouple-based thermometer. Following overnight hybridisation and washes, the arrays
were scanned (figure 9A and 9B). Upon simple visual inspection of these scans it is evident
that cDNA has bound to the array at both 50°C and 57.5°C, suggesting these temperatures
are not too high to prevent specific binding. To accurately determine which temperature was
optimal, the signal intensities of all probes were plotted as a whisker diagram (figure 10).
Thorsten Forster (ScGTI) kindly assisted in the creation of these diagrams. They show the
distribution of all probes as grouped in four categories: those signals produced by spots of
buffer alone, signals from probes that bind to genes of interest, signals from negative control
probes, and lastly signals form probes that bind to housekeeping genes. The signals from
96

























































Figure9B,close-upofthlowerefthandsub-array.Thsign l:back roundratioincreasehybr dis tiontemper tureincrea ed.T lowerev lofbackgroundatthhigh rtempe at resallowedrsensitivcanningfthrraygeneratstro gp big l.Indditio , thebuff rspotsdidn texhibitanyig al,sugg stingthaDNAc rryoverw sminimala dinoco t butt esignalinte si y(col mns bufferspotsarlabell dwithrrow).Signalint sityasvisu li edhecol ursc lithincr asingi t ityden tedfrombla kt ,l , green,yellowr danwhit(m ximalsignalintensity).
Chapter 3 Microarray development
buffer spots were all minimal as expected and represent the background level binding of
cDNA to the array surface. For all four temperatures the probes that bind to genes of interest
were highly variable in their signal intensities. This was to be expected since not all genes
were expressed in this resting macrophage cell line - indeed the low mean signal intensity
suggests most genes were either not expressed or were expressed at a level too low for the
array platform to detect. The signal intensity of the negative probes is critical since they
inform on the level of non-specific binding by labelled cDNA to non-complementary probes.
It was evident that the ratio between the mean signal of the negative probes and the mean of
the positive control changed dramatically as the temperature increased. At 50°C the negative
and positive probes produced a signal that was not too dissimilar, whilst at 57°C the signal
intensity of the positive control probes was substantially higher than that of the negative
control probes. Not only were these two signal means very different but there was very little
overlap of the signals generated by positive controls and negative controls at 57°C,
suggesting the ideal hybridisation temperature was 57°C or higher.
To determine whether a temperature higher than 57°C would give a higher positive control:
negative control probe signal ratio, another experiment was undertaken at 52, 57, 62 and
67°C. Figure 11 shows the whisker plots of these hybridisations and clearly demonstrates
that 57°C was the optimal temperature, possessing the highest positive: negative probe signal
ratio. The hybridisations at other temperatures exhibited populations of positive control
probes that produced signals that were not substantially different from the negatives.
3.3.2 Optimisation of blocking strategy and cDNA production
Prior to hybridisation the array surface was processed to block sites that would otherwise
non-specifically bind labelled cDNA. Different blocking strategies had differing results. The
data presented so far relied on a simple blocking procedure that was effective but
inconsistent. This method relied on using in-house manufactured poly-L-lysine coated slides
that immediately prior to hybridisation were blocked using succinic anhydride dissolved in
anhydride N-methyl-2-pyrrolidinone (similar to method described in 2.11.4). This blocking
protocol occasionally resulted in artefacts that obscured meaningful data. Considering the
high cost of microarray labelling and of the arrays themselves, it was essential to spend time
developing the best blocking strategy. An experiment was undertaken to compare the relative
blocking efficiency of the succinic anhydride/NMP method alone with succinic
anhydride/NMP plus an addition blocking in bovine serum albumin (BSA). The BSA
mixture was created by dissolving 2.2 g of BSA (fraction V) in 100 ml nuclease free water,





















Buffer spot Gene of InterestNegative Control Positive control
Group.variable
Figure 10, whisker plots showing the spread of probe signal intensities for buffer spots,
gene of interest probes, negative control probes and positive control probes. Samples
sourced from the same cDNA substrate were used for each hybridis ation and were undertaken at: 50 °C,
52.5°C, 55°C and 57.5°C as labelled. Each whisker plot shows the spread of probe signa Is: the grey
block signifies all the data points between the 25 th and 75lh percentile (constituting 50% of all values).
The line that intersects a black dot signifies the mean average of all data points. The area that is covered
by the two horizontal brackets, which is connected by a vertical straight line, constitutes 90% of all the
data points. The remaining values that fall outside of these (re ferred to as outliers) are signified with
grey lines. Notice that the maximal difference between negative control signal and positive control
signals was at 57°C. The expression of genes of interest are expected to be highly variable and mostly






















Buffer spot Gene of Interest Negative Control
Group
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Figure 11, whisker plots demonstrating the spread of probe signals at differing hybridisation
temperatures. The positive control probes at 52, 62 and 67°C are not substantially different from the
negative control probes. However, the mean of the positive probe s hybridised at 57°C is substantially higher as
is the spread of the data points. Notice that the mean of the ge nes of interest are also higher than the negative
controls only at this temperature. The probe signal values are p lotted on a log scale.
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NMP, two arrays were washed and dried as before and then immersed in the BSA mix for 45
minutes. Following this the arrays were washed by submerging the slides in 500 ml milliQ
purified water twice, then in 250 ml isopropanol five times and spun dry. Two other arrays
were also blocked using the same NMP mixture but were not further blocked with BSA.
J774.1 macrophage labelled cDNA was then hybridised to the two groups of arrays and their
background fluorescence measured (figure 12). There was a clear difference between the two
methods of blocking, not only did the additional step of BSA blocking reduce general
background signal, but the presence of fluorescent artefacts was reduced. Indeed, analysis of
the data from these arrays showed that the ratio of positive control signal to negative control
signal was higher following BSA blocking (figure 13). It should be noted that despite the
improvement there was still considerable background signal present.
To determine whether background and fluorescent artefacts were partly due to
inconsistencies in the manufacture of in-house poly-lysine coated slides, an experiment was
undertaken to determine whether commercially available Corning Gap™ slides produced a
lower background signal. Corning Gap slides have the advantage of being subjected to more
thorough quality control by the manufacturer although they increase the cost of the
experiment. In addition, these slides require slightly different processing compared to the in-
house manufactured slides (as detailed in 2.11.4): an exposure to UV that cross-links the 50-
mer oligonucleotide probes followed by a blocking step in the NMP/succinic anhydride
solution alone (figure 14). The results demonstrated that Corning Gap slides consistently
produced a lower background than in-house manufactured slides blocked with either NMP or
NMP/BSA.
The level of cDNA production is critical for the generation of a sensitive microarray
platform. Not only does the total amount of cDNA have to be optimised but also the length
of each cDNA strand must be long enough to encode the site complementary to its probe. An
experiment was undertaken to compare the relative abilities of two different enzymes to
produce labelled cDNA: Superscript II verses the Fluoroscript™ microarray labelling system
(Invitrogen). The Fluoroscript enzyme has been specifically altered so that incorporation of
Cy-dyes occurs more readily and has been optimised by the suppliers for microarray
labelling (see section 2.11.3). In addition, the Fluoroscript enzyme has the advantage of
using less reagents including Cy3-dCTP, making it more affordable and takes half the time
to make cDNA, an important consideration due to the time consuming nature of the
microarray protocol. An experiment was undertaken to analyse differences in cDNA
labelling by comparing the signal intensities of the housekeeping probes. In this experiment
the same RNA substrate was labelled using the separate enzymes and hybridised to the array
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Figure 14, Corning Gap slides exhibit a low level of background signal. Two in-house poly-L-
lysine slides (A and B) and two coming gap slides (C and D) were compared as substrates for microarray
hybridisation. The four microarrays were blocked concurrently in the same NMP/succinic solution and the
two in-house slides were subjected to a further block in BSA. N9 microglia RNA was labelled and
hybridised to these arrays and scanned. Shown above are representative sections of each array scanned at
the same PMT level, displayed both in "raw image" format (left-hand side) and in a format in which the
colours have been inverted to better demonstrate background signal (right-hand side). The in-house slides
clearly have a higher background signal as shown by the blue colour in the raw image format and the
darker yellow colour in the inverted format. Conversely, the Coming Gap slides exhibit little background
signal as shown by the black on the raw image format and the pale yellow on the inverted format. Signal
intensity was visualised in the raw image as a colour scale with increasing intensity denoted from black to,
blue, green,yellow red and white (maximal signal intensity). The scale is inverted for the other images (i.e.
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surface in an otherwise identical manner. Following scanning and data acquisition the probe
signals were normalised to one another using global normalisation to correct for differing
hybridisation efficiencies and scan settings (this method of normalisation was chosen since it
takes into account the overall signal intensity of the array and was influenced by all probe
signal intensities). Since the hybridisations were undertaken using the same RNA sample,
differences in signal intensity were minimal and reflected differences in the labelling
strategy. Figure 15 shows the signal intensities of all 30 positive control probes for two
arrays that utilised the new fluoroscript enzyme and a third array that utilised Superscript II
to label the cDNA. The signal intensity for the fluoroscript-labelled arrays appeared to not
only be adequate compared to the superscript-labelled array, but also more efficient despite
using less Cy3-dCTP in the labelling master mix. In addition, visualisation of the array
surface revealed that fluoroscript labelled arrays had a lower level of non-specific signal,
resulting in a higher specific signal: background ratio (figure 16). This may be due to a
reduction in the amount of unlabelled Cy3-dye present. In addition, the higher signal:
background ratio on the fluoroscript arrays may be due to the production of more full-length
cDNA that generate specific signals. (Note that this experiment used in-house poly-lysine
coated slides and not the corning gap slides that give more optimal background and so
cannot be directly compared to figure 14).
3.3.3 An initial assessment of replicate variability / reproducibility
To determine the reproducibility of the microarray platform an experiment was undertaken
to measure inter-array variability independent of sample variation. Total RNA from J774.1
macrophages sufficient for five microarrays was labeled in a single reaction and prepared for
hybridisation to five microarray chips that were prepared and blocked concurrently, using the
same conditions and reagents. The data was analysed as detailed in section 3.3.5. Briefly, the
median of each probe (printed in triplicate) was taken and the other replicates for each probe
discarded. Using these values each array was normalised relative to the first array.
Normalisation was essential since each array was scanned at a differing sensitivity and
produced different global signal intensities. Normalisation is a data transformation that
adjusts values and allows the data from any two or more groups to be appropriately
compared. In this experiment, each array was globally normalised by comparing the 75th
percentile of all probes on the array to each other to generate a normalisation factor. The 75th
percentile has the advantage of being relatively insensitive to outliers, compared to the mean
average, and accurately reflects the signal intensity of any given population of probes












































































































Figure16,fluoroscriptlabell ngre ultsine son-specificbi dfcDNAtprob sc mpl mentaryA.thaliana transcripts.(AandB)Twoeparaterr yshybridisedtocDNAmfluoroscript.C)Rep en iver ayellu ingDNA SuperscriptII(RNAwassourcedfromthea eampl ).E him gobt in dus ngt mc ingensitivitysettin(PMT=52).Th imagesdemonstratethafluoroscript-labell drr ysh vsbackg ounsignalndt tpr bi lsam rs ecific.Nh superscript-labelleda raypo sess sobethath vboundlab lledcDNAinappar ntnon-sp cificma n r.I ar icular,tprob sk theredboxarspecificA.thalianar nscriptsnhouldlabell d.Nev rthe ess,rwoti eablesig lft sbei superscript-labelleda raycom rethefluoro cript-labelr ys.Sign lint itywvi u list awimago ours ith increasingten itydenotedfromblack,lu ,gr en,yellowwhite(m xi alsignintensity).Thcav rt drot rs (i.e.whiteisminimumgnalintensitya dbl ckaxi u ltensity).
Chapter 3 Microarray development
the observed inter-array variability and so balance the fluorescence signal. Global
normalisation is advantageous in this experiment since there will not be large differences in
overall signal, since the same labeled cDNA substrate has been used in each case. Despite
global normalisation probe signal can still vary substantially.
Figure 17 shows the spread of probe signals for all the housekeeping genes for all five
arrays. This population of genes was chosen to determine inter-array variability since they
represent a group of genes known to be expressed in the cell line and to be present at varying
levels, enabling determination of the extent of variability for highly and lowly expressed
transcripts. Figure 17 demonstrates that whilst the arrays showed some consistency there was
also a large amount of variability for both high and low expressed transcripts. For example,
the probes complementary to EF-1 and ferritin generated a consistent signal on all five
arrays, whilst the probe complementary to cofilin and lactate dehydrogenase generated a
signal that was highly variable between arrays. The introduction of error during data analysis
was unlikely since the values had simply been adjusted using one normalising value and
whilst the second array (pink squares on figure 17) produced the lowest signal for several
probes it also generated some of the highest signals for other probes, indicating that the
normalisation process had not consistently skewed the signals from this array in any
particular direction. This implies that variation was occurring across the array surface
irrespective of the normalisation procedure i.e. one part of the array was brighter/produced a
stronger probe signal than other parts of the array. Indeed, figure 18 shows the signal for
selected probe replicates varied across the array. This finding has implications for further
work when analysing different cDNA samples. Indeed, the ability of the array to discriminate
subtle changes in gene expression from one biological sample to the next is questionable
considering the extent of the variation shown in figures 17 and 18. Thus, there was a clear
need for a system to efficiently measure signal differences across the array surface and
correct for this.
3.3.4 The SpotReport™ system can efficiently normalise probe signal across
the microarray surface (intra-array normalisation)
The SpotReport system (Stratagene) is a useful tool in facilitating the optimisation,
validation and standardisation of microarray data. The system consists of ten A.thaliana
genes that have been cloned and characterized for use as exogenous nucleic acid controls for
non-plant microarrays. Supplied with the system are ten mRNA "spikes" each of which
represents an A.thaliana transcript and ten 70-mer oligonucleotides that are complementary
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Figure 18, probe replicates generated different levels signal intensity that
depended on their position on the array surface. Non-normalised values for specific
probe replicates have been plotted from the third array (top graph) and fifth array (bottom
graph), and both show that the signal decreases from replicate 1 (located at the top of its sub-
array) to replicate 3 (located at the bottom of its sub-array).
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The mRNA spikes are added to the experimental RNA and utilised to synthesize labeled
cDNA as usual. The hybridisation signals from the SpotReport probes on the array can be
evaluated to determine the sensitivity, specificity, signal linearity and consistency of the
microarray (for example, whether signal varies across the array surface). Importantly, this
system can also be used as a basis for normalising the signal intensity across the array
surface (intra-assay normalisation) and as method to normalise signal intensity between
arrays (inter-assay normalisation) (Causton et al., 2003).
To incorporate the SpotReport system a second-generation array was designed and printed.
This had several changes compared to the first-generation array. These changes are
summarised in figure 19. Most importantly the ten SpotReport probes were spotted in
triplicate in each of the four sub-arrays so that in total each array possessed a total of 120
spots from the SpotReport system. In addition, 50-mer probes complementary to
housekeeping genes that were shown to give a strong signal upon binding from the previous
hybridisations were spotted in the top-left hand corner of each sub-array. This positioning
was undertaken to aid orientation upon image capture, to enable quick evaluation that the
entire array is present and to ensure that the hybridisation solution has been in contact with
the whole array surface (figure 19A).
There were several factors that affected the ability of the SpotReport system to function.
Firstly, the SpotReport probes arrayed onto the microarray were 70 nucleotides long whilst
all the other probes were 50 nucleotides long. These two populations of probes have very
different thermodynamics and do not hybridise to complementary sequences to the same
extent at any given temperature. Theoretically, 70-mer probes possess a Tm that is higher
than the smaller 50-mer probes. Thus hybridisation to cDNA at temperatures optimal for 50-
mer probes (shown in section 3.3.1 to be 57.5°C) may have resulted in non-specific binding
of cDNA to the longer 70-mer probes. Figure 19B shows that upon hybridisation to murine
cDNA alone, the SpotReport probes did not bind non-specifically to murine cDNA at
57.5°C. This suggests that the 70-mer and 50-mer probes can be used concurrently on the
same array and that the array platform as whole exhibits high specificity to the probes
intended cDNA targets.
To determine the amount of mRNA spike required, an experiment was undertaken whereby
differing amounts of mRNA spike were added to J774.1 RNA prior to synthesis of labeled
cDNA. Each spike was diluted in water containing 10 ng/pl yeast tRNA as a carrier to
prevent loss of specific spike mRNA at low concentrations. Two microarrays were
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Figure 19, layout of a sub-array on the second generation microarray. (A) Representative portion of
the second generation microarray with SpotReport™ spikes added to RNA prior to labelling. The major difference
between the previous microarray was the inclusion of SpotReport™ probes. These 70-mer oligonucleotide probes
were arrayed at the bottom of each replicate. There were 10 different SpotReport probes used in triplicate across
each sub-array, which makes a total of 30 spots per sub-array and a total of 120 spots across all four sub-arrays.
The positioning of the probes has also been subtly changed so that a positive control probe known to give to
generate a strong signal was included in the top-left hand corner of each sub-array (Ferritin:252, Ferritin:468, EF-
la: 1143 and EF-la:1469). This aids in orientation of the array upon scanning. (B) Representative portion of the
second generation array following hybridisation to cDNA that was not spiked with SpotReport prior to labeUing.
Signal intensity was visualised in these inverted images as a colour scale with increasing intensity denoted from
white to red, green, blue, and black (maximal signal intensity)
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cDNA spiked with 1 ng of each mRNA and two microarrays were hybridised to cDNA
spiked with 0.2 ng of each mRNA (figure 20). Ideally, the signal intensity of the SpotReport
probes should be similar to that of the 50-mer probes so that the signal from the SpotReport
probes can be measured at the same scan settings (PMT setting) as the 50-mer probes. In
addition, the signal from the SpotReport probes should not be saturated. Figure 20 shows
representative sections of one array at each of the spike concentrations and demonstrates that
the addition of either 5 ng or 1 ng of spike saturated the scan. In addition to saturation, large
smears were apparent that blocked the signal from other probes on the array. This occurred
since a small amount of oligonucleotide probe often binds to the array surface when the
microarray is blocked with the NMP/succinic anhydride solution, but is not normally
detected. However, since the amount of cDNA species that was specific for these probes was
present in such amounts, these smears have been labeled. The addition of 0.2 ng of each
spike did not saturate the spot report probes at a scanning setting that was also appropriate
for the 50-mer probes, indicating that this was a suitable working concentration of spike.
Notice that the intensity of the SpotReport probes was between that of the highly expressed
housekeeping gene probe located on the very top-left of the array and other 50-mer probes
that gave lower signals.
In addition, notice that the SpotReport probes individually differed in their signal intensity.
This was advantageous since it can be used to demonstrate the variability of signal across the
array for cDNA species that bind at high levels and at low levels (the signal intensity of each
probe is product of cDNA level and of probe/cDNA affinity).
The SpotReport system was used to both highlight signal variation across the array and to
correct any signal bias by normalising the sub-arrays; figure 21 demonstrates an example of
this. Total RNA from J774.1 cells was spiked with 0.2 ng spike and hybridised to the array
surface. The top graph of figure 21 shows the signal intensities for all 120 spot report probes,
and demonstrates that there is a modest but clear increase in signal on the bottom right sub-
array (D) for this particular hybridisation (as represented by the last three data points for
each probe on the right of the graph). To correct for this bias, the 75th percentile of all 30
SpotReport probes from each sub array was calculated to generate a normalisation factor and
used to adjust the data to compensate for the observed intra-subarray variability (Table 6).
The resulting normalised signal intensity of each probe was plotted (bottom graph of figure
21). This shows the normalised probe signal intensities, as a population are consistent across
the array.
This process successfully normalised signal between sub-arrays. However, as figure 21
demonstrates, within any given triplicate in a sub-array the probe signal can vary as well.
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Figure 21, differences in probe signal corrected by SpotReport Shown are the probe signal
intensities for all SpotReport spots across the microarray surface. The top graph shows the signal
intensities as scanned, whilst the lower graph demonstrates the signal intensities post-normalisation. The
first three triplicates (A) represent the top left sub-array, the second set (B) the top right, the third set (C)
the bottom left and the fourth set (D) the bottom right. Theoretically, an ideal hybridisation to an ideally
printed microarray would produce signals from SpotReport probes that were identical across the array
surface for each particular probe. The top graph demonstrates that the bottom right hand-side of the
microarray produced a higher signal. To correct for this bias, each sub array was normalised to the mean
of the 75th percentile (see section 3.3.7 for more details on intra-normalisation) and then the resulting
SpotReport signals plotted (bottom graph). The process of normalisation, although not perfect, has
modified the signals so that as a population they are more homogenous. This has corrected the signal
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Figure 22, selection of the median from each triplicate reduces probe signal variation.
The normalised values plotted in figure 20 were taken and the median from each triplicate plotted. The
graph demonstrates that by using a combination of normalisation and restricted selection of the median,
the final signal intensity values are consistent across the array surface. From this detailed analysis of ten
genes, it can be assumed that a similar processing of the signal values for the genes of interest and
positive controls will also generate robust reproducible results. The lines that connect each data point
have been included to better demonstrate the consistency of each probe signal across the array surface.
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However, the process of data analysis negates the need for intra sub-array normalisation,
because only the median signal intensity for each probe triplicate is used. The median has the
advantage of being relatively insensitive to outlying, high intensity spot signals (which can
be caused by dust, unincorporated dye, or other artifacts that cause a small number of
saturated pixels within a spot area). By taking the median value the variation within the sub-
array is negated. For example, the normalised data from figure 21 was taken and the medians
calculated for each SpotReport probe. These probe signal medians were then plotted (figure
22) and demonstrate that individual probes generated a similar signal across the array surface
when only the median value was taken into account.
The ability of the second-generation platform to account for signal variation across the array
surface is important since this reduces the variability between arrays. Indeed, the ability of
the system to normalise probe signal across the array reduces the array-to-array variability
considerably and is illustrated in figure 24. This shows that the inter-array variability of
housekeeping probe signals is far less following intra-array normalisation (figure 24
compared to figure 17, where intra-normalisation had not been applied). Moreover, the data
in figure 24 was generated using different flasks of microglia cultures, and thus also was
affected by inter-flask biological variation, whilst the data in figure 17 was generated by
using a single cDNA source. There has been a clear improvement in the ability of the array
platform to repeatedly generate a consistent signal for a particular probe.
3.3.5 Probes complementary to house keeping genes can be effectively
utilised to normalise probe signal intensity between arrays (inter-array
normalisation)
Individual hybridisations tend to vary in the intensity of signal they generate due to factors
that cannot be easily controlled, such as; quality and amount of starting RNA; reverse
transcriptase efficiency; cDNA purification; microarray slide blocking efficiency, defects in
the microarray such as cracks and scratches in the slide coating, and subtle differences in
hybridisation conditions such as salt concentration and minor temperature differences (e.g.
the center of the hybridisation oven can be slightly hotter than the sides). In addition,
differing microarrays were scanned at differing levels of sensitivity depending on the overall
signal intensity of the array and an optimal scan chosen (see section 3.3.8 for more details).
Thus, hybridisations were represented by scans of differing signal intensity, which
complicates the comparison of absolute probe signals from one array to the next. However,
despite all these factors, the signal intensity of the housekeeping and SpotReport probes
should be equivalent. The non-variable nature of these probes enables their use as reference
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Sub-array position 75 Percentile Ratio to Mean
Top Left 10502 0.821
Top Right 12106 0.946
Bottom Left 13024 1.018
Bottom Right 15560 1.216
Mean Value 12798
Table 6, the determination of the normalisation factor for each sub-array. The
SpotReport values for each sub array were analysed and the 75 th percentile calculated (30
spots in each sub-array). The ratio between each 75 th percentile and the mean average 75 th
percentile value was determined. The signal intensity of every spot in each respective sub-
array was divided by this ratio. This modification normalised si gnal across the array. In this
case the bottom-right of the array has a higher signal than elsewhere on the arr ay. This bias
is negated by dividing each probe signal by the respective ratio .
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population of probes to normalise between hybridisations, and thus allow effective
comparison of absolute probe signal.
The SpotReport probes cannot control for the level and quality of starting RNA. The
housekeeping probes can control for all the factors listed above. Conversely, housekeeping
genes may be differentially modulated in some experimental conditions such as in vitro virus
infection whilst SpotReport probes will be unaffected by this (Causton et al., 2003).
However, if the number of housekeeping probes is sufficiently large and experimental-
induced expression changes affect only a few of these genes, housekeeping probes could
remain valid for normalisation. Global normalisation was considered to be unsuitable since a
large number of genes were expected to be altered during biological stimulation or infection.
This would result in differing global signals between control array and test array. To
determine the most effective strategy for inter-array normalisation five cultures of N9
microglia were grown until semi-confluent and RNA individually extracted. Each sample
was spiked with SpotReport RNA and cDNA synthesised separately and hybridised to the
second-generation microarray. The arrays were scanned and signal variation across
individual arrays was negated by intra-array normalisation using the SpotReport system (as
described above in section 3.3.4). The data was then normalised between arrays using one of
two methods. The first method involved determining the 75th percentile of all SpotReport
probes for all five arrays. A ratio was generated by comparing the five 75th percentile values
to the mean average 75th percentile and then used to adjust all other probes signals on each
respective array. Thus all probes were normalised to a reference value, the mean 75th
percentile. The second method was identical except that it involved determining the 75th
percentile of all 30 housekeeping probes (including all probe replicates so that 30 x 3 = 90
signals in total). To assess the success of each normalisation method the variation in absolute
probe signal intensity between arrays was compared for a set of probes chosen at random
(figure 23). Probe signal variation was a product of both biological and technological
variation. Figure 23 demonstrates that the method that utilises the housekeeping probes as
references for inter-array normalisation generates a lower degree of inter-array variability.
Note that not all error can be accounted for since the normalisation procedure can only
reduce error introduced by the microarray platform and cannot influence variation of gene
expression that occurs between differing cultures. The standard error of the mean (SEM) of
each probe was ascertained for each method and the difference between each SEM plotted
(figure 23C). Figure 23 shows that the method that utilises housekeeping genes produces a
lower SEM value for most probes, indicating that this method produced the least error. This
analysis was repeated and assessed by determining the spread of housekeeping probe signals
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themselves (figure 24) and again the SpotReport probes when used as reference probes for
normalising produces a higher SEM value for all but three probes. These three probes
possessed the three highest signals and may represent probes that saturated the scan. The
signal from probes that were saturated would not equate with the level of starting cDNA,
which means normalisation have little effect on reducing its variation between arrays. This
suggests the variation in probe signal for these three probes should not be used as a measure
forjudging the relative success of each normalisation protocol.
Interestingly, those probes that generate a signal intensity that is close to the background
level such as the two probes for c-yes are more highly influenced by the background noise.
Consequently, the signal from these probes are more prone to error and do not reflect a
failing in the ability of the system to normalise signal intensity between arrays. An example
of inter-array normalisation can be found in appendix 8 (found as a Microsoft Excel file on
the attached IBM PC formatted CD-ROM).
Housekeeping probes may be more accurate at determining and correcting inter-array
variability because these levels accurately reflected the amount of starting RNA whilst the
SpotReport probes did not inform on the starting RNA levels. This factor was particularly
relevant since the amount of RNA added to each reverse transcription was prone to a 30%
error (Agilent Bioanalyser). Nevertheless, the results demonstrate that this microarray
platform can accurately quantify gene transcript levels in a reproducible manner.
3.3.6 Estimation of dynamic range
The dynamic range of the microarray can be calculated by comparing the background signal
to the signal generated by housekeeping probes. The signal generated by the 50-mer negative
control probes that are 100% complementary to only non-animal gene sequences represents
the level of non-specific interaction between a 50-mer probe and a murine cDNA. Any probe
generating a signal at this level or below does not bind to a sufficient quantity of specific
cDNA to be above the detection threshold. The microarray platform must be able to
differentiate between probes that generate signal resulting from specific probe-cDNA
interaction and probes where signal results from non-specific interactions. For genes that are
lowly expressed this difference may be very small. To ensure that there is clear distinction
between these two categories of probes, the detection threshold was set high so that any
probe generating a signal above this level can be confidently considered a specific
interaction between probe and its target cDNA. Setting a high detection threshold meant
lowly expressed genes weren't detected but it ensured that transcripts detected were unlikely
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Figure 23, probes complementary to housekeeping probes are more
effective than the SpotReport probes at normalising signal between
arrays. (A) The signal intensity of several probes following inter-array normalisation
using SpotReport probes. (B) The signal intensity of the same probes following inter-
array normalisation using housekeeping probe signal intensities. (C) The SEM for each
probe for each normalisation method (A and B) were calculated and the difference
between the SEM calculated. A positive value indicates that the SpotReport normalised
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Figure 24, probes complementary to housekeeping probes are more effective than
SpotReport probes at normalising between arrays. (A) The signal intensity of all housekeeping
probes following inter-array normalisation that utilised the SpotReport probes. (B) The signal intensity of
all housekeeping probes following inter-array normalisation that utilised housekeeping signal intensities.
The blue line represents the detection threshold (mean + 2 standard deviation). (C) The SEM for each
probe for each normalisation method (A and B) were calculated and the difference between the SEM
calculated. A positive value indicates that the SpotReport normalised probes exhibit a higher SEM value.
N.B. A reciprocal plotting of SpotReport probes normalised by these two methods also demonstrated that
the normalisation method based on housekeeping genes was less error-prone.
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The background level was calculated for each array as being the product of the mean signal
of all negative control probes plus two standard deviations i.e. mean + (2 x SD). Figure 24B
shows the mean detection threshold for five arrays hybridised to N9 microglia cDNA. The
mean value of all negative control probes for these arrays was 2,370 arbitrary signal units
whilst the standard deviation of all the negative probes was 582 units. Thus the detection
threshold was calculated to be: 2,370 + 1164 = 3,534 units, and is plotted as a blue line on
figure 24B. All but two housekeeping genes were expressed at a sufficiently high level for
detection. Several housekeeping probes, including those for EF-1, generated a near maximal
signal and almost saturated the scan. The signal from these probes represents the highest
possible signal the microarray platform can measure. The probes that detect EF-1 transcripts
generated a signal of roughly 55,000 units. Therefore the dynamic range of the platform is
between 2,370 and 55,000 units and all gene products detected by the array will fall in this
range. Theoretically, if the dynamic range is linear, the largest fold increases detected will be
in the order of 55,000 / 3,534 = 15.6 fold change. However, the linearity of the microarray
platform has yet to be fully examined, and is explored further in chapter four.
3.3.7 Scan selection, image processing and an overview of data analysis
For clarity the complete methodology of microarray data manipulation is summarised below.
1. Image processing. The first step of image processing involved identifying the spots
on the array from spurious signals resulting from precipitated dye or other
hybridisation artefacts, contaminants such as dust on the surface of the slide or other
sources of non-specific background. This undertaking was greatly simplified by the
regular arrangement of features on the array surface as rectangular grids of sub-
arrays. The QuantArray1™ image analysis package was used to identify each spot.
This software required the user to identify approximately where each sub-array lies
along with other parameters, such as number of array rows, array columns and spot
size. "Nominal location" was used to identify each spot and its local region used to
estimate background signal (figure 25). The placement of the grid is extremely
important since the grid coordinates are used to identify each spot. To facilitate grid
placement "landing lights" were utilised on the second-generation array. These were
specific housekeeping probes that generated strong fluorescent signal regardless of
the quality of the hybridisation and were spotted at the very start and end of each
sub-array to facilitate unambiguous placement of the array grid.
2. Determination of local background. This microarray platform utilised a local
estimate of the background, a sophisticated technique that identified the number of
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pixels surrounding each spot to calculate a median background value. This process
involved determining the precise spot boundary and measuring the spot signal by
including only those pixels within the boundary. Accordingly the background signal
for each spot was determined by the number of pixels lying outside the spot
boundary but within the spots local region identified by the "nominal location".
Before any of the data was analysed further, the "true" signal of the spot was
calculated by subtracting the local background signal from the spot signal. All spots
underwent this process including positive and negative probes. Note that the
background signal described here is separate to the background signal of negative
control probes that represent the amount of labelled cDNA that binds non-
specifically to a 50-mer oligonucleotide probe.
3. PMT scanning value. The microarray was scanned using a 16-bit analogue-to-digital
converter that converts the signal from the photomultiplier tubes (PMT), which
measured fluorescence, to a digital value for each pixel in the resulting image. This
process generates relative intensity levels that are reported in a range from 0 to
65,535 arbitrary units. Differing intensities of image were captured by using
differing PMT values whilst keeping the level of laser intensity the same. Typically,
when the array was scanned at sensitivity of PMT 43 and below the probe signal
intensities were mostly at background level. As the sensitivity was increased by
increasing PMT, the signal intensity of the probes increased disproportionably to the
background signal. The optimal scanned image was one in which as many spot
signal intensities were as high as possible whilst avoiding saturation of any of the
spots. To determine the optimal scan, arrays were routinely scanned from PMT 43 to
PMT 61 and each image processed as detailed above. The signal intensities were
then plotted as scatter diagrams in which each scan is compared to the next (figure
26). Saturation of signal was evident by a curvature of the scatter plot and lowering
of the correlation coefficient (r2).
4. Normalisation. Once an optimal scan was identified the resultant signal intensities
could not be directly compared from array to array. There are a variety of reasons
why the raw measurements for two samples may not be directly comparable: the
quantity of staring RNA may not be equal, there may be differences in labelling and
each sample may generate a signal that is optimally scanned at differing PMT
settings. This microarray platform utilised two steps for normalisation: the first step
was to normalise signal across the array surface. This utilised the SpotReport system
as (detailed in section 3.3.4). The second was to normalise signal between arrays,
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this utilised housekeeping genes (detailed in section 3.3.5). In addition, the probe
signals from the SpotReport probes were used as basis for validating each
hybridisation. Hybridisations in which the signals varied dramatically across the
array surface were rejected as where hybridisations that generated little global
signal. Hybridisations that exhibited moderate variation of signal across the image
where successfully utilised once corrected by SpotReport and the data refined by
utilising only the median signal intensity from each probe triplicate. An example of
inter-array normalisation can be found in appendix 8 (found as a Microsoft Excel file
on the IBM PC formatted CD-ROM).
3.4 A study to investigate the effect of probe design on hybridisation
signal
The design of microarray probes is still one of trial and error. In this study the probes were
designed using a series of strict criteria detailed in section 3.2.2. Despite the implementation
of these strict criteria the probes as a population exhibited some diversity in respect to their
Tm values, AG value, probability of forming hairpin loops and their distance between site of
complementation and the cDNA polyT tail. Each gene was assayed by at least two probes
and examination of the data shows that each probe bound to a particular cDNA at differing
levels, reaffirming that probe signal intensity was a product of cDNA levels and sequence
specific probe affinity. For some probe pairs, such as the probes complementary to MARCO,
one probe bound with high affinity and generated substantial signal whilst the other probe
generated signal at background levels. Within a given hybridization the amount of cDNA for
any given transcript is the same. Thus, such discrepancies must be due to probe sequence
differences. To investigate this phenomenon all probe pairs that generated substantially
different signal intensities were examined in an attempt to identify which, if any of the probe
characteristics may be responsible. The ability of a probe to bind to cDNA and generate
signal was almost certainly due to a combination of all these factors. However, it was
possible to group probe pairs into categories; i) probe pairs that bind at least 400 bp apart on
the cDNA strand and don't have divergent probe Tm values; ii) probe pairs that have
divergent Tm values and bind within 400 bp of each other; and iii) probes pairs in which at
least one has substantial hairpin prediction (Tm of hairpin above 26°C).
Figure 27A demonstrates that the Tm of the probe did not correlate with probe signal
divergence. For example, the two probes for CD68 each possessed highly similar Tm values
and yet each probe generated substantially different signal intensities. The two probes for
Tubal exhibited more similar signal intensities than the CD68 probes and yet possessed
126
Chapter 3 Microarray development
markedly different Tm values. Therefore, the small difference in predicted probe Tm value
had little impact on probe pair signal differences. Likewise, figure 27B demonstrates that
predicted Tm of hairpin loops does not correlate with signal difference between probe pairs.
Figure 27B shows the Tm of the most stable hairpin for each probe. If the predicted hairpin
impacted on probe signal intensity, one would observe the signal intensity to be less for
probes that had high hairpin Tm values compared to its probe pair that has a less stable
hairpin. However, probe 1 for CD68 possessed the highest hairpin Tm and yet it is this
probe that possessed the highest signal. Whilst the probe pair for ScyblO possess markedly
differing hairpin Tm values and yet each produced a signal that was equivalent. Therefore it
would appear that predicted hairpin formation has no obvious impact on the ability of a
probe to generate differing signal intensities.
In contrast the site of probe complementation on the cDNA strand did affect the signal
intensity. Figure 28 shows the differences in signal intensities for probes that bind at least
400 bp apart on the cDNA strand but have similar Tm values. The signal intensity of the
most 3' probe was subtracted from the signal intensity of the probe that binds closer to the
5'polyT tail. A positive value indicates the 5' binding probe generated a stronger signal. The
graphs shows that the majority of 5' probes generated more signal than their more 3'
counterparts. In particular the probes for (3-actin and MARCO exhibited substantial signal
differences. However, it must be noted that not all probe pairs that bound at least 400 bp
pairs apart exhibited substantial signal differences, suggesting that as yet undefined factors
influence signal intensity between probe pairs.
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Figure 25, screen shots of a computer running QuantArray™. The top image
shows the raw image for a section of the microarray. Each spot fluoresced red due to the
presence of Cy3-Iabelled cDNA. The software locates each spot using "nominal location",
bottom image. The number of pixels within a spot was converted into signal intensity. The
level of background signal on the array surface was measured individually for each spot (the
area in each box surrounding a spot).
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Figure 26, a scan was selected that
detected as many spots as possible
but did not contain spots that were
saturated
Graph A shows a scatter diagram plotting
the probe signal intensities generated from
two scans of the same array set at PMT
43 and PMT 46 (the higher the PMT
value, the more sensitive the scan). This
graph demonstrates that most probes
produced a low signal in both scans and
few were substantially above background
levels
Graph B shows an ideal scatter plot in
which there are many probes that have
high signal and yet there is no evidence of
probe saturation. The scatter plot is
relatively straight and demonstrates good
correlation (r2 = 0.984), since the increase
in signal intensity from one scan to the
next was linear. Consequently, the scan at
PMT 51 was selected to represent this
hybridisation.
Graph C demonstrates that the next more
sensitive scan (PMT 53) generated
saturated spots, evident as a curving of the
line i.e. the increase in signal intensity
from PMT 51 to PMT 53 was not linear
for some of the probes. Accordingly the
correlation between the two scans was not
as high as that found in graph B.
All probe signal intensities were plotted
excluding negative control probes.
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Figure 27, differences in probe Tm values and hairpin Tm values did not correlate with
signal difference between probe pairs. (A) Probe pairs that generate a signal difference of at least
2,000 units and bound within 400 bp of the polyT tail have been plotted. The Tm of each probe has
been plotted on the left hand y-axis (squares) and the signal difference between each probe has been
plotted in respect to the right-hand y-axis (green triangle). The degree of signal difference did not
correlate with differences in probe Tm variation. (B) Probe pairs that bound within 400 bp of the polyT
tail and in which at least one probe possessed a predicted hairpin Tm of at least 26°C have been plotted.
The Tm of each probe's hairpin has been plotted on the left-hand y-axis (squares) and the absolute
signal generated by each probe has been plotted in respect to the right-hand axis (triangles). The Tm of
hairpin loops did not correlate with a difference in signal intensity, suggesting that this probe
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Figure 28, probes that bound closer to the 5'polyT tail produced more signal than
probes that bound at least 400 bp more 3'. Probe pairs that were separated by more than 400
bp were selected and the difference between their signal intensities plotted. The signal of the probe
that bound more 3' on the cDNA strand was subtracted from the signal of the the more 5' probe. A
positive value indicates the 5' probe generated a more intense signal. The graph demonstrates that
for the majority of probe pairs, it is the 5' probe that generated a higher signal intensity (blue
diamonds). However, this was not the case for all probe pairs (empty diamonds).
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3.5 Summary
This chapter has reported the development of a novel custom microarray platform. This
platform can effectively and repeatedly measure the expression of a multitude of genes of
interest. Probes have been designed to assay the expression of several key genes, including;
PRRs such as the TLR and scavenger receptor families; cytokines; chemokines; stress-
associated genes; and other genes of interest. These probes form a relatively
thermodynamically homogenous population of probes that hybridise optimally at 57.5°C. At
this temperature negative probes produce relatively little non-specific signal whilst positive
control probes produce a strong signal that can be readily detected. The glass surface, to
which the probes are spotted, bound DNA with high affinity and required blocking prior to
hybridisation. In house poly-lysine coated slides required two stages of blocking with
NMP/succinic anhydride followed by BSA. However, commercially available Corning Gap
slides blocked with NMP/succinic anhydride alone were found to generate the lowest
background signal in a reproducible manner. The cDNA labeling reaction was studied and it
was found that the reverse transcriptase enzyme Fluoroscript labeled cDNA more efficiently
and more cheaply than Superscript II.
This chapter also reported that the signal from probe replicates varied across the array and
was hampering effective inter-array comparisons. To address this issue the RNA was spiked
with exogenous A.thaliana mRNA controls that bound to specifically designed probes
spotted extensively across the array surface (SpotReport system). By normalising the signal
of each sub-array using the A.thaliana probes as references the variation in signal intensity
was controlled.
To examine gene expression in test and control samples, effective inter-array comparison is
critical. This chapter has shown that housekeeping probes can effectively be used as a
population of reference probes to normalise microarray signal intensities. Once normalised
the probe signal intensities can be effectively compared between arrays and replicate cultures
of resting N9 microglia. This demonstrated that the entire process of RNA extraction, cDNA
labeling, microarray printing, blocking, hybridisation, image processing and data analysis
resulted in a reproducible signal for transcripts that do not vary considerably between resting
cultures of microglia.
The exact criteria that are critical for microarray probe design are still not well defined. This
study investigated which probe characteristics were responsible for a probe's failure to
generate signal. Several transcripts possessed probe pairs in which one generated signal and
the other did not. Investigation of probe pairs that generated divergent signal intensities
demonstrated that probe Tm or their predicted ability to form hairpin secondary structures
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did not correlate with probe signal intensity. This suggests that the strict rules imposed on
probe design had prevented the design of inappropriate probes for these two criteria. It was
determined that probes that bound at least 400 bp apart produced divergent signal, with the
more 3' probe generating less signal. This can be explained by the reported relative
inefficiency of reverse transcriptase activity when incorporating bulky Cy dyes, which limits
the production of long cDNA strands and enriches the number of short cDNA strands
(Causton et al., 2003). Despite this finding, a number of probe pairs generated different
signal intensities for unknown reasons. Conceivably, the oligonucelotide probes may have
been synthesised incorrectly by the manufacturer. More work needs to be done to better
understand which probe characteristics are responsible for affecting the level of probe
binding at a given hyrbidisation condition.
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Chapter 4. Validation of the custom microarray and characterisation of gene





4.1.2 Aims and objectives
4.2 N9 microglia express a multitude of genes involved in innate immune
responses at rest
4.3 The microarray was able to discern gene transcript changes in N9
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4.1.1 Introduction
In the previous chapter a novel custom microarray was designed and developed to assay
gene transcripts associated with innate immune responses. Methods to accurately normalise
and analyse the data were optimised to provide consistent reproducible results for biological
replicates. The ability of the microarray to produce a reproducible signal was demonstrated
in chapter 3 but not its ability to accurately discern gene expression changes. This chapter
exploits the microarray platform to characterise the levels of gene transcripts involved in
innate immune responses of microglia.
The N9 microglia cell line was first characterised due to its ability to respond to LPS and has
since been extensively used as a cell line representative of resting microglia (Ferrari et al.,
1996; Meda et al., 1995). In this study the cell line was used to ascertain whether the
microarray could describe changes in several key immune gene transcripts upon exposure to
LPS or infection with SFV. LPS is a potent stimulator of the innate immune response in
microglia and upregulates several transcripts, including the pro-inflammatory cytokines
(Olson and Miller, 2004). SFV is a neuroinvasive virus that initiates encephalitis and
activates glial cells in vivo. Microglia play an important role in the initiation of CNS immune
responses and possess an ability to trigger processes that are destructive to neurones, yet the
innate immune response of microglia to SFV infection has been little studied. This chapter
investigates the ability of the microarray platform to discern changes in microglial transcripts
under two different forms of innate immune stimulus; LPS stimulation and infection with
SFV. In addition, this chapter examines the qualitative and quantitative differences in
microglial responses to these two stimuli. The initial response of innate immune cells, such
as microglia, is pivotal in initiating appropriate adaptive immune responses that act to clear
microbes. In particular, dendritic cells can activate differing adaptive immune responses to
differing pathogens (Re and Strominger, 2001; Qi et al., 2003). This chapter aims to
determine whether microglia, the only cell in the CNS capable of activating T -cells, have the
capacity to trigger different and appropriate responses to different innate immune stimuli.
Control, LPS stimulated and SFV infected microglia cDNA were hybridised to microarrays
and gene transcript levels determined using the techniques developed in chapter 3. To
validate changes in transcript levels a robust quantitative PCR (QPCR) technique, able to
accurately measure transcript levels was developed.
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4.1.2 Objectives
1. To discern the expression profile of several key genes involved in innate immune
responses in resting N9 microglia with use of the custom microarray
2. To investigate changes in gene transcript levels in N9 microglia upon stimulation
with LPS with use of the microarray
3. To utilise the microarray to assay gene transcript changes of microglia upon
infection with SFV
4. To develop QPCR assays for several key genes; including the TLRs and other gene
transcripts such as IFN-a
5. To validate the results of the microarray by assaying key gene transcript changes
with the use of the QPCR platform
4.2 Resting N9 microglia express a multitude of genes involved in innate
immune responses
To determine the expression profile of resting N9 microglia, four cultures were grown for 48
hours until semi-confluent and harvested for RNA extraction. cDNA from individual
cultures grown in parallel were hybridised to the microarray and transcript levels determined
as detailed in chapter 3 (figure 29). All probes that generated a signal greater than the
detection threshold (see section 3.3.6) are plotted in figure 29. Since the signal intensity
generated by a particular probe is a product of both the amount of transcript present and the
degree to which the hybridisation conditions allow probe binding, it cannot be firmly
inferred that differing signal intensity between differing probes accurately reflects the
starting amount of cellular transcript. Indeed, each probe must be treated independently; for
example most probe pairs give differing signal intensities despite the amount of a specific
transcript being uniform e.g. the two probes for (3-actin differed substantially in their signal
intensity.
Figure 29 demonstrates that resting N9 microglia expressed a range of genes including all
housekeeping genes with the exception of c-yes, a gene previously shown to be lowly
expressed in some tissue types, and one probe for GSK-3 (Warrington et al., 2000). That
probes did not generate a signal above the threshold of detection may be due to several
factors including; low level of gene transcript; unfavourable hybridisation conditions; probe
secondary structure; or erroneous oligonucleotide synthesis by the manufacturer. Since c-yes
is known to be lowly expressed and both probes generated minimal signal it is likely that
transcript levels were below the level of detection. Conversely, one of the GSK-3 probes was
the only probe that unexpectedly failed to produce a positive signal whilst the other GSK-3
136
Figure 29, signal intensity of probes above background level indicate those genes
expressed by resting N9 microglia. Four cultures of resting N9 microglia were hybridised to four
separate arrays and data analysed as detailed in chapter 3. The signal intensity from probes
designed to be complementary to transcripts of non-animal origin indicated the level of non-specific
hybridisation. The threshold for a positive signal was set as the mean plus two standard deviations
of the average signal of 12 negative control probes (each spotted 3 times). Those probes
generating a signal higher than this threshold value in at least three of the four arrays are plotted
here. Error bars indicate ± SEM from four arrays. In some cases only one probe out of a probe pair
generated a signal higher than background. In the case of both probes generating a positive signal
(such as CD14), the probe that bound closest to the 5' poly T tail is plotted after the more 3' probe.
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probe generated substantial signal. This failure to generate signal was therefore most likely
due to factors other than transcript levels. This single example indicates that the numbers of
probes failing to hybridise was very low. This suggests the probe design criteria had
successfully generated a population of homogenous probes that hybridised under similar
conditions.
Figure 29 demonstrates that a wide variety of gene transcripts were detected in resting N9
microglia, including typical markers of microglia/macrophages such as CD 14, CD68,
complement receptors 1 and 3, and scavenger receptors. Additional cell surface markers
whose probes generated signal included CD36-like 2, formyl-peptide receptor, HM74,
laminin receptor, peptidoglycan receptor protein (pgrp), TLR 2, 4, 7 and 9 and TREM-2
amongst others. Figure 29 also demonstrates that N9 microglia constitutively expressed
transcripts for cytokines such as TGF-p, chemokines such as MlP-la and MIP-1|3 (whose
probe names are Scya3 and Scya4 respectively), gene associated with phagocytic responses
such as NCF 1 and 2 (part of the NAPDH-oxidase system that generates toxic free radicals),
Cathepsin D (a lysosomal protease) and Ptgs-1 and Ptgs-2 (also known as COX-1 and COX-
2 that mediate prostaglandin synthesis). Finally, probes complementary to transcripts
associated with responses to stress were also expressed, such as Osi (induced by stress in
macrophages), SOD-1 and SOD-2 (scavengers of free radicals), genes involved in
glutathione synthesis (such as GSS that acts to protect against free radicals) and heat shock
proteins hsp25 and heme oxygenase 1. The functions of all gene transcripts assayed by the
microarray are briefly summarised in appendix 2.
4.3 The microarray was able to discern gene transcript changes in N9
microglia following LPS stimulation
In parallel, ten cultures of N9 microglia were grown until semi-confluent and then treated
with either LPS in PBS or PBS alone for 18 hours and harvested for RNA extraction. The
resultant cDNA was hybridised to the microarray platform and data analysed as detailed in
chapter 3. During RNA extraction one control sample was degraded and a further control
sample failed to hybridise effectively to the microarray, such that the final data represented
three cultures of PBS exposed microglia and five cultures of LPS stimulated microglia
(figure 30). The microarray data demonstrates that a multitude of probes gave significantly
differing signal intensities when hybridised to cDNA from LPS stimulated N9 cells
compared to cDNA from resting cultures, indicating transcript levels were altered. In
particular, a series of cytokines were significantly upregulated following LPS stimulation
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referred to as ScyblO). Several transcripts associated with stress were also upregulated. The
free-radical scavenger SOD-2 exhibited the largest increase. Significant increases were also
seen for heme oxygenase, catalase, GSR, Osi, and free radical generator NCF1. The lectin
Clecsf 9 (also known as Mincle) was also upregulated in cDNA from LPS cells. Conversely,
several transcripts that encode cellular receptors were down-regulated in LPS stimulated
samples, such as TREM-2, TLR 4, scavenger receptor B-I and mannose receptor 1. The
analysis of microarray data for this experiment can be found in appendix 9, a Microsoft
Excel™ file, on the IBM PC formatted CD-ROM.
4.4 A separate population of gene transcripts were altered in N9 microglia
following infection with SFV4
Parallel cultures of N9 microglia were grown until semi-confluent and infected with SFV
(MOI=0.1) and harvested for RNA extraction at 3, 12 and 24 hours post infection. The
resultant cDNA were hybridised to the microarray platform and data analysed as detailed in
chapter 3. It has been reported that infection with virus can decrease the level of
housekeeping genes during the course of infection and in the process render them
inappropriate for normalisation purposes (Goodbourn et al., 2000). However, the infection of
glial cultures with a HSV at a low MOI has been shown to have minimal effect on
housekeeping transcript levels (Michael Buchmeier, Scripps Research Institute - personal
communication). To determine if any housekeeping transcript were altered by SFV infection,
the signal intensities of all housekeeping probes post normalisation were plotted for
uninfected samples (0 hour) and for samples 12 hours post infection (figure 32). This graph
indicates that housekeeping transcript were unaffected by SFV infection at 12 hours. Note
that these probe signals have been normalised to a value generated by the levels of
housekeeping transcripts. In effect, this graph shows levels of transcripts normalised to them.
Thus, individual probes that are affected by SFV infection would be identified, although a
generalised down-regulation of all transcripts to an equal extent would not be identified by
this plot. However, further analysis of housekeeping transcripts (3-actin and GAPDH by
QPCR demonstrated levels were not significantly altered by SFV infection (Figure 41A).
Consequently housekeeping probe signals were used to normalise the array data. A similar
analysis was undertaken for samples 24 hours post infection and housekeeping genes were
similarly unaffected (data not shown).
Following SFV infection, there were no significant changes in gene transcript levels at 3
hours. Changes were observed at 12 hours and are shown in figure 33. Down regulated
transcripts included the complement receptors ClqR and CR1, scavenger receptors CD68
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Figure 32, housekeeping transcripts levels were unaffected by infection with SFV4. cDNA
from N9 microglia at 0 hour post infection of 12 hours post infection were hybridised to
microarrays and data analysed and normalised as detailed in chapter 3. To demonstrate that the
normalisation process had worked, the signal intensities of the housekeeping transcripts are
plotted above. None of the probes, with the exception of the one of the Pbs probes, appeared to
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Figure 35, mean probe signal intensities at 0, 12 and 24 hours post infection with
SFV4. Some probes that gave signal intensities that were significantly different at 12 or 24
hours post infection compared to the 0 hour time point are plotted here as a time course to
show how transcript levels varied over time. The bars marked with an asterisk indicate that
the probe signal intensity was significantly different from 0 hour time point (Student's t-test,
p<0.05). All cultures ( n = 12) were grown in parallel.
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and SR-BI and GST-Pi (involved in glutathione synthesis). Despite the majority of
housekeeping probes being unaffected two were marginally down regulated, GNAS and Pbp.
Several transcripts were upregulated including some that mediate responses to viruses. These
included; IFN-a and IFN-(3; IL-6; chemokines MIP-1|3 and IP10; scavenger receptor A-I;
HM74; TLR 2 and 3; CD40 and Nos2 (the gene product responsible for inducible nitric
oxide synthesis in macrophages). There was no marked increase in the gene expression of
pro-inflammatory cytokines IL-la, IL-1J3 or TNF-a or in genes associated with cellular
stress such as heat shock proteins, Osi or SOD-2. The greatest fold increases were observed
for the chemokines MIP-1(3 and IP-10 followed by IFN-a.
Figure 34 shows the probes that gave significantly different signal intensities at 24 hours
post infection. Some of these were different to those identified at 12 hours post infection, but
many were the same. By 24 hours, the immunosuppressive cytokine TGF-(3 was down
regulated, as was TREM-2. Several cell surface receptors were upregulated such as CD14,
CD36 and TLR 2. TLR 3 was no longer significantly different from controls. Several
chemokines were upregulated including MlP-la (which was at basal levels at 12 hours post
infection). The highest fold increases were again observed with the chemokines MIP-1(3 and
IP-10. Both probes for the free-radical scavenger SOD-2 also gave a marginal but significant
higher signal at 24 hours.
Figure 35 summarises some of the changes in probe signal intensities over the course of
infection. The graph shows that most of the probes with decreased signal at 12 hours remain
depressed at 24 hours. Meanwhile, the probes for the type-I IFNs and IL-6 appear to peak at
12 hours post infection and then decrease. Conversely, the chemokines that are upregulated
at 12 hours remain at these higher levels or continue to increase. Finally, the probe signal
intensities for scavenger receptor A and TLR 2 progressively increase with time post
infection.
4.5 A series of QPCRs were designed and optimised to validate microarray
results and further explore gene transcript levels
To verify the microarray results another method of gene transcript quantification was used.
QPCR was developed for selected genes. A series of primers were designed and QPCRs
optimised as described in chapter 2. The QPCR could detect transcripts that were present
below the threshold of detection on the microarray. For example, on the microarray the
majority of probes complementary to the TLR transcripts were at or below the threshold of
detection. This meant that changes in TLR expression might not be adequately described.
The one exception was TLR 2 where signal was high enough to be detected at rest and was
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upregulated at 12 and 24 hours post infection with SFV. Nevertheless, a major aim of this
thesis was to describe TLR expression in cells of the CNS and the microarray platform
appeared to lack the sensitivity required to assay TLR transcripts in cultured N9 microglia.
The probability of the array platform being able to assay TLR transcripts in CNS tissue was
even less likely, due to the presence of numerous cell types in the CNS unlikely to express
TLRs that would dilute TLR transcripts from expressing cells. Thus, primers for all TLR
members were designed and TLR QPCRs optimised.
There are several methodologies that can be used to detect PCR amplification in real time
that rely on the production of a fluorescent signal once a PCR product is formed. These
techniques include the use of probes conjugated to a fluorophore, which directly label the
specific PCR product (a technique first developed by TaqMan™). This technique, whilst
highly sensitive, is prohibitively expensive and therefore inappropriate for extensive research
work. Alternatively, the PCR product can be labelled in real-time with SYBR-green dye, a
molecule that is only fluorescent upon intercalation into the double stranded DNA PCR
product. This method is considerably less expensive but requires greater optimisation of PCR
conditions, primarily because the non-specific nature of this dye means the PCR itself must
be highly specific. To ensure primers were specific, a set of strict criteria was used to design
primers and limit primer-dimer formation (see chapter 2 for criteria). Each QPCR was based
on the amplification of DNA by a set of "inner primers". To quantify transcript levels a
standard DNA template was assayed concurrently with samples of interest. Each specific
DNA template was generated in a standard PCR using a set of "outer" primers that
encompassed the region amplified by the inner primers (more details are found in chapter 2).
Figure 36A and B demonstrates the large dynamic range that the QPCR platform affords.
This figure shows the amplification of a DNA template present at a variety of concentrations.
The DNA template diluted 1 in 100 (1x10 2) was amplified first and each subsequent ten-fold
dilution was amplified at intervals of 3.3 cycles until the DNA template was diluted by 10
orders of magnitude. Software analysis located a threshold at which all curves represented
logarithmic growth, and the point at which the curve intersected this threshold determined
the CT value given in PCR cycles (see figure 36 for more details). Each QPCR experiment
included a series of diluted DNA template so that a standard curve could be constructed in
each case. The inclusion of a standard curve in each QPCR assay enabled the determination
of the threshold of detection, and demonstrated the ability of the platform to accurately
quantify starting DNA levels.
Figures 37, 38, and 39 demonstrate the specificity of each PCR primer set. Figure 37A















Figure 36, DNA standards were used to determine PCR sensitivity and quantify levels of
transcripts. (A) The TNF-a DNA template standard was diluted in ten-fold serial dilutions and 10~2
to 10~10 was used as a template in QPCR reactions along with a negative control in which there was
no template. Software analysis calculated the level of fluorescence at which all curves were
representative of logarithmic growth, known as the threshold value (shown here as a blue line
labeiled "Th"). The number of cycles completed by each PCR at the intersection of each curve with
this threshold was measured and is know as the CT value (given in cycle numbers). (B) This graph
plots the log of DNA template concentration against the CT values to create a standard curve and
thus equate PCR cycle number with starting DNA concentration. Note that the correlation of this
graph was high with R2=0.99 (1 = perfect correlation whilst 0 = no relationship). The standard curve
was used to quantify unknown transcript levels. Each QPCR experiment included a standard curve
along with samples of interest.
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Gene Genbank PCR product size
(in base pair (bp))
TLR1 NM 030682 216
TLR2 NM 011905 119
TLR3 NM 126166 406
TLR4 NM 021297 225
TLR5 NM 016928 169
TLR6 NM 011604 170
TLR7 NM 133211 270
TLR8 NM 133212 156
TLR9 NM 031178 304
TLR13 NM 205820 131
IL-1 alpha NM 010554 228
IL-1 beta NM 008361 269
Figure 37A, primers designed for use in quantitative PGR were specific. PCR products were
generated by amplifying cDNA from LPS stimulated N9 microglia. The resulting reactions were
analysed on an Agilent DNA chip using capillary electrophoresis; the single band demonstrates the



















Column Gene Genbank PCR product size
(in base pair (bp))
A Beta-actin NM_007393 202
B GAPDH NM_001001303 269
C IL-6 NM_031168 171
D SFV E1 X74491 173
E TNF-alpha NM 013693 260
F GFAP NM 010277 128
G IFN-alpha NM 010504 186
Figure 37B, primers designed for use in quantitative PCR were specific. PCR products
were generated by amplifying cDNAfrom LPS stimulated N9 microglia. The resulting reactions
were analysed by standard agarose gel electrophoresis; the single band demonstrates the
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Figure 39, melt-curve analysis was used to determine the specificity of all QPCRs.
Following optimisation of PCR conditions, the specificity was ascertained by undertaking a
melt curve analysis for all primer sets. Each graph shows the change in fluorescence over
time (dF/dT) on the y-axis, as the PCR mixture is heated from 65 to 93°C. The presence of a
single peak demonstrates the production of a single PCR product that represents a
homogeneous species of DNA that melts at a given temperature This figure is continued on
the next page.
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product for inner QPCR primers. Notice the absence of bands indicative of primer dimer or
other non-specific products. Figure 37B continued this analysis using standard gel
electrophoresis for inner QPCR primers. Figure 38 demonstrates the specificity of the outer
primers used to generate DNA templates. In addition to gel electrophoresis melt-curve
analysis was used to determine the specificity of each QPCR. Melt-curve analysis exploits
the thermodynamics of DNA complementation by assuming that at a given salt concentration
the amount of dsDNA present is dependent on temperature. Thus, following QPCR
amplification the mixture was heated from 63 to 93°C and the level of fluorescence measured
at 0.2°C increments. At 63°C fluorescence was high since at this temperature most PCR
product was present as dsDNA, whilst at 93°C almost all DNA had melted and fluorescence
was therefore minimal. The presence of specific PCR product was detected by a sudden loss
of fluorescence as the population of homogenous DNA strands melted. Non-specific
products of differing sizes could be detected as irregular decreases in fluorescence (figure
39). In practice the specificity of each QPCR was undertaken without exception by melt
curve analysis, rather than gel electrophoresis. Gel electrophoresis is relatively time intensive
whilst melt-curve analysis is a technique that can be programmed into the QPCR machine to
occur automatically at the end of each PCR.
To determine the reproducibility of the QPCR platform, 18 cDNA samples were assayed for
(1-actin content. Each cDNA sample was assayed twice and the standard deviation of the two
CT values calculated for each cDNA sample. The smallest standard deviation observed for
two samples was 0.0007 (mean = 13.325) whist the largest was 0.17 (mean = 13.22), whilst
the average standard deviation for all 18 samples was 0.049 (mean = 13.61). In addition, the
technique was developed and validated on two differing QPCR machines: the Rotor gene
3000 (Corbett Research) and the Lightcycler II (Roche). The Lightcyler offered the
advantage of being particularly quick and robust whilst the Rotor gene 3000 allowed a larger
number of samples to be assayed concurrently in a significantly less expensive manner.
4.6 QPCR was used to validate gene expression changes observed by the
microarray in LPS stimulated and SFV infected N9 microglia
The microarray results demonstrated several probe signal intensities were significantly
increased in LPS treated microglia, indicating that their complementary gene transcripts
were elevated. To validate this and more accurately determine changes, QPCR was
undertaken on two gene transcript: IL-la and IL-1(L In addition, although LPS stimulation is
known to upregulate IL-6 in primary microglia (Godbout et al., 2004), the microarray
identified no significant differences; to determine if the array results represented a false
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Probe 1 Probe 2 QPCR
IL-la 5.06* 5.57* 148.9*
IL-lp 1.92* 1.14 66.87*
IL-6 0.99 0.87 20.68*
Figure 40, validation of microarray results using QPCR and ELISA. The LPS
stimulated N9 RNA samples that generated the cDNA used for the microarray
hybridisations were also used to generate full-length cDNA for validation purposes. (A) The
transcript levels for IL-1a, IL-1 (3 and IL-6 were measured using QPCR. (B) The levels of IL-
6 in the tissue culture supernatant of the PBS and LPS stimulated N9 microglia were
measured using an ELISA and expressed as pg per ml tissue culture supernatant. (C) A
comparison of the estimates of fold change in transcript levels in LPS stimulated microglia,
as determined by probes on the microarray and the QPCR platform. Those values marked


































































Figure 41, QPCR analysis of SFV4 infected N9 cDNA. Transcript levels were determined
by QPCR as previously described. (A) Housekeeping gene transcripts were assayed and
absolute levels determined.(B) Genes of interest were assayed and expressed as fold
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Figure 42, infection of microglia with SFV4 increased levels of active caspase 3. The level
of caspase 3 activity was determined by assaying the cleavage of a caspase-specific substrate,
with and without the presence of a caspase 3 inhibitor. Cleavage of the substrate by caspase 3
released the colourimetric compound pNA. The level of non-specific conversion undertaken in
the presence of the caspase 3 inhibitor was subtracted to reveal the level of specific caspase 3
activity. Microglia were infected with SFV4 and sampled at 0, 3, 12 and 24 hours post infection.




negative, the levels of this cytokine transcript were also determined by QPCR (Figure 40A).
QPCR confirmed significant upregulation of both IL-la and IL-1(1 indicating that the
microarray correctly reported the increased expression of these two gene transcripts. QPCR
analysis also revealed a significant increase in IL-6 transcripts, a finding not observed by the
microarray. To confirm that expression of IL-6 resulted in de novo protein production, the
tissue culture supernatant of the LPS stimulated microglia was assayed by ELISA and
revealed significant IL-6 protein production (Figure 40B).
The level of upregulation on the array and on the QPCR platform was compared (Figure
40C). The fold increase in mean signal intensity for each microarray probe is shown along
with the fold increase of transcripts as determined by the QPCR platform. This table shows
that the fold increases estimated by the array platform were substantially lower than those
estimated by the QPCR platform. For example, the array indicated an increase in IL-la
transcripts of 5 fold, whilst the QPCR platform determined this increase to be 149 fold.
QPCR validation of SFV infected microglia was also undertaken (Figure 41). The
microarray results indicated a marginal increase in IL-6 transcripts at 12 hours post infection,
whilst IFN-a levels were clearly increased at 12 hours. QPCR analysis confirmed this
pattern of upregulation, and showed IFN-a to be also significantly upregulated at 24 hours.
Furthermore, the magnitude of fold increase for IFN-a at 12 hours was substantially higher
by QPCR than by array. Note that the level of housekeeping genes |3-actin and GAPDH were
unaffected by SFV infection.
To further investigate the effects of SFV infection on N9 microglia, levels of apoptosis were
measured (figure 42). Cultures of N9 microglia were infected with SFV4 concurrent with
those used for gene expression studies. At 3, 12 and 24 hours post infection; the cells and
tissue culture supernatant were harvested, lysed and assayed for caspase 3 activity, a marker
of late-stage apoptosis. At 3 hours no significant increase was seen in caspase 3 activity, by
12 hours a substantial increase in activity was observed that was maintained at 24 hours post
infection. Levels of caspase 3 activity did not reach that observed in staurosporin treated
(positive control) cultures of N9 cells.
4.7 Discussion
This chapter aimed to determine the ability of the custom microarray to detect gene
transcripts and discern changes in transcript levels between control and test samples. An
experiment was undertaken to determine whether the microarray could discern changes in
transcript levels following stimulation with LPS, a potent stimulant of the innate immune
system. This generated clear differences in a multitude of gene transcripts assayed by the
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array platform. A QPCR technique was developed for selected genes to quantitatively
determine transcript levels. The first part of this discussion examines the success of the
microarray and QPCR platform to discern transcript changes, whilst the second half
examines the biological meaning of the data.
4.7.1 The custom microarray can discern changes in gene transcripts
The microarray not only successfully characterised the transcript profile of resting N9
microglia but also was also able to discern changes in a multitude of transcripts following
LPS stimulation. Selected changes were validated by QPCR. Array analysis indicated that
following LPS stimulation, gene transcripts were both up and down-regulated, demonstrating
that the array platform can detect both increases and decreases in transcript levels. The signal
for individual probes demonstrated only a small variation between arrays hybridised to
biological replicates, a consequence of both biological variation and error introduced by the
experimental system and normalisation protocols. The small variation observed did not
confound the ability of the platform to generate statistically significant results. The
differences in probe signal intensities were subjected to Student's t-test and numerous probe
sets were significantly altered when hybridised to LPS stimulated samples. However, the
variation in probe signal between arrays may have been of sufficient magnitude to hide more
subtle changes in gene transcript levels. This could be overcome by increasing replicate
number to highlight trends in the changes of transcript levels.
The QPCR technique was developed for a panel of genes studied here and in later chapters.
This technique was highly sensitive and accurately distinguished changes in transcript levels
in a DNA template diluted from 1 x 10 2 to 1 x 10"10. The technique was highly reproducible
and generated only very marginal differences in cT values for replicates of the same DNA
sample. The QPCR assay was also very specific and following PCR amplification lacked
primer or other non-specific products.
The microarray demonstrated that LPS induced the upregulation of IL-la and IL-1|3 in
microglia, a finding validated by QPCR analysis. The degree of upregulation estimated by
the array and QPCR platforms differed. In addition, the microarray did not report IL-6
expression following LPS stimulation, despite confirmation of IL-6 synthesis by QPCR and
ELISA. It is perhaps inappropriate to directly compare the exact quantifiable nature of these
two techniques since they are based on very different chemistries; hybridisation of DNA
probes verses amplification-based technology. Nevertheless, QPCR was the more sensitive
technique by several orders of magnitude as demonstrated by the dilution of DNA templates,
and as shown by analysis of IL-6 levels (and TLR analysis in chapter 5). It is highly likely
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that QPCR more accurately discerned basal levels of transcripts in resting microglia.
Consequently, the degree of fold increase in stimulated cells was more substantial than that
described by the microarray. Several gene transcripts were below the threshold of detection
on the array in resting cultures, but upon LPS-induced upregulation became detectable. An
example is MARCO; MARCO may well be expressed at low levels in resting N9 microglia
but was not detected by the array. QPCR would better describe the basal levels of MARCO
expression in unstimulated microglia.
The QPCR work did accurately validate the changes in expression of ILr6 and IFN-a 12
hours after SFV infection of microglia. Again the fold increase was underestimated by the
array in the case of IFN-a, presumably because the starting signal on the array was high
compared to the basal transcript level determined by the QPCR platform. The ability of the
array to detect upregulated IL-6 transcripts in the case of SFV infected N9 cells but not in the
case of LPS stimulated N9 cells is puzzling, but probably reflects the differing level of
background that exists between microarray hybridisations. In summary, direct comparison of
transcript levels reported by the microarray and QPCR platforms do not agree. Almost
certainly, the QPCR values are the most accurate. The microarray can therefore distinguish
up or down regulation, but the fold changes should not be relied upon. Further development
to increase the sensitivity of the microarray platform would be a productive future strategy.
The current system relies on a rather inefficient reverse transcription reaction that directly
labels cDNA with Cy3 dye. This system results in the generation of many short cDNA
strands and few full-length cDNA strands. There now exists a method that indirectly labels
cDNA that is substantially more efficient and critically produces full-length cDNA.
Conceivably, this labelling system may increase the sensitivity of the platform by; increasing
the number of target labelled cDNA strands; reducing the number of non-specific small
cDNA that represent the region proximal to the 3' of the mRNA; reducing the level of
unincorporated Cy3 dye in the hybridisation mixture.
It was not possible to validate the upregulation of all transcripts identified by the array. To be
definitively certain of all transcript levels required validation by QPCR and preferably
quantification of protein levels in each case. Developing individual assays for each gene
transcript/product would take considerable time and the feasibility of undertaking this
analysis for each transcript was beyond the scope of this investigation. In addition, it has
been assumed that altered levels of transcripts observed by either the array or QPCR leads to
a respective change in protein levels and hence function. Whilst this is likely to be the case
for the vast majority of transcripts, it cannot be guaranteed.
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The detection of transcript levels in a population of unsynchronised cells does not imply all
cells altered their transcript levels. For example, SOD-2 transcripts were marginally
increased in SFV infected N9 microglia. Potentially infected cells could have down regulated
SOD-2 whilst uninfected cells could have upregulated SOD-2 in response to the cytokine
milieu. The overall change in transcript levels would not have reflected this diversity of
expression. Indeed, it is impossible to determine the exact phenotype of each cell in culture
using microarrays or QPCR. Methodologies such as immunocytochemistry would be
necessary to further describe gene expression at the cellular level.
The microarray demonstrated that two housekeeping genes, GNAS and Pbp, were marginally
down-regulated 12 hours post infection with SFV. These transcripts may be inappropriate for
normalisation purposes in SFV infected N9 cells when used in isolation. The use of multiple
housekeeping genes on the array for normalisation purposes likely negated the marginal
decreases observed in these transcripts. This finding further underscores the necessity of
using two or more housekeeping genes when normalising transcript levels.
4.7.2 Resting N9 microglia express a broad range of PPRs
Several gene transcripts not previously associated with microglia were shown to be
constitutively expressed on N9 microglia in culture. These include two lectins. Clecsf 5 and
9, HM74, pgrp, SRCL and TLR 2, 4, 7 and 9. Lectins are sugar-binding proteins that can
mediate both pathogen recognition and cell-cell interactions. Clecsf 5, also known as
myeloid DAP-12-associated lectin (MDL)-l, is expressed in peripheral blood monocytes and
macrophages and together with DAP-12 may signal to initiate an oxidative burst, cytokine
production and induction of co-stimulatory molecules (Bakker et al., 1999). Clecsf 9, also
known as mincle, is strongly induced in murine peritoneal macrophages in response to
several inflammatory stimuli such as LPS and TNF-a and may play a role in the function of
macrophages infiltrating sites of inflammation (Matsumoto et al., 1999). The upregulation of
clecsf 5 and 9 reported here suggests these lectins may have similar functions in microglia.
HM74, also known as PUMA-G in mice, is a novel chemokine receptor that is best known as
a nicotinic receptor in adipose tissue. Its potential role in the CNS remains to be elucidated
(Tunaru et al., 2003). Pgrp, also known as peptidoglycan recognition protein (PGRP)-S is a
member of a family of pattern recognition molecules conserved from insects to mammals
that bind to bacteria and their peptidoglycan components. Mice deficient in pgrp have
increased susceptibility to intraperitoneal infection with some gram-positive bacteria and
possess neutrophils that exhibit defective intracellular killing of pathogens (Dziarski et al.,
2003; Dziarski, 2004). SRCL, also known as scavenger receptor with C-type lectin, is a
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novel member of scavenger family expressed in the macrophage cell line J774A.1 and can
bind gram-negative bacteria when transfected into CHO-K1 cells (Nakamura et al., 2001). In
addition, TLR 2, 4, 7 and 9 have not been previously reported in N9 microglia. Together
these results demonstrate that microglia express a wide variety of PRRs that have not been
previously associated with these cells. In addition to these transcripts a variety of other PRRs
were detected in resting N9 microglia that have previously been associated with microglia
including; mannose receptor 1; scavenger receptor-AI (SR-AI), scavenger receptor-BI (SR-
BI), triggering receptor expressed on myeloid cells (TREM)-2 and, CD14. These results
suggest N9 microglia are able to detect the presence of a considerable range of pathogen-
associated molecules and endogenous altered or oxidised proteins that require clearing. In
addition, the expression of prostaglandin synthase 1 and 2 (also known as COX-1 and COX-
2) suggests these cells have an innate capability to generate pro-inflammatory
prostaglandins.
4.7.3 LPS stimulation and SFV infection invoked qualitatively and
quantitatively different gene expression changes
Microarray analysis revealed that LPS stimulation and infection with SFV invoked
qualitatively and quantitatively different changes in gene expression in N9 microglia.
Importantly, these gene transcript changes appeared to be appropriate to the pathogen; LPS
invoked substantial pro-inflammatory cytokine gene expression whilst SFV infection
induced type-I IFN transcripts. Specifically, N9 microglia reacted to LPS with the
upregulation of a several pro-inflammatory cytokines and chemokines. Were this to occur in
vivo microglia would actively induce an inflammatory response in the brain and recruit
blood-borne leukocytes. MlP-la, MIP-1|3 and IP-10 are well characterised potent attractants
of monocytes and other leukocytes. The proinflammatory cytokines TNF-a and IL-la/|3 are
known to activate leukocytes and are pro-active in the induction of immune responses. These
cytokines are also actively neurotoxic and may contribute towards neuronal damage and
death that can be observed during inflammatory responses of the brain (Kielian, 2004; Streit,
2002; Wang et al., 2004). Conversely, during SFV infection microglia exhibited a less
pronounced pro-inflammatory response, with no increases seen in TNF-a, IL-la, IL-1[3 and
only a slight increase in IL-6 production. However, the expression of the anti-inflammatory
cytokine TGF-(3 was reduced. TGF-|3 directs gene expression of activated microglia by
primarily preventing the induction of chemokines and genes involved in cell migration
(Paglinawan et al., 2003). The reduction of this cytokine suggests the threshold for induction
of these genes was reduced. Indeed, these cells demonstrated large increases in chemokine
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production. In addition, SFV infection induced large fold increases in the levels of both IFN-
a and IFN-[3, both of which exert powerful anti-viral effects in an auto- and paracrine
fashion. Nos2, also known as iNOS, was also uniquely upregulated by SFV. This inducible
gene product mediates the production of anti-microbial nitric oxide and whose expression is
detectable in embryonic microglia, but is suppressed in microglia derived from the adult
brain. This is unlike peripheral macrophages that readily synthesise NO following
stimulation with a range of microbial products (Brannan and Roberts, 2004). Primary
microglia derived from embryonic CNS cultures can increase iNOS expression following
infection with another RNA virus, TMEV, or stimulation with LPS, peptidoglycan and CpG
motifs (Olson and Miller, 2004). In light of these reports, careful validation of the microarray
data will be required before N9 microglia can be considered active producers of NO upon
SFV infection. If substantiated, the ability of N9 cells to upregulate iNOS suggests this cell
line possessed a phenotype more analogous to embryonic microglia than adult microglia.
LPS stimulation increased the transcript levels of NCF1 (also known as p47phox). The
NCF1 gene product activates the phagocyte NADPH oxidase system that generates
superoxide anions, a precursor of microbicidal oxidants (Tsunawaki et al., 1996). Perhaps in
response to the increased production of free radicals, N9 microglia upregulated several
transcripts known to counteract the damaging actions of free radicals such as SOD-2 and
catalase. SOD-2 acts to convert oxygen free radical to less reactive compounds (Zelko et ah,
2002), whilst catalase plays a major role in cellular antioxidant defence by decomposing
hydrogen peroxide and preventing the generation of the highly reactive hydroxyl radical (Ho
et ah, 2004). In addition several heat shock protein transcripts were increased, indicating
LPS exposure or cellular responses to this compound are harmful to the cell. In comparison,
at least by 24 hours, SFV infection did not upregulate these stress-associated gene
transcripts, with exception of a marginal increase in SOD-2.
Infection by SFV uniquely initiated the upregulation of CD40. Expression of this molecule
has previously been reported in microglia in two disease states: in inflammatory lesions of
demyelination observed in multiple sclerosis and in activated microglia of Alzheimer's
disease. Importantly, ablation of CD40L or pharmacological intervention ameliorates
pathology or attenuates progression in models of both disease states (Howard et ah, 1999;
Tan et ah, 2002). It has been suggested that interaction of CD40 on microglia with its
ligands, expressed on CD4+ T-cells, may enhance inflammation through the production of
cytokines, chemokines, prostaglandins and NO (DAversa et ah, 2002; Jana et ah, 2001;
Okuno et ah, 2004). The data here suggests SFV infection upregulated microglial CD40 and
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as such may represent a new mechanism in which SFV infection induces inflammation by
activated microglia.
Stimulation with LPS and infection with SFV altered the expression of several key scavenger
receptors (SRs). SRs are defined by their ability to bind chemically modified low density
lipoprotein but can also bind a variety of other ligands that are either poly-anionic or possess
cross pleated (3-sheets and can function as PRRs (Krieger and Stern, 2001; Franc et al.,
1999). Reports suggest the expression of SR-AI is restricted to peripheral macrophages at
sites of important immunosurveillance, such as the spleen. However, the receptor is
expressed in microglia of the embryonic brain, and is lost as the brain develops (Honda et al.,
1998; El Khoury et al., 1996). This receptor can recognise a variety of ligands such as
modified lipoproteins, apoptotic cells and gram-negative bacteria (Husemann et al., 2002).
Following LPS exposure SR-AI can induce the production of pro-inflammatory cytokines
and acts to clear LPS in vivo (Hampton et al., 1991; Ashkenas et al., 1993). The upregulation
of SR-A seen in the present study in N9 microglia agrees with previous work that
characterised increased expression in primary rat microglia following LPS stimulation
(Grewal et al., 1997). The upregulation of SR-AI during SFV infection is a novel finding and
may represent a response to either direct SFV infection or the effect of SFV infection on
neighbouring cells. The cytokine milieu of the infected tissue culture may well alert non-
infected cells to the infection and stimulate upregulation of receptors that detect infection
such as SR-AI. Alternatively, the level of caspase 3 activity was high following SFV
infection, suggesting a large number of apoptotic cells were present. This may have driven
upregulation of SR-AI that, among many functions, mediates the uptake of dying cells.
Furthermore, PSR the receptor for phosphatidylserine (a lipid that is uniquely expressed on
apoptotic cells) was also upregulated. This may reflect the extent of apoptosis that occurred
in these cultures. Microglia are capable of recognising and engulfing apoptotic cells. Indeed,
the phagocytosis of apoptotic lymphocytes makes microglia refractory to further pro¬
inflammatory cytokine release, if further stimulated with LPS (Magnus et al., 2002).
Conceivably, the absence of pro-inflammatory cytokine release in these cultures; concurrent
with substantial chemokine release, may partly be a product of the anti-inflammatory action
of apoptotic cell engulfment.
SR-BI is expressed on macrophages and endothelia in cholesterol rich tissues and
participates in reverse cholesterol transport to the liver (Hirano et al., 1999; Krieger, 1999).
Like SR-AI, SR-BI appears to be developmentally regulated being expressed at high levels
in the immature brain and at low levels in the adult brain (Husemann et al., 2001). The
function of this receptor in the brain is yet to be fully elucidated however it has a putative
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function in lipid metabolism and the clearance of apoptotic cells and denatured proteins
(Husemann et al., 2002). SR-BI is down-regulated in macrophages following exposure to
TNF-a, although there is no work reporting transcript levels in microglia (Buechler et al.,
1999). The results here suggest that either the LPS stimulus or subsequent TNF-a production
acts to down-regulate this receptor in N9 microglia. However, since SR-BI down-regulation
occurred during SFV infection in the absence of LPS or significant TNF-a production,
molecules other than these two can modulate its expression. In addition, the expression of
both SR-AI and SR-BI in resting cultures of N9 microglia further highlights the likely
embryonic origin and phenotype of this cell line.
CD36 is another SR related to SR-BI that is expressed in both macrophages and vascular
endothelium (Febbraio et al., 2001). CD36 protein is expressed in human microglia in vivo
and on N9 microglia. This receptor has the capacity to recognise (3-amyloid and initiate the
production of reactive oxygen species, and may play role in the pathogenesis of Alzheimer's
disease (Coraci et al., 2002; El Khoury et al., 2003). The finding that CD36 is highly
upregulated in N9 microglia 24 hours post infection with SFV is a novel finding, although
the exact functional significance of this is not clear due to the scarcity of reports on the
innate immune functions of CD36 (Husemann et al., 2002).
MARCO, also known as macrophage receptor with collagenous structure, is a scavenger
receptor expressed in a limited sub-set of macrophages and in granulocyte-macrophage -
colony stimulating factor (GM-CSF)-treated microglia. LPS stimulation can induce MARCO
expression in most other macrophage populations and dendritic cells (van der Laan et al.,
1999; Palecanda et al., 1999). The results here suggest N9 microglia also dramatically
upregulate this receptor upon LPS exposure. This receptor can bind both gram-positive and
negative bacteria but not yeast, and its expression correlates with profound changes in actin-
cytoskeleton organisation and decrease in antigen uptake in dendritic cells and microglia
(Granucci et al., 2003).
TREM-2 is expressed on monocyte-derived dendritic cells and upon activation dramatically
increases the expression of molecules associated with antigen presentation to T-cells
(Bouchon et al., 2001). Whilst TREM-2 expression is lacking on monocytes and
macrophages, the receptor was among the few mRNAs identified as being expressed by
resting microglia and down regulated by LPS. Thus, TREM-2 is considered a marker of
resting microglia in vivo, and brain regions with incomplete blood-brain barrier exhibit
reduced expression. Indeed, regional variations in TREM-2 CNS expression may contribute
to the varying sensitivities of different brain regions to pathogenic signals (Schmid et al.,
2002). The work here confirms that TREM-2 down-regulation occurs in N9 microglia
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following LPS stimulation and following SFV infection. Further work would be required to
determine if concurrent changes in co-stimulatory molecules occurs. In addition, the
expression of TREM-2 in resting N9 cultures further underscores their phenotype as a resting
microglial cell line.
The upregulation of TLR 2 and 3 during SFV infection suggests that these two receptorsmay
function to recognise virus infection in N9 microglia. However, the sensitivity of the
microarray precluded any substantial analysis of TLR expression. The analysis of these
transcripts by the more sensitive QPCR technique would provide a more comprehensive
description of expression levels during SFV infection.
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4.7.4 Summary
This chapter has successfully proven the ability of the microarray to assay key gene
transcripts of interest in cultured N9 microglia and discern changes in gene transcript levels.
The microarray has comprehensively described the expression of a multitude of genes
involved in innate immune responses of cultured N9 microglia, several of which have not
been previously associated with this cell type. This work has demonstrated N9 microglia
express a broad range of PRRs that were differentially modulated upon stimulation with LPS
or infection with SFV. The expression of many of these receptors suggested N9 microglia
possessed an embryonic (i.e. SR-AI), unactivated (i.e. TREM-2) phenotype, which suggests
they are functionally equivalent to microglia found in the developing brain. In addition, key
differences in the form of innate immune response generated by N9 microglia in response to
LPS stimulation verses SFV infection was observed. LPS stimulation generated a substantial
pro-inflammatory response with the induction of several stress-associated genes, whilst SFV
infection induced substantial increases in type-I interferons and chemokines. The feasibility
of utilising this microarray platform for the characterisation of further innate immune
responses is substantial and includes characterising the responses of; primary microglia to
SFV infection; microglia to amyloid fibrils formed by either PrPSc or (3-amyloid; and
astrocytes to LPS or SFV infection.
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Chapter 5. In response to LPS and virus infection, neural cells dynamically
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5.1 Introduction
Toll-like receptors (TLR) are an expanding family of receptors that recognise unique
molecular patterns characteristic of different types of pathogen. A growing consensus
suggests they are key to the initiation of innate immune responses (Akira and Takeda, 2004).
Thirteen TLR are now recognised. These are predominantly expressed on cell types likely to
be the first to encounter antigen such as phagocytic cells. TLR 1 to 9 are expressed in both
mice and humans. TLR 10 is present in mice only as a degenerate pseudogene. TLR 11, 12
and 13 are expressed in mice but lack human orthologs (Medzhitov et al., 1997; Rock et al.,
1998; Takeuchi et al., 1999b; Chuang and Ulevitch, 2000; Chuang and Ulevitch, 2001; Du et
al., 2000; Tabeta et al., 2004). All TLR share a similar structure with extracellular leucine
rich repeat (LRR) motifs and an intracellular Toll/IL-1 receptor domain. TLR 1, 2, 4, 5 and 6
appear to recognise the repeating patterns on the structural components of pathogens,
principally bacteria. TLR 2 is known to be involved in the recognition of bacterial
peptidoglycan, fungal components and viral glycoproteins (Takeuchi et al., 1999a; Underhill
et al., 1999a; Bieback et al., 2002). TLR 4 is involved in the recognition of lipopolysacharide
(LPS) and viral envelope proteins (Poltorak et al., 1998; Rassa et al., 2002). TLR 5 can
recognise bacterial flagellin (Hayashi et al., 2001) whilst TLR 11 is involved in the
recognition of uropathogenic bacteria (Zhang et al., 2004). TLR 1, 2 and 6 appear to act
together to discriminate between bacterial lipoproteins (Takeuchi et al., 2001; Wyllie et al.,
2000). Pathogen nucleic acids are also recognised by several TLR. In contrast to TLR that
recognise structural components these TLR have also been observed in intracellular
compartments (Matsumoto et al., 2003). TLR 3 can recognise dsRNA (Alexopoulou et al.,
2001), TLR 7 and 8 can recognise ssRNA (Heil et al., 2004; Diebold et al., 2004) and TLR 9
is involved in the recognition of CpG motifs present in bacterial and viral DNA (Hemmi et
al., 2000; Tabeta et al., 2004).
There is little information on TLR expression and function in CNS cells. In response to a
variety of pathogens both microglia and astrocytes can undergo hypertrophy and hyperplasia
and express cytokines. Astrocytes can initiate the production of complement proteins and
microglia can become active phagocytes, capable of producing many of the same anti¬
microbial molecules as activated macrophages and capable of activating T cells (Mack et al.,
2003; Olson and Miller, 2004), but it remains unclear how this early glial cell response is
activated. The putative expression of TLR on glial cells may provide one mechanism by
which these specialised cells are stimulated. Previous work has shown cultured primary
microglia from SJL/J mice were shown to express TLR 1 to 9 (Olson and Miller, 2004)
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whilst a more limited study demonstrated primary cultures of astrocytes from Balb/c mice
express TLR 2, 4, 5 and 9. TLR levels in neurones have not been investigated.
Virus-like particle (VLPs) are infectious agents that upon entry to a cell can initiate genomic
replication, but lack structural genes necessary to form nascent mature virus. Since VLPs
cannot produce mature virus they cannot spread from cell-to-cell. As with the virus, VLPs
can fuse with the plasma membrane and initiate viral genome replication and synthesis of
sub genomic RNA; however, VLPs cannot express structural proteins and replicated viral
RNA remains unpackaged in the cytoplasm.
The previous two chapters successfully explored the expression patterns of several key genes
involved in innate immune responses in N9 microglia following LPS stimulation and SFV
infection. However, the microarray was unable to adequately assay TLR expression. This
study has examined TLR expression using quantitative real time PCR developed in chapter
4. Cultures of microglia, astrocyte and neuroblastoma cells were analysed to determine
constitutive levels of TLR transcripts and their differential regulation according to the
microbial stimulus.
5.2 Objectives
To determine TLR expression in microglia, astrocyte and neurones
To describe TLR expression changes in response to
LPS stimulation
SFV infection
To describe cytokine and type-I interferon expression in response to LPS and SFV
To describe levels apoptosis of CNS cells in response to SFV
5.3 Absolute levels of transcripts were assayed by determining copies of
DNA molecules in DNA standards
The level of TLR expression in cultured cells was determined by QPCR using DNA
standards. To assay the absolute level of TLR transcript it was necessary to determine the
absolute amount of DNA copies in the standards. The DNA standards constituted PCR
products amplified by outer primers that encompassed the region amplified by the inner
primers. To effectively assay the amount of each standard, samples were diluted 4-fold in
water and were analysed on an Agilent Bioanalyser (see methods section for more details).
The amount of DNA copies for each standard was then calculated (Table 7). In contrast,
absolute value of SFV RNA was calculated by using a plasmid that contained the SFV gene
assayed (the structural gene El). The plasmid had been previously amplified in bacteria and
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quantified by optical density. Subsequently, each QPCR experiment assayed absolute levels
of transcripts by correlating amplification levels of DNA standards with copy number.
5.4 CNS cells express a broad repertoire of TLR at rest
RNA was prepared from N9 microglia, differentiated primary astrocyte cultures and N2a
neuroblastoma cells. At the time of sampling the microglia had been cultured for 48 hours
and had a semi-amoeboid morphology with occasional processes. The primary astrocyte
cultures were grown from neonatal brains. Fibroblasts, microglia and oligodendrocytes were
excluded or removed from the cultures. The cultures were differentiated with dibutyryl
cyclic adenosine monophosphate (dbcAMP) and the cells exhibited a mature phenotype
analogous to the type 1 astrocytes found in adult brain (Raff et al., 1983) (Figure 43). The
cultures lacked microglial or myeloid contaminants as determined by glial fibrillary acidic
protein (GFAP) and CDllb staining (>99% cells were GFAP positive). Cells of the N2a
neuroblastoma cells were grown for 48 hours by which time the majority of cells possessed
multiple, short processes as previously described (Shea and Beermann, 1994). Analysis of
resting microglia revealed the presence of TLR 1, 2, 3, 4, 6, 7, 8 and 9 (Figure 44A). TLR 2
transcripts were most abundant, followed by TLR 4 and TLR 7. TLR 1, 3, 6 and 9 were
expressed at moderate levels, whilst TLR 8 was expressed at very low but reproducibly
detectable levels. TLR 5 was not detected. Analysis of astrocytes demonstrated overall TLR
transcript expression at a level comparable to the microglia cells (Figure 44B). TLR 7 had
the highest expression, with TLR 2, 3, 8 and 9 also expressed at high levels. TLR 1, 4, 5 and
6 were expressed at low but detectable levels. N2a cells expressed TLR 3 transcripts at a
level comparable to microglia but TLR 1, 2, 4 and 6 transcripts were at levels considerable
below those described in either of the glial cultures and transcripts for TLR 5, 7, 8 and 9
could not be detected (Figure 44C).
5.5 CNS cells differentially regulate TLR expression upon stimulation with
LPS or infection with SFV
N9 microglia were grown for 48 hours and then exposed to LPS for 0, 3, 6 or 12 hours.
Within 3 hours the cells increased their levels of TNF-a and IL-6 transcripts; in the case of
IL-6 by 190 fold, demonstrating their ability to be activated by this microbial component
(Figure 45). TLR 4 is well known to be involved in LPS recognition (Poltorak et al., 1998).
Given that N9 microglial cells express TLR 4 (Figure 44A), activation could be occurring
via this pathway. As expected, LPS exposure did not induce high levels of IFN-a transcripts.
LPS activation of N9 cells resulted within 3 hours in 3-fold increased expression of TLR 2,
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PCR product Size (bp) Avergae Mass Molecular weight Daltons Copies/ul
(Daltons) per mole
TLR1 436 4.08E-08 2.878E+05 2.878E+05 8.54E+10
TLR2 211 2.93E-08 1.393E+05 1.393E+05 1.27E+11
TLR3 849 4.04E-08 5.603E+05 5.603E+05 4.34E+10
TLR4 393 3.15E-08 2.594E+05 2.594E+05 7.31E+10
TLR5 535 1.77E-08 3.531 E+05 3.531 E+05 3.02E+10
TLR6 262 2.18E-08 1.729E+05 1.729E+05 7.58E+10
TLR7 844 7.67E-08 5.570E+05 5.570E+05 8.29E+10
TLR8 269 1.01E-08 1.775E+05 1.775E+05 3.41E+10
TLR9 423 7.97E-08 2.792E+05 2.792E+05 1.72E+11
B-actin 278 7.04E-08 1.835E+05 1.835E+05 2.31E+11
IFN alpha 382 1.82E-08 2.521 E+05 2.521 E+05 4.35E+10
IL-1 alpha 419 5.60E-09 2.765E+05 2.765E+05 1.22E+10
IL-1 beta 409 1.22E-08 2.699E+05 2.699E+05 2.72E+10
CathespinD 389 3.80E-09 2.567E+05 2.567E+05 8.91E+09
C1q alpha 378 2.40E-09 2.495E+05 2.495E+05 5.79E+09
TNF alpha 365 8.00E-09 2.409E+05 2.409E+05 2.00E+10





Figure 43, primary astrocytes were positive for GFAP and lacked myeloid contaminants.
(A,B,C) Representative pictures of astrocyte cultures stained for GFAP. (D) Representative
picture of astrocyte culture stained for CD11b. (E) QPCR of resting astrocyte cultures for GFAP
transcripts.Included is a QPCR negative control that amplified at a high cycle number. (F) QPCR
of resting astrocyte cultures for p-actin transcripts. Note that the level of GFAP transcripts was
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Figure 44, glial cells and neurones express TLR. Copy numbers of (3 -
actin and TLR 1 to 9 were determined using quantitative RT-PCR and
expressed as copies per 1,000 copies (3-actin. (A) N9 microglia grown for 48
hours until semi-confluent. (B) Expression in cultures of primary astrocytes,
3 weeks post-creation. (C) Expression in cultures of N2a neuroblastoma
cells grown for 48 hours until semi-confluent. The bars are mean of 4
replicate samples. The error bars are± SEM.
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whilst TLR 3 was also upregulated, though more slowly. In contrast, all other TLR were
either unaffected or even down-regulated. TLR 8 exhibited the most profound decrease
whilst TLR 4 and 7 were also consistently down-regulated in a consistent manner. Astrocyte
cultures exhibited more pronounced changes in TLR expression in response to LPS (Figure
46). In common with microglia, TLR 2 and 3 exhibited the largest increases, whilst sizeable
decreases were observed for other TLRs. In contrast to microglia, astrocytes upregulated
TLR 1 and down-regulated TLR 5. Neuroblastoma cells showed no change in TLR
expression upon LPS stimulation (Table 8). In addition, astrocytes down-regulated
transcripts of GFAP four-fold. Neuroblastoma cells showed no change in TLR expression
upon LPS stimulation.
5.6 SFV infection of CNS cells triggered substantial changes in TLR
transcripts
To determine whether neural cells support SFV replication in culture, cultures were infected
with virus and levels of virus RNA determined over time by QPCR (Figure 47). The MOI
used was low and is analogous to virus infection in vivo in which few cells within a given
population are infected. Infection of mice with virulent strains of SFV results in infection of
neurones and glial cells to a higher degree than avirulent strains. (Fazakerley et al., 1993;
Smyth et ah, 1990; Balluz et ah, 1993). To ensure efficient infection in the present study,
cells were infected with the virulent SFV 4 strain. The virus was able to replicate and induce
caspase 3 activity, indicative of late stage apoptosis, in all three types of culture (Figure 47).
In contrast to LPS, virus infection microglia resulted in a large increase in IFN-a transcripts.
Virus infection also dramatically altered TLR expression profiles with strong upregulation of
several TLR. The largest increase was observed with TLR 3 but TLR 8 and 9 also
demonstrated high fold increases (Figure 48A). However, TLR 8 upregulation was from a
very low basal level (Figure 43A). TLR 4 was significantly and consistently down-regulated.
Furthermore, in contrast to LPS stimulation, pro-inflammatory cytokines IL-6 and TNF-a
were only marginally increased by 12 hours. Infection of astrocyte cultures resulted in high
levels of viral RNA molecules; an order of magnitude higher than in microglia (Figure 47).
Interestingly, the microglia had a stronger IFN-a response than the astrocytes (Figures 48A
and 48B). More efficient IFN-a production in microglial cells than astrocytes could have
reduced virus replication in microglial cells relative to astrocytes. In astrocytes, TLR 3 and
TLR 9 upregulation was not as great as that observed in microglial cells, although TLR 2
upiegulation was greater. Unlike microglia infection, astrocytes dramatically down-regulated
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Figure 45, TLR transcripts were dynamically regulated by microglia in response to
stimulation with LPS. N9 cells were stimulated with LPS for 3, 6 and 12 hours and transcript
levels expressed relative to unstimulated cells. cDNA levels were normalised relative to . -actin.
Bars show the mean of 4 replicates ± SEM. Marked bars are statistically different from the






















l OHr O 12Hr
Figure 46, TLR transcripts were dynamically regulated by astrocytes in response to
stimulation with LPS. Astrocytes were stimulated with LPS for 12 hours and transcript levels
expressed relative to unstimulated cells. cDNA levels were normalised relative to . -actin. Bars
show the mean of 5 replicates ± SEM. Marked bars are statistically different from the respective 0
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Figure 47, SFV replicates in cultured CNS cells and induces caspase 3 activity. (A) SFV RNA
copies were determined by QPCR. Notice that astrocytes were only sampled at 0 and 12 hours
whilst neuroblastoma cells were sampled at 0, 3 and 12 hours only. Bars show the mean of 3
replicates ± SEM. Dotted line indicates the level of detection of this assay. (B) Caspase 3 activity
was determined in cultures of microglia and astrocytes following SFV infection. For a positive
control, cells were treated with staurosporin for 4 hours to induce apoptosis. Note astrocytes were
only sampled at 0 and 12 hours following SFV infection. Caspase activity was not measured in


























Figure 48A, TLR transcripts were dynamically regulated by microglia in response to
infection with SFV. N9 cells were infected with SFV4 (MOI = 0.1) and gene expression
assayed at 3, 12 and 24 hours post-infection and expressed relative to uninfected cells. cDNA
levels were normalised relative to . -actin. Bars show the mean of 4 replicates ± SEM. Marked
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Figure 48B, TLR transcripts were dynamically regulated by astrocytes in response to
infection with SFV. Astrocytes were infected with SFV4 and gene expression assayed at 12
hours post-infection and expressed relative to uninfected cells. Bars show the mean of 5
replicates ± SEM. Marked bars are statistically different from the respective 0 hour time-point
(Student's t-test; *p<0.05, n=5).
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As with LPS stimulation, the neuroblastoma cell line did not alter TLR expression despite
active viral replication as determined by high levels of viral RNA (Figure 47). IFN-a
expression could not be detected in these cells at 0, 3, 6 or 12 hours post-infection.
A summary of TLR, IFN-a and SFV transcript levels is given in table 8.
5.7 Infection of microglia with virus-like particles caused TLR 3
upregulation
Infection of microglia with SFV was further dissected by infection with virus-like particles
(VLPs). VLPs attach to and enter host cells and replicate virus RNA exactly as for virus;
however, replacement of structural genes with eGFP precludes the production of mature
virus and labels infected cells with eGFP. eGFP is highly expressed upon infection in a
variety of cells and in the CNS upon inoculation (personal communication-Audrey Graham).
VLPs used here were based on the SFV 4 strain and were synthesised by Audrey Graham,
Centre for Infectious Disease, University of Edinburgh, UK. This system was used to
determine whether attachment, entry and viral RNA replication were sufficient to induce
TLR 3 upregulation. Microglia were infected with VLPs (1% cells infected as measured by
eGFP expression) and TLR 3 transcripts measured. Transcripts were significantly
upregulated by 24 hours infection (Figure 49).
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LPS SFV
N9 N9 Astrocyte N2a N9 Astrocyte N2a
3 Hr 12 Hr 12 Hr 12 Hr 12 Hr 12 Hr 12 Hr
TLR1 0.80 1.37 2.1* 1.00 1.20 0.82* 1.00
TLR2 2.80* 1.44* *oo!> 1.00 1.7* 7.92* 1.00
TLR3 1.39* 1.02 3.6* 1.00 19.2* 7.46* 1.00
TLR4 o 4^ h-^ * 1.24 0.3* 1.00 0.59* 0.41* 1.00
TLR5 ND ND 0.17* ND 9.6* 0.12* ND
TLR6 0.78 0.95 0.66* 1.00 1.4* 0.39* 1.00
TLR7 0.67* 0.67* 0.36* ND 1.20 0.61* ND
TLR8 0.14* 0.39* 0.23* ND 4.0* 0.30* ND
TLR9 0.732 0.82 0.08* ND 1.3* 1.33 ND
IFN-a 1.01 1.05 0.70 ND 130* 28.7* ND
SFV NA NA NA NA 1.87x10 07 2.97xl008 8.47xl005
Table 8, mean (n=4) fold changes of TLR, IFN-a, and absolute copies of SFV transcripts 3
or 12 hours post stimulation with LPS or post infection with SFV. Values a re normalised to (3-
actin. Levels significantly different from controls are marked with an asterisk (Student's t-
test; p < 0.05). SFV RNA values are given as absolute levels rather than fold increases,
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Figure 49, infection of microglia with virus like particles upregulated TLR 3. Virus like
particles are infectious agents that upon entry to a cell can initiate genomic replication, but
lack structural components that enable the production of mature virus and spread from cell-
to-cell. N9 microglia were infected with a low MOI (MOI=0.1) and TLR 3 transcripts assyed
at 0, 12 and 24 hours post infection. Bars represent mean of five cultures ± SEM. Bars
marked with an asterisk are significantly different from 0 hour time point (Student's t-test,
p<0.05).
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5.8 Discussion
5.8.1 Expression of TLR on glia indicates they can recognise a multitude of
microbial components
This thesis reports the first systematic comparison of TLR gene expression in cultured neural
cells. The finding that cells of the CNS have the ability via TLR expression to detect
infection and discern its type provides an important contribution to understanding
pathological processes of this tissue. Parenchymal microglia populate the CNS during
embryogenesis and are not derived from circulating monocytes (Streit, 2002; Hickey and
Kimura, 1988; Ford et al., 1995). They have a multitude of roles involved in neuronal
support and they function to synergise immune responses once initiated. Two previous
reports have documented extensive expression of TLR transcripts in cultured human
microglia (Bsibsi et al., 2002), and in primary cultures of murine microglia (Olson and
Miller, 2004). The present quantitative study reveals that TLR 2 is the most highly expressed
TLR on N9 microglia. TLR 2 is also high expressed on circulating human monocytes
(Hornung et al., 2002), which underscores the phenotypic similarity of microglia to blood-
borne myeloid cells despite their differing lineages. Astrocytes predominantly function as
support cells for neurones but also have a documented role in immune function in vitro,
being able to react to several prototypic microbial components such as LPS and CpG motifs
(Lieberman et al., 1989; Schluesener et al., 2001). This study demonstrates that primary
cultures of astrocytes express levels of TLR comparable to the immortalised N9 microglial
cell line, suggesting that astrocytes are well endowed with the ability to detect a variety of
pathogens. Unlike microglia, astrocytes express high levels of TLR 3, 7, 8 and 9; a TLR
subfamily well known to recognise microbial nucleic acids (Kadowaki et al., 2001c;
Hornung et al., 2002). Astrocytes were of embryonic origin and were cultured for several
weeks in vitro that included maturation with dbcAMP. This compound is known to increase
GFAP expression in primary astrocytes and generates cells with a more mature phenotype
that is representative of adult astrocyte populations (Murphy, Jr. et al., 1993). The effect
dbcAMP treatment had on TLR expression was not explored. Conceivably dbcAMP
treatment could modulate TLR expression and may explain why a previous study, which
used embryonic astrocytes, failed to detect TLR 7, 8 and 9 in astrocytes (Carpentier et al.,
2005). N2a neuroblastoma cells expressed TLR 1, 2, 3, 4 and 6, albeit at low levels and it
was notable that TLR 3 expression was comparable to that observed in microglial cells. This
expression may indicate that neurones are able to recognise some forms of infection, perhaps
particularly viral dsRNA via TLR 3. The ability of both microglia and astrocytes to express
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all nine TLR assayed suggests they are capable of recognising a vast array of microbial
associated molecules, a strategy that may be an essential requirement for a tissue mostly
devoid of recognisable immune processes.
Microglia are the principal phagocyte of the CNS and have the potential to release large
amounts of inflammatory mediators, whilst astrocytes appear primarily to act as support cells
for neurones. TLR expression by these cell types may function to induce an inflammatory
reaction upon infection. However, TLR expression on astrocytes may be a later event
requiring activation by other processes in this regard. TLR expression by microglia may
initiate responses whereas TLR expression by activated astrocytes may function to
perpetuate or amplifying them. Another possibility is that TLR expression allows activation
of astrocytes to augment their neuroprotective functions. In this scenario astrocyte TLR
primarily acts to protect neurones rather than initiate immune responses.
5.8.2 TLR transcripts are differentially modulated on glia in a manner
appropriate to the innate immune stimuli
5.8.2.1 Response of glia to LPS stimulation
The level of TLR expression affects macrophage responses to microbial stimuli. Macrophage
responses have been correlated with levels TLR expression. TLR 4 ligands appear to induce
an early TNF-a response, whilst TLR 2 ligands generate a later TNF-cx response. These
responses correlate with the timing of TLR expression; TLR 4 ligands induce a response
until TLR 4 has become down-regulated; whilst TLR 2 ligands only induce cytokine release
once TLR 2 is upregulated (Weiss et al., 2004). Furthermore, monocyte-derived dendritic
cells induced to upregulate TLR 7 expression have increased sensitivity to the TLR 7 ligand
imiquimod (Mohty et al., 2003). Together these data suggest that TLR expression change
can have dramatic effect on the responsiveness of macrophages to microbial stimuli.
Stimulation of microglia with LPS upregulated TLR 2. This parallels the increase in TLR 2
observed following exposure of microglia to Staphylococcus aureus (Kielian et al., 2002). .
LPS down-regulated several TLR including TLR 4. This has also been reported for murine
LPS-stimulated macrophages in vitro (Nomura et al., 2000), and may represent a mechanism
to prevent over stimulation of innate immune responses. Indeed, LPS exposure is known to
sensitises the rat brain to ischaemic injury (Eklind et al., 2001), whilst work investigating
LPS-induced injury of oligodendrocytes in mice has documented a pro-active role for TLR4
expressing microglia (Lehnardt et al., 2002; Lehnardt et al., 2003). Circulating LPS is the
major cause of sepsis and initiates a systemic release of pro-inflammatory cytokines that can
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lead to organ failure and death (Beutler, 2002). LPS-stimulated macrophages become
tolerant to further LPS exposure and fail to express additional pro-inflammatory cytokine.
This phenomena is known as endotoxin tolerance and represents a mechanism by which the
host attempts to protect itself from endotoxin shock. This partly occurs through down-
regulation of TLR 4 and adaptor molecules that signal from this receptor, such as IRAK and
MyD88 (Fan and Cook, 2004). The present study suggests a similar mechanism may occur
in glial cells to limit damaging pro-inflammatory responses in response to LPS.
However, a recent report has suggested primary microglia derived from SJL/J mice react
differently to LPS (Olson and Miller, 2004). This study stimulated microglia with a dose of
LPS 50-fold higher than that used here and transcript levels were measured 24 hours post
stimulation. In agreement with the present study, TLR 2 and 3 were upregulated. In contrast,
the study also reported upregulation of type-I interferons and TLR 4, 6, 8 and 9 with no TLR
transcripts down-regulated. These conflicting results can almost certainly be explained due
to differences in experimental conditions and sampling times. The present study has shown
transcript levels fluctuate overtime following T,PS stimulation and that the time of analysis is
critical. The Olson and Miller study recorded TLR transcripts levels at 24 hours only, whilst
the present study reports transcript levels at 3, 6 and 12 hours (since some TLR trasmcripts
returned to base line by 18 hours, data not shown). In addition, the Olson and Miller report is
not directly comparable to the present study since N9 microglia represent a cell line derived
from CD1 mice whilst the Olson and Miller study utilised primary cultures from embryonic
SJL/J mice. Differing strains of mice are well-known to respond differently to microbial
stimulus and immune responses between strains cannot be directly compared (Smyth et al.,
1990; Tabeta et al., 2004). In addition, whereas LPS is known to induce type-I IFN synthesis
in vitro, a comprehensive study has also demonstrated that activation of IRF3 (necessary for
type-I IFN transcription) is more potent and rapid through dsRNA/TLR 3 signalling than that
triggered through LPS/TLR 4 signalling, and it is likely that LPS-induced IFN-(3 synthesis in
the present study was too little and too late to trigger a detectable increase in IFN-a
transcripts at the time points investigated.
The intermediate filament protein GFAP is a specific marker of astrocytes, is important in
modulating astrocyte motility and shape by providing structural stability to astrocytic
processes (Eng et al., 2000) and is upregulated during maturation with dbcAMP. In
agreement with previous data (Letournel-Boulland et al., 1994), astrocytes down-regulated
GFAP in response to LPS. Housekeeping genes (3-actin and GAPDH were unaffected. These
cultures had been aged and differentiated in vitro and were likely to be highly activated. LPS
stimulation upregulated TLR 2 and 3 but down-regulated all other TLR. This is in
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comparison to embryonic cultures of undifferentiated astrocytes that demonstrate
upregulation of TLR 2, 4, 5 and 9 (Bowman et al., 2003). Note that the Bowman et al. study
utilised end-product PCR analysis on agarose gels, a less sensitive, accurate and quantitative
technique than used here. In addition, the strain from which the astrocyte culture was derived
may have had some impact on these divergent results.
5.8.2.2 Response of glia to infection with SFV
In microglia, infection with SFV resulted in increases of gene transcripts for TLR 2, 3, 6, 8
and 9. TLR 3, 8 and 9 had the greatest increases; these TLR each have been linked to sensing
viral nucleic acid sequences. The response of astrocytes to SFV infection was similar in that
TLR 2, 3 and 9 were upregulated but dissimilar in that expression of all other TLR genes
were severely curtailed. Upregulation of TLR 2 occurred in both astrocytes and microglia in
response to both LPS and SFV. The amount of IFN -a produced by astrocyte cultures was far
lower than microglial cultures despite a higher level of SFV replication. More efficient IFN-
a production in microglial cells than astrocytes could have reduced virus replication in
microglial cells relative to astrocytes, although levels of caspase 3 activity was similar in
both SFV infected glial cultures. A recent report has shown infection of primary microglia
with TMEV selectively upregulates TLR 2, 3 and 9, with TLR 3 upregulation being greatest
(Olson and Miller, 2004). Together with the present data this suggests upregulation of TLR
2, 3 and 9 by cultured microglia and astrocytes may be a common response to several RNA
viruses. TLR 3 is a well-described sensor of virus infection and recognises dsRNA whilst
TLR 9 recognises viral CpG motifs of DNA viruses. In mice, deficiency of TLR 3 or 9
dramatically increases susceptibility to CMV infection (Tabeta et al., 2004). Selective
upregulation of TLR 3 and 9 is therefore a highly appropriate response to a virus infection
and upregulation of these molecules would act to increase the sensitivity of the tissues to
respond to any spread of infection.
Infection of microglia with VLPs initiated significant increase in TLR 3 expression. The
upregulation of TLR 3 transcripts suggests that either virus entry or virus RNA replication
was sufficient to induce an increase in TLR 3 expression and consequently increase the
sensitivity of the detection system that senses virus dsRNA. This informs us that neither viral
structural proteins nor virus particle assembly are required for TLR 3 upregulation, although
the enhancement of upregulation by virus structural proteins cannot be excluded. VLPs lack
the ability to spread from cell to cell and consequently the dynamics of infection compared
to SFV infection were highly divergent. Microglia infected with SFV4 would have been
subjected to several waves of infection as cells were lysed and new infectious virus released.
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In comparison VLPs cannot spread from cell to cell and so the total number of cells infected
at 12 and 24 hours would be significantly less. Accordingly, TLR 3 transcripts were not as
dramatically upregulated in VLP infected cultures compared to SFV 4 infected cultures.
The mechanisms that modulate TLR expression are yet to be determined. In the case of SFV
infection, direct recognition of virus glycoproteins by TLR 2 is a distinct possibility since the
hemagglutinin protein of the measles virus signals through TLR 2 (Bieback et ah, 2002) as
may glycoproteins of the Herpes Simplex virus (Kurt-Jones et al., 2004b). In addition,
responses of microglia to poly (I:C), a stimulator of the dsRNA sensor TLR 3, are very
different to microglial responses to TMEV and that described here to SFV, suggesting virus
may activate innate immunity via multiple TLR such as TLR 2 in addition to TLR 3.
However, this activation may not necessarily represent a direct recognition of viral
components by TLR 2, since a variety of pathogens as well as cytokines alone can
upregulate TLR 2 expression (Liu et al., 2000; Kirschning and Schumann, 2002; Matsuguchi
et al., 2000; Wang et al., 2000) as does sterile inflammatory events such as rheumatoid
arthritis in vivo (Seibl et al., 2003). Thus, upregulation of TLR 2 may represent a general
maker of inflammation in both peripheral and CNS settings or may represent a direct
recognition of viral components. Further study will be required to clarify the exact nature of
this interaction. SFV infection down-regulated TLR 4 in both microglia and astrocytes. Since
activation of TLR 4 by LPS similarly down-regulates TLR 4 expression, TLR 4 itself may
have been activated during SFV infection, perhaps via recognition of viral glycoproteins, as
occurs for the respiratory syncytial virus and the mouse mammary-tumour virus (Kurt-Jones
et al., 2000; Rassa et al., 2002). Alternatively, TLR 4 down-regulation may represent a
generalised mechanism in response to stimulation by a variety of microbial components. In
contrast to glial cells, neuroblastoma cells did not dynamically regulate TLR levels in
response to either LPS stimulation or SFV infection, but neither did they express cytokines
or IFN.
5.8.3 Summary
This chapter has demonstrated that cultured glial cells expressed a multitude of TLR that
were differentially modulated in an appropriate manner in response to microbial stimuli.
Microglia reacted to LPS stimulation with the expression of pro-inflammatory cytokines,
whilst infection with SFV predominantly induced the expression of type-I interferon. These
divergent responses underlie the capability of glial cells to determine the type of pathogen
and initiate an innate response that differs in its form and effect. These findings are in
agreement with the microarray data presented in chapter 4. LPS stimulation resulted in the
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down-regulation of several TLR and may contribute to a localised state of endotoxin
tolerance, whilst TLR 2 and 3 were upregulated. SFV infection specifically upregulated TLR
known to be involved in virus sensing whilst other TLR where either unaffected or down
regulated. Whether this upregulation occurs in infected cells, in adjacent uninfected cells, or
in both, remains to be determined. The mechanisms that mediate TLR up and down-
regulation are still to be clarified. Potentially, direct exposure to either SFV itself or
components of SFV, such as dsRNA, may modulate TLR gene expression. Alternatively,
signalling in response to extracellular molecules such as cytokines and interferon may
contribute to the modulation of TLR expression. These issues are further investigated in
chapter 6.
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Chapter 6. An investigation of TLR expression in the CNS at rest, in viral
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6.1 Introduction
The mechanisms that mediate the detection of infection in the immunospecialised
environment of the CNS are poorly characterised. CNS immune responses are crucial to the
control of infections, disease such as bacterial meningitis and viral encephalitis, but are also
important in neuroinflammatory diseases such as multiple sclerosis. More recently, innate
immune responses have been suggested to be important in the pathogenesis of
neurodegenerative diseases such as Alzheimer's disease and the transmissible spongiform
encephalopathies. Whilst there is growing information on the expression and function of
TLR in the lymphoid system, there is little information on TLR expression and function in
the CNS; indeed the profile of TLR expression in the brain remains undefined. The CNS is
the most complex organ in the mammalian body. Specific neuronal nuclei and circuits are
vital and cannot be replaced if damaged or lost and inflammatory and immune responses are
tightly controlled. Lymphocytes, antibodies, complement and MHC-I expression are
generally absent, and consequently the CNS is often described as an immunologically
privileged site. Immunospecialised may be more appropriate since specialised glial cells can
fulfil some of the functions of the innate immune system (Streit, 2002) and even florid
inflammatory responses with highly active immune responses can develop.
The results from previous chapters of this thesis have demonstrated that cultured glial cells
were capable of responding appropriately to differing microbial stimuli. These cells were
also found to express a broad range of TLR suggesting they are well endowed with the
ability to detect infection and discern its type. However, the situation in vivo could be quite
different. N9 microglia represent an embryonic immortalised cell line selected for its
responsiveness to LPS and its resting phenotype; whilst the astrocyte cultures were of
embryonic origin and were treated to several weeks of culture that included maturation with
dbcAMP. Whether either of these cell types adequately begins to describe in vivo expression
is a matter of debate. Expression of TLR was therefore investigated in the brain at rest and
during infection with two neuroinvasive viruses and with a strain of transmissible
spongiform encephalopathy (TSE).
To, avoid the trauma and glial cell activation that can be associated with intracerebral
inoculation, a neuroinvasive virus, SFV, was principally used in these studies. SFV is a
positive-stranded RNA virus that generates an exceptionally high viremia following
extraneural inoculation, and is efficiently neuroinvasive (Fazakerley, 2002). Upon entry into
the brain SFV initiates encephalitis characterised by activation of endogenous glial cells and
a later infiltrate of T- and B- cells. To determine the extent of TLR expression by
endogenous glial cells, TLR transcript levels were compared in both immunocompetent
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Balb/c mice and nu/nu Balb/c mice. The nu/nu Balb/c mice are athymic, lack T-cells, and do
not exhibit an inflammatory leukocyte infiltrate in the brain. The levels of TLR transcripts
during SFV infection of the brain in these two groups of mice were studied in detail.
Standard immunocytochemistry has so far failed to identify TLR protein expression in the
resting brain primarily due to a lack of sensitivity and of good quality commercial antibodies
for murine TLR. This study has examined TLR expression using quantitative real time PCR
developed in chapter 4.
To determine whether transcript changes during SFV encephalitis were unique to this
positive-stranded RNA virus, gene expression changes were also studied in rabies virus
(RABV) encephalitis. RABV is a negative stranded RNA virus that remains a significant
cause of human mortality in the developing world for which there is no treatment following
the development of symptoms. Exposure to the virus, principally through a bite from an
infected animal, enables the virus to infect sensory neurons, with or without local replication
in muscle tissue (Shankar et al., 1991). The virus rapidly ascends the central nervous system
to the brain where uncontrolled viral replication and a prominent pro-inflammatory response
lead to the inevitable death of the host (Theerasurakarn and Ubol, 1998). This work was
undertaken in collaboration with Nick Johnson of the Veterinary Laboratory agency who
infected the animals and sampled whole brains for RNA. Nick and I jointly undertook QPCR
analysis at the University of Edinburgh.
Type-I IFN is a potent anti-viral extracellular messenger that has multiple dramatic effects
on cellular metabolism and antigen presentation, as well as possessing immunomodulatory
effects (Goodbourn et al., 2000). The ability of this messenger to sensitise cells to and resist
virus infection is well described. TLR expression was examined in the CNS of mice lacking
a functional IFN system.
The TSEs represent a unique group of chronic neurodegenerative diseases that are caused by
an infectious protein component, termed prions (PrPSc). The TSE-infected CNS does not
exhibit typical signs of inflammation and most immune processes are absent. However, the
TSE-infected CNS is characterised by a strong glial reaction, with significant activation of
microglia and astrocytes (Williams et al., 1997a). During infection with the ME7 strain of
scrapie, CV mice exhibit pronounced activation of microglia that precedes significant
neuronal loss in the hippocampus and may contribute indirectly to the neurodegeneration
observed in this model (Brown et al., 2003). This chapter explores whether glial cells in the
TSE-infected CNS exhibit altered levels of TLR transcripts. The differences and similarities
of glial reactions during viral encephalitis and prion encephalopathy are discussed.
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6.2 Objectives
To determine TLR expression in the resting CNS of several mouse strains
To compare CNS TLR expression in different strains of mice
To compare TLR levels in the spleen and CNS
To determine TLR expression in the SFV infected CNS
To determine TLR expression in the RABV infected CNS
To determine TLR expression in the scrapie infected CNS
To examine the dependence of any TLR transcription change on:
the presence of lymphocytes
interferon signalling
6.3 The resting mouse brain demonstrates extensive expression of TLR
To determine levels of TLR transcripts in the resting mouse brain four strains of mice,
Balb/c, athymic Balb/c (nu/nu) CBA and 129 were investigated. TLR transcripts were
detectable in the PBS perfused brains of all four strains. As expected the Balb/c mice and
nu/nu (Balb/c background) mice exhibited similar levels of TLR expression. Substantial
differences existed between the Balb/c and the other two strains (Figure 50A). Most
strikingly, 129 mice expressed significantly higher levels of TLR 2, 3, 5, 7, 8 and 9 than
Balb/c mice, whilst CBA mice expressed significantly higher TLR 9 than Balb/c mice.
Furthermore, both CBA and 129 mice demonstrated a significantly lower expression of TLR
1 and 6 compared to Balb/c mice (Figure 50A). For Balb/c mice, TLR transcripts in the brain
were compared to those in the spleen (Figure 50B). Generally, as normalised to either (3-
actin or GAPDH housekeeping genes, the CNS expressed far fewer TLR transcripts than the
spleen. The single exception to this was TLR 3, where transcript levels were comparable
between the two organs.
6.4 Infection with SFV A7(74) triggers profound changes in CNS TLR
expression
To determine the response of the TLR expression profile of the CNS to virus infection and to
distinguish whether changes were due to inflammatory infiltrates, Balb/c and Balb/c nu/nu
mice were infected with the A7(74) strain of SFV. Intraperitoneal infection of Balb/c mice
with SFV A7(74) results in virus invasion of the brain within 48 hours followed by a
predominantly mononuclear inflammatory infiltrate starting at around 4 days (Fazakerley
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Figure 50, TLR transcript levels in the brain and spleen. Groups of four six-week old mice
were perfused with PBS to remove blood-borne leukocytes and their brains and spleens
immediately processed for RNA extraction. Absolute levels of |3 -actin and TLR 1 to 9 were
assayed by QPCR. The data is expressed as a ratio of copies of TLR per 100,000 copies (3 -
actin. (A) TLR transcripts in the resting CNS of Balb/c, Balb/c nu/nu, CBA and 129 mice,
expressed as copy number per copy (3-actin. Levels of (3-actin transcripts per . g brain RNA
were equivalent in all four mouse strains. (B) Comparison of TLR transcript levels in brains and
spleens of Balb/c mice. Analysis comparing TLR copy number per GAPDH copy number (data
not shown) revealed marginally higher TLR expression in the spleen. All bars show mean














Figure 51, SFV RNA levels in the brain during infection. Mice were inoculated
intraperitoneally with either PBSA or SFV A7(74) and sampled on post infection day 3, 7 or
140 (PID). SFV RNA copy number was determined by QPCR using primers to E1 gene


















Figure 52, IFN-a transcripts correlate with SFV RNA levels. Mice infected intraperitoneally
with SFV A7(74) were sampled on PID 7. (A) Balb/c mice. (B) nu/nu Balb/c mice. R2 values


























Figure 53, TLR 2 transcripts are elevated in SFV A7(74) infected brains of Balb/c
mice. TLR 2 transcript were assayed by QPCR and absolute levels calculated and
normalised to p-actin transcripts. Shown above are the amounts of TLR 2 in the cDNA
samples from SFV-infected brain (grey circle) and brains inoculated with PBSA alone
(empty squares). A slight but non-significant increase in TLR 2 expression was observed
in SFV infected brain at PID 3. Levels of TLR 2 were significantly higher in SFV infected
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Figure 54, TLRs are differentially regulated in the CNS during SFV infection. Mice
were inoculated intraperitoneal^ with either PBSA or SFV A7(74) and sampled on post
inoculation day 3 or 7 (PID). (A) Balb/c mice (B) nu/nu Balb/c mice. Each bar represents
the mean fold increase of 4 mice ± SEM relative to PBSA inoculated mice. Marked bars

















































0 T . 1

















0 100000 200000 300000
SFV copy number
R2 = 0.9572
Figure 55, TLR 2 (A), 3 (B), 7 (C), and 8 (D) transcripts correlate with SFV RNA
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Figure 56, TLR transcripts were elevated in both uninfected and SFV infected brain
of nu/nu Balb/c mice at PID 140. Mice were inoculated intraperitoneally with either PBSA
or SFV A7(74) and sampled on post infection day 3 or 140 (PID). (A) Fold increase of TLR
transcripts at PID 140 relative to levels at PID 3 in PBSA inoculated mice ± SEM. (B) Fold
increase of TLR transcripts in SFV infected mice at PID 140 relative to levels in mice
inoculated with PBSA at PID140 ± SEM.
197
Chapter 6 TLR expression in the CNS
invading mononuclear cell response (Jagelman et al., 1978). All mice were infected via the
intraperitoneal route, avoiding CNS trauma, and CNS gene expression in the PBS perfused
brain was assayed on post infection days (PID) 3 and 7. SFV and IFN-a levels in the CNS
were determined by QPCR (Figure 51 and 52). SFV levels peaked at PID 7 and were
significantly higher in nu/nu mice. SFV RNA was detectable at PID 140 only in the nu/nu
mice, suggesting that virus had persisted. Both groups of mice demonstrated increased
IFN-a transcripts; the levels of which correlated with levels of virus RNA (Figure 52).
SFV infection upregulated TLR transcripts with clear variation between individual mice
(Figure 53). Balb/c mice exhibited a broad increase in TLR expression, with TLR 2, 3, 7, 8,
9 and 13 significantly upregulated. TLR 2 upregulation was greatest at 3.6 fold (Figure 54A).
Athymic nu/nu mice had a more extensive infection as determined by viral RNA levels
(Figure 51) and greater increases in TLR transcripts were observed (Figure 54B).
Qualitatively, TLR changes were similar in both strains of mice with TLR 2, 3, 7, 8, 9 and 13
upregulated. TLR 2 and 9 showed the greatest fold-change. As with IFN-a (Figure 52), TLR
2, 3, 7, 8 and 9 showed good correlation with virus RNA levels in nu/nu mice at PID 7,
suggesting virus levels were driving TLR upregulation (Figure 55). TLR upregulation did
not correlate with SFV levels in Balb/c mice.
TLR transcripts were also analysed at PID 140. Surprisingly, PBSA inoculated mice
exhibited TLR levels that were elevated compared to their littermates sampled 137 days
previously (Figure 56A). All TLR assayed, except TLR 5, were shown to be elevated,
suggesting the aged mice possessed more TLR transcripts in general. To determine whether
persistently infected nu/nu mice exhibited chronically elevated TLR transcripts, the levels of
TLR were examined and compared to age matched controls (figure 56B). Upregulation was
highly variable with no significant differences between the groups. However, the results
Suggest thdl TLR 2, 3, 4, 8 and 9 may be elevated by the persistent virus infection. This
profile is different to that observed at PID 7. Elevated levels of IFN-a transcripts were
detected (figure 56B) and similarly to PID 7 correlated with viral load (data not shown).
6.5 TLR levels are altered during rabies encephalitis
To determine whether TLR expression changes were unique to SFV infection, mice were
infected intracerebrally with the rabies virus (RABV) Intracerebral inoculation was utilised
since this generates a reproducible CNS infection. In this study, inoculation resulted in
uncontrolled viral replication, a prominent pro-inflammatory response and death of the host.
All mice had reached defined clinically terminal end points or were dead by 6 days post
infection. QPCR analysis revealed extensive upregulation of several pro-inflammatory
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cytokines and type-I IFN, with IL-6 and TNF-a demonstrating the greatest fold-increases
(figure 57B). Concurrent with this rampant pro-inflammatory response, RABV infection
resulted in substantial upregulation of most TLR transcripts, with TLR 2, 3 and 9
demonstrating the greatest fold-increases. TLR 3 was uniquely upregulated at both PID 2, 4
and 6 (Figure 57A). Mice sampled at PID 0, before virus had time to replicate but had
experienced the trauma of a needle-stick injury, demonstrated transcript levels that were not
significantly different from uninoculated mice (data not shown).
6.6 Mice lacking a functional IFN system cannot upregulate TLR 3 or TLR 9
upon SFV infection
To determine whether the correlation between SFV RNA and TLR transcripts levels in the
brain was dependent on, or independent of the type-I interferon response, 129 mice
possessing a functional type-I IFN system and 129 mice lacing a functional type-I IFN
system (IFN-a/(3-R_/") were infected with either avirulent SFV A7(74) or virulent SFV4 via
the intracerebral route. For these studies mice could not be inoculated intraperitoneally as
they die of peripheral pathology prior to neuroinvasion. All IFN-a/|3-R_/~ mice had reached
clinically defined terminal end points or were dead by 42 hours; gene expression was
therefore only analysed at 24 hours. In comparison, 129 mice demonstrated no or only mild
clinical signs 42 hours following SFV A7(74) infection, but 50% mice had reached terminal
disease or were dead 42 hours post SFV4 infection.
A7(74) infection of 129 mice produced no or minimal changes in TLR, IL-la or TNF-a
transcripts at 24 hours. However, by 42 hours there was upregulation of TLR 1, 2, 3, 7, 8, 9
and 13 with TNF-a, IL-la, TLR 3 and 9 demonstrating the greatest fold-increases. TLR
transcripts in sham-infected brain were equivalent to uninoculated brains at this time. In
contrast, IFN-a/p-R mice demonstrated large increases in proinflammatory IL-la and
TNF-a cytokine transcripts by 24 hours (Figure 58). This earlier increase most likely reflects
the increased virus loads in these mice, which were an order of magnitude higher in IFN-
a/(3-R_/" than 129 mice (Table 9). Transcripts for TLR 1, 2, 4, 6, 7, 8, and 13 showed greatest
upregulation at 24 hours, with TLR 2 and 8 exhibiting the largest increases. Strikingly,
despite higher levels of viral RNA and transcripts for IL-la, TNF-a , and TLR 1, 2, 7, 8 and
13, levels of expression of TLR 3 and 9 transcripts showed no increase in the IFN-a/p-R"'"
mice.
Intracerebral inoculation with virulent SFV4 produced similar results with even greater
changes in TLR expression (Figure 59). Again this correlated with virus titres (Table 9).
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Figure 57. RABV infection elicits large changes in TLR and cytokine transcripts.
Mice were inoculated intracerebral^ with RABV and sampled on post infection day (PID)
0, 2, 4 and 6. (A) TLR transcripts (B) Cytokine and type-l IFN transcripts. Each bar
represents the mean fold increase of 3 mice ± SEM relative to PID 0 time point. Marked
bars are statistically different from control (Student's t-test, n=3, p<0.05).
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Higher levels of virus RNA in SFV4 infected mice than in SFV A7(74) infected mice
produced greater fold increases in TLR and IFN-a. Upon infection, 129 mice upregulated
TLR 1, 2, 3, 4, 6, 7, 8, 9 and 13, with TLR 2, 3 and 9 exhibiting the largest increases (29 fold
for TLR 2 and 16 fold for TLR 9 at 42 hours). Proinflammatory cytokines were detected by
24 hours and continued to rise at 42 hours. IFN-a/(3-R"/_ mice also exhibited high levels of
cytokine transcripts at 24 hours and exhibited levels of SFV RNA that was equivalent to the
levels in SFV4 infection of 129 mice at the later time-point of 42 hours. Interestingly, TLR
1, 2, 4 and 7 were upregulated in IFN-a/fl-R mice to a similar extent to 129 mice at 24
hours post infection, whilst TLR 6, 8 and 13 and the cytokines were more substantially
upregulated. As with A7(74) infection, there was a striking failure of IFN-a/p-R _/ mice to
upregulate TLR 3 and 9. Expression levels were not significantly different from uninfected
littermates despite a high virus load, and a substantial pro-inflammatory response. These
results demonstrate that an intact type-I IFN system is critical for upregulation of TLR 3 and
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Figure 58, Infection of 129 mice and IFN-ap-R
deficient mice with avirulent SFV A7(74). 129
and 129 IFN-ap-R7" mice were infected
intracerebrally with either PBSA or SFV and
sampled at 24 hours or 42 hours post infection.
By 42 hours all IFN-ap-R7- mice had died. Mice
inoculated with PBSA alone demonstrated no
TLR up-regulation compared to the resting brain.
129 mice sampled at 42 hours exhibited markedly
varied levels of SFV RNA. (A) Transcripts
expressed at a higher level in IFN-ap-R7-
compared to 129 at 24 hours post infection. (B)
Transcripts up-regulated in 129 mice but not in
IFN-ap-R7- mice.
TLR3 TLR9
Table 9 SFV RNA transcripts per ng total RNA
24 hours 42 hours
SFV A7(74) SFV4 SFV4
129 mice 37 4,956 17,420
IFN-a/p-R -/- mice 351 17,718 N/A
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Figure 59, Intracerebral
inoculation with virulent
SFV4 results in large
changes in TLR levels. TLR3
and TLR9 were not up-
regulated by infection in IFN-
ap-R -/- mice. (A) Transcripts
expressed in IFN-a|3-R -/- mice
at a level equivalent to 129
mice at 24 hours post infection.
(B) Transcripts expressed at a
higher level in IFN-ap-R -/-
compared to 129 mice at 24
hours post infection.
C) Transcripts up-regulated in
129 mice but not in IFN-ap-R -
/- mice.
"T i T-' fI r
TLR6 TLR8 TLR 13 IL-1C TNF-a
16-
IPBSA HE! 129 mice 24 h QlFN-R-ap -/- 24 h 0129 mice 42 h
203
Chapter 6 TLR expression in the CNS
6.7 TLR expression is modulated during scrapie neuropathogenesis
In contrast to viral encephalitis TSEs exhibits no obvious inflammatory infiltrates or BBB
permeability. Lymphocytes and other immune cells such as natural killer cells are absent
despite a prominent glial reaction. During scrapie pathogenesis glial cells undergo
hyperplasia and hypertrophy, and yet the level of pro-inflammatory cytokine release relative
to the degree of reactive gliosis is highly restricted, temporally late and disproportionately
low (Brown et al., 2003). The work above has described large changes in TLR expression
during viral infection of the brain. To determine whether the glial activation that occurs in
the scrapie brain is associated with TLR expression change, samples of ME7 scrapie infected
hippocampus and age matched control hippocampus were examined. These samples were
taken from a library of samples available in the Fazakerley laboratory (Brown et ah, 2003).
The dynamics of TSE infection and onset of clinical disease, along with levels of glial
activation and neuronal death in these samples have been previously reported (Brown et ah,
2003). The ME7 hippocampus was chosen since this area of the brain has particularly well
described pathological changes. PrPSc deposition and glial activation are evident from 100
days post infection (dpi) and increase until terminal disease. In addition, between 160 and
180 dpi 50% of the CA1 neurones of the hippocampus are lost. Accordingly, TLR transcript
levels were assayed at 169 dpi, 180 dpi and 237 dpi (approaching terminal disease). Fold
increases of TLR transcripts were calculated relative to age matched controls inoculated with
normal brain homogenate; this negated any possible effect of age related changes due to the
phenomenon of age-related increases in TLR expression, described in section 6.4. Increases
in TLR 2, 3, 7, 8 and 9 were seen at 169 dpi, whilst TLR 2, 7 and 9 were in addition
significantly elevated at 237 dpi (Figure 60). To determine whether increases in TLR 2
continued to terminal disease, a second set of hippocampus samples weie examined which
included mice sampled beyond 237 dpi at the time at which they reached a clinically defined
terminal end point of disease (Figure 60B). TLR 2 transcripts continued to increase towards
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Figure 60, TLR transcripts are up-regulated during scrapie infection of the
hippocampus. Mice were inoculated with either ME7 scrapie brain homogenate or
normal brain homogenate and hippocampal samples taken at 169, 182 and 237 days
post infection (dpi). (A) Fold increase of TLR transcripts significantly altered relative to
uninfected controls. Bars represent the mean fold change in transcript level of the
infected mice relative to age matched controls. Bars marked with an asterisk are
statistically different from control (Student's t-test, n=3, p<0.05). (B) TLR 2 transcripts
were analysed in more detail and revealed higher TLR 2 expression at terminal disease.
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6.8 Discussion
This chapter reports the first systematic analysis of TLR gene expression in the CNS. It
reveals extensive expression in the resting CNS and differential modulation during viral
encephalitis. The finding that the brain has the ability via TLR expression to detect infection
and discern its type provides an important contribution to understanding pathological
processes in this organ. This chapter also demonstrates for the first time that upregulation of
transcription for TLR 3 and 9 is dependent upon type-I IFN responses whereas for other
TLR, increased expression is proportional to virus load but is independent of type I
interferon. TLR expression has also been described for the first time during scrapie infection
and suggests an interaction between innate immune processes and infection with PrP50.
6.8.1 TLR expression in the uninfected brain indicates endogenous CNS cells
can sense infection at rest
This is the first comprehensive in vivo analysis of TLR gene expression in the mouse brain.
TLR 1 to 9 and TLR 13 were all expressed but at levels lower than immunological organs
such as the spleen. An exception to this was TLR 3, which was uniquely expressed in the
brain at a level comparable to that of the spleen. This novel finding could reflect an
evolutionary history of RNA virus infection as the major pathogen selective pressure in the
CNS. Indeed, on a worldwide basis, RNA virus infections remain the most common type of
pathogen infecting the CNS. Viruses such as polio, rabies, West Nile and Japanese
encephalitis, are all important causes of human morbidity and mortality. The relatively high
CNS expression of TLR 3 may be an evolutionary selected response to the pressure of RNA
virus infections. The finding that astrocytes express TLR 3 at relatively high levels (chapter
5) suggests that most of the TLR 3 detected in whole brain may be of astrocyte origin in
addition to microglia.
It is interesting to note that differing strains of inbred mice exhibited differing TLR
expression levels in the brain. 129 and CBA mice are both derived from the C57B1/6 mice
and would be expected to exhibit some of their characteristics. The more substantial
expression of TLR 2, 3, 5, 7 8 and 9 in 129 mice compared to Balb/c mice and of TLR 9 in
CBA mice compared to Balb/c mice is interesting in the knowledge that these strains differ
in their susceptibility to a variety of microrganisms. Differential TLR gene expression could
contribute to some of these susceptibility differences. For example, in C576B1/6 mice,
absence of TLR 3 and particularly TLR 9 renders them as susceptible to CMV-associated
morbidity as the susceptible Balb/c strain (Tabeta et al., 2004). Unlike all other TLR, CBA
and 129 mice exhibited lower levels of TLR 1 and 6 compared to Balb/c mice. The
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concurrent lowly expressed nature of both TLR 1 and TLR 6 in both CBA and 129 mice
suggest these two highly related TLR members are expressed in a coordinate manner.
6.8.2 Virus infection selectively and appropriately upregulates Toll-like
receptor gene expression in the central nervous system
Upregulation of TLR expression can increase a cell's sensitivity to microbial components
and infection. Macrophages can upregulate TLR 2 in response to stimulation with a variety
of microbial components. Upregulation of TLR 2 correlates with increased responsiveness to
further microbial challenge (Nilsen et al., 2004), whilst down-regulation of TLR 4 correlates
with decreased responsiveness to LPS (Nomura et al., 2000). Dendritic cells induced to
express high levels of TLR 7 makes them more sensitive to challenge with TLR 7 ligand
imiquimod (Mohty et al., 2003). Together this data indicates changes in TLR transcript
levels modulate responsiveness to innate immune stimuli.
The data reported here show for the first time that TLR are upregulated during viral
encephalitis and presumably increase the tissues sensitivity to microbial components.
Furthermore, the response is appropriate to the pathogen. During SFV infection, TLR 2, 3, 7,
8 and 9 were significantly upregulated while TLR 1, 4, 5 and 6 were not. TLR 2 may a have
role in detecting viral glycoproteins (Bieback et al., 2002; Kurt-Jones et al., 2004a), whilst
TLR 3, 7, 8 and 9 are all critical for recognising viral nucleic acid sequences and TLR 1, 4, 5
and 6, which were not upregulated, are principally associated with bacterial infections
(Takeda et al., 2003). This selective upregulation does not require lymphocytes, as
demonstrated by infection of the nu/nu mice. In these mice the IFN response was able to
control the infection; levels of IFN-a correlated with levels of virus and increases in TLR
transcripts. These results demonstrate that either a direct effect of virus replication or an
indirect effect, mediated perhaps by interferon, results in a selective increase in gene
expression for those TLR able to sense virus infection. This would increase the sensitivity of
the system to detect spread of infection and presumably allow cells to react more rapidly to
infection. Infection of the CNS with RABV resulted in TLR transcript changes that were
qualitatively similar to that which occurred during SFV infection. Indeed, the substantial
upregulation of TLR 2, 3 and 9 was a response common to both intracerebral inoculation
with SFV and RABV, suggesting upregulation of these three TLR is a response common to
several types of neuroinvasive RNA virus. Upregulation of TLR 3 may be a particularly
early response to RNA infection of the brain, since TLR 3 alone was significantly
upregulated at PID 2 with RABV. Events were further dissected by the analysis of IFN-afJ-R
-/- mice infected with SFV. These mice showed no defect in the upregulation of
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proinflammatory cytokines or TLR 2, 7 or 8 but were unable to upregulate gene expression
of TLR 3 and 9.
An interferon independent mechanism mediated the substantial upregulation of TLR 2
following SFV infection in a manner proportional to the virus load. Cell stress responses
such as induction of heat shock proteins, direct viral glycoprotein-mediated activation of
TLR 2 or the presence of cytokines could be responsible for this. Cytokines have been
shown to upregulate TLR 2 in other settings whilst TLR 2 is well known to be upregulated in
myeloid cells in response to a variety of pathogens (Matsuguchi et al., 2000) and during
sterile inflammatory events such as rheumatoid arthritis in vivo (Seibl et ah, 2003), and thus
may represent a general maker of inflammation in both peripheral and CNS settings.
Similarly, in both Balb/c and 129 mice, SFV infection with either avirulent or virulent SFV
triggered moderate increases in TLR 7 and 8 expression, which did not require IFN-a/(3
signalling. TLR 13 is a newly described member of the family whose function is
uncharacterised but possesses sequence similarities to TLR 3 (Tabeta et ah, 2004). TLR 13
was examined here to determine whether its expression was, as with TLR 3, controlled by
IFN. Moderate up regulation of TLR 13 was observed in the infected CNS that was not
dependent on IFN.
Two previous studies have linked TLR 3 upregulation to IFN-a/(3 production in cultured
monocyte-derived macrophages (Doyle et ah, 2003; Miettinen et ah, 2001). This report
demonstrates for the first time that this occurs in vivo, in this case, during viral encephalitis,
and in addition informs us TLR 9 is also under IFN control. It is likely that by upregulating
TLR 3 and 9, IFN-a/(3 acts to increase the sensitivity of cells in the vicinity of virally
infected cells. This parallels events with PKR another interferon inducible activator of innate
cellular defences (Meurs et ah, 1992; Tanaka et ah, 1998; Goodbourn et ah, 2000). Basal
levels of PKR detect viral RNA and induce type-I IFN synthesis. This IFN acts in both an
autocrine and paracrine way to upregulate a number of genes including PKR itself (Meurs et
ah, 1990). In this way cells in the vicinity of virally infected cells have their virus sensing
mechanisms upregulated. The finding here, is that this also applies to the two TLR most
associated with recognition of virus nucleic acids, TLR 3 and 9.
6.8.3 Functional significance of in vivo TLR 3 expression
Several reports have begun to address the functional significance of TLR 3 expression in
vivo. TLR 3 is necessary and sufficient for responses to poly(I:C) and reovirus RNA in vitro
(Alexopoulou et ah, 2001). However, recent reports have questioned the in vivo relevance of
these findings. The ability of TLR 3 deficient mice to resist infection with several viruses
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including, CMV, reovirus and LCMV were investigated. This report found the outcome of
infection was independent of TLR 3 (Edelmann et al., 2004), although this report did not
examine innate immune responses. In comparison, innate immune responses are significantly
curtailed in TLR 3 deficient mice following CMV infection and demonstrate increased
mortality (Tabeta et al., 2004). Furthermore, mice deficient in a downstream component of
TLR 3 signalling, TRIF, are more susceptible to infection with CMV when given at higher
doses (Hoebe et al., 2003) than that used in the report by Edelmann et al. In addition, TLR 3
deficient mice have significantly elevated levels of spleen virus following infection with
WNV and decreased cytokine production (Wang et al., 2004). Together this suggests TLR 3
expression does impart some function to viral immune responses. In addition, TLR 3
deficient mice are protected from shock induced by poly(I:C) treatment, suggesting the
receptor has an in vivo role in the recognition of and responses to extracellular dsRNA
(Alexopoulou et al., 2001).
It has been suggested that the concentrations of dsRNA made during some natural infections
may not be sufficient to bind to and significantly influence TLR 3 signalling, when
compared to the high concentrations used for in vitro studies (Edelmann et al., 2004).
Elowever, the amount of dsRNA generated during the course of infection with several
viruses may well be sufficient to activate TLR 3. This may be the case following infection
with SFV. SFV is a positive-stranded RNA virus that replicates very rapidly upon infection
and initiates high levels of viremia within 24 hours of infection (Fazakerley, 2002). The
present study demonstrates intra-peritoneal infection with SFV generates relatively low
levels of brain virus levels at PID 3 and 7, and appropriately TLR 3 upregulation was
minimal. Conversely, in mice infected with SFV intracerebrally, transcripts were assayed far
earlier at 24 and 42 hours post infection. These inoculations resulted in several orders of
magnitude higher levels of brain virus by compared to intraperitoneal inoculation and
appropriately exhibited dramatic upregulation of TLR 3. In addition, RABV infection given
by the intracerebral route resulted in very high levels of viral replication (Theerasurakarn and
Ubol, 1998), and the data here shows it was TLR 3 that was upregulated first at PID 2 and to
high levels by PID 4 and 6, suggesting that TLR 3 function may be important during the
early stage of infection. However, whether TLR 3 expression is a critical component of CNS
immune responses to viruses remain to be determined. Investigating the course of infection
and host immune responses during infection of TLR 3 deficient mice with SFV would be one
way to enhance our understanding of the in vivo significance of TLR 3 expression.
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6.8.4 Elevated TLR expression in the CNS of aged mice may partly explain the
increased sensitivity of the brain to infection
TLR upregulation during the initial stages of SFV infection in both Balb/c and nu/nu was
appropriate and specific. This perceived specificity is maintained following persistent
infection of the brain as seen in nu/nu mice sampled 140 days post infection with SFV, with
TLR 3 and 9 most substantially upregulated. In addition, Balb/c mice that were inoculated
with PBSA alone upregulated most TLR transcripts by PID 140 despite the absence of
infection. This would suggest glial cells exhibit higher levels of TLR expression as the brain
ages. Age related increases in TLR expression would parallel the higher expression of other
markers of activated microglia such as MHC-II and F4/80 in the aged human brain. Infant
humans have few if any activated microglia in resting brain tissue and the number of
activated microglia gradually increases with age (Streit et al., 1999). Alternatively, the
increased level of TLR transcripts in the older mice may have represented expression by
circulating monocytes that gradually infiltrate the brain as it matures. Unlike endogenously
derived microglia, these infiltrating cells are known to express high levels of MHC and
CD45 (Ford et ah, 1995), and undergo cytoskeletal rearrangements so that they possess a
morphology reminiscent of endogenous microglia (Streit et ah, 1999). Nevertheless, TLR
transcripts in the brain appeared to be higher in older mice. The brain is well known to
become more sensitive to infection and prone to neurodegeneration as it ages; a phenomenon
that could in part be a consequence of higher TLR expression that lowers the threshold for
glial activation. In elderly humans, peripheral infections often result in the onset of dementia
and putative glial cell activation. This suggests microbial components or extracellular
messengers, induced by peripheral infection, trigger inflammatory processes in the brain that
become clinically apparent as an episode of dementia (Perry, 2004; Perry et al., 2003;
Holmes et al., 2003). In addition, the elderly are more susceptible to a range of neuroinvasive
viruses such a West Nile virus and Japanese encephalitis virus, again perhaps a consequence
of excessive glial activation (Solomon, 2004). Microglial activation and inflammatory
reactions co-localise with viral antigen in the brain, and several reports have linked neuronal
damage and dysfunction with microglial activation during viral encephalitis (Wang et al.,
2003; Xiao et al., 2001; Shrestha et al., 2003). The production of several inflammatory
mediators including TNF-a and IL-6 appear necessary and sufficient to induce neuronal
death (Jeohn et al., 1998; Meda et al., 1995; Wang et al., 2004), whilst an absence of TLR 3
protects the brain from the counterproductive immune responses relating to infection with
West Nile virus infection (Wang et al., 2004). TLR 9 signalling in microglia has also been
shown to induce neuronal injury in vitro (Iliev et al., 2004). Taken together this would
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suggest increased TLR expression in glial cells may partly contribute to the increased
sensitivity of the aged brain to infection and enhance the susceptibility of the organ to
inflammatory processes associated with viral infection.
6.8.5 Increased TLR expression in scrapie-infected brain indicates an
involvement of innate immune processes
The form of glial activation observed during viral encephalitis could differ from that in
scrapie. During viral encephalitis glial activation is rapid and associated with substantial
cytokine and chemokine production. An inflammatory infiltrate of mononuclear cells and
serum proteins develops which may contribute to the destruction of neural cells (Morris et
al., 1997; Mack et ah, 2003; Olson and Miller, 2004; Amor et ah, 1996). Conversely, glial
activation in scrapie is prominent but there is little associated production of inflammatory
mediators and it occurs over a considerably longer period of time. An influx of inflammatory
mononuclear cells is not evident in scrapie (Williams et ah, 1997a; Brown et ah, 2003).
Appropriately the dynamics of TLR expression have been shown here to be different in each
case, with the exception of TLR 2 upregulation that was prominent in both conditions.
TLR 2 upregulation was substantial and significant towards terminal disease during scrapie
neuropathogenesis. This correlates with increased levels of several glial-associated
transcripts such as CD68, complement components and GFAP (Brown et ah, 2004;
Eikelenboom et ah, 2002). As described above, TLR 2 upregulation may represent a non¬
specific marker of innate immune activation. Alternatively, the substantial upregulation of
TLR 2 may represent a mechanism by which the innate immune system senses infection.
Indeed, small but physiologically relevant levels of bacterial lipoproteins upregulate TLR 2
expression in macrophages. This upregulation causes an increase in the cell's sensitivity to
further challenge with TLR 2 ligands, and may represent an important mechanism by which
the immune system boosts its response during the beginning of an immune response (Nilsen
et ah, 2004). Conceivably the upregulation of TLR 2 in the scrapie brain may represent a
response by glial cells to determine the source and type of infection in a tissue undergoing
extraordinary levels of neuronal damage and death.
These findings are relevant for our understanding of scrapie neuropathogenesis, since unlike
viral encephalitis, few immune processes are observed and cytokine production is minimal.
The data here suggests that activation of innate immunity in the brain, as demonstrated by
TLR upregulation, occurred before clinical disease and was substantial at terminal disease.
Upregulation of several TLR transcripts at 169 dpi correlated with neuronal loss in the
hippocampus and may reflect activated glial processes that are toxic to resident neurones. In
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comparison, upregulation of TLR at terminal disease occurred in a tissue demonstrating
severe pathology that included; cell death, destruction of tissue architecture in addition to
chronic glial activation (Brown et al., 2003). Further work will be required to determine the
identities of the cell types exhibiting TLR upregulation. In addition, the number of mice
sampled was small and the upregulation at 169 dpi for all TLR was variable. More work will
be required to clarify whether the transcript changes described here can be repeated in both
ME7 scrapie and in other TSE models.
It will be interesting to determine whether the upregulation of TLR in the scrapie brain is a
reaction to neuronal damage or a contributor to that damage. Mice deficient in the TLR
signalling adaptor Myd88 exhibit the same classic neuropathological changes that occur in
wild type mice following infection with scrapie, suggesting TLR signalling is dispensable for
disease progression (Prinz et al., 2003). However, it is now clear that some TLR can signal
independently ofMyD88 and so these results do not preclude the possibility that TLR have a
role to play during scrapie neuropathogenesis. The increased level of TLR may explain why
patients suffering from neurodegeneration are more sensitive to cognitive dysfunction
following peripheral infection. Microglia are capable of releasing a wide barrage of
neurotoxic mediators and have been implicated as a major determinant factor in the
progression of neurodegeneration in TSE and AD (Eikelenboom et al., 2002). Marked
activation of microglia occurs in close parallel to the deposition of amyloid fibrils, such as
PrPSc in TSEs and P-amyloid in AD. In TSE, microglial activation is not only strictly
associated with neurodegeneration (Williams et al., 1994; Muhleisen et al., 1995), but
precedes neuronal death in the hippocampus of mice and is prior to the onset of clinical
symptoms (Williams et al., 1997a; Giese et al., 1998). Several in vitro models have also
implicated microglial processes as the major contributory factor in the death of PrPSc-
infected neurones (Bate et al., 2001; Brown et al., 1996). These findings suggest activation
of microglia may contribute to neuronal damage rather than be a reaction to it.
The initial stimulus that activates microglia in TSEs is likely to be the abnormal form of the
prion protein, PrPSc. This agent is directly toxic to neurones, although significant neuronal
death only occurs in the presence of glial cells (Brown et al., 1996). In the TSE-infected
brain, PrPSc can be found as polymers of repeating units in the form of amyloid fibrils (Wille
et al., 2002). Potentially these abnormal repeating patterns may be recognised by PRRs such
as TLR and trigger a response more appropriate for defence against pathogens than
endogenously derived protein, be they infections in the case of TSE, or non-infections as in
the case of AD. Several studies have suggested PRRs are involved in the recognition of
amyloid and the pathogenesis of neurodegeneration; CD14 binds p-amyloid and is
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upregulated in mouse models of AD (Fassbender et al., 2004), whilst microglia deficient in
CD14 cannot kill neurones through (3-amyloid induced inflammation (Bate et al., 2004); and
mice deficient in CD36 have marked reductions in the recruitment of microglia following (3-
amyloid injections and secrete lower levels of neurotoxic, inflammatory mediators (El
Khoury et al., 2003). Together this suggests that PRRs may recognise amyloid and trigger an
innate immune response that is damaging to CNS tissue.
Animal models of AD suggest that when activated microglia are stimulated by a systemic
infection this results in significantly raised levels of IL-1(3 within the CNS, which may in
turn potentiate neurodegeneration. In addition, humans suffering from AD are more prone to
CNS complications and demonstrate decreased cognitive functions following systemic
infection (Holmes et al., 2003; Perry et al., 2003). A mouse model of motor neurone disease
suggests activation of innate immunity through TLR signalling in the brain exacerbates
neurodegeneration (Nguyen et al., 2004). The present study suggests TLR may be
upregulated during scrapie neurodegeneration and during the course of normal aging. TLR
impart the ability to recognise infectious agents and increased TLR expression correlates
with increased cytokine release upon TLR activation (Weiss et al., 2004). One can speculate
that TLR may also be upregulated in other types of neurodegeneration such as AD, and may
in part explain the more sensitive nature of degenerating CNS tissue to infection.
The innate activation of glia in neurodegeneration appears non-productive, i.e. neither is the
adaptive immune system engaged nor is the stimulatory agent effectively removed, perhaps
because the stimulus does not represent an immunogen of significant strength to activate T-
cell responses. Indeed, models of TSE and AD in which adaptive immune responses are
induced experimentally; demonstrate clearance of amyloid, reduced neuropathology and less
severe cognitive dysfunction (Heppner et al., 2001; Enari et al., 2001; Janus et al., 2000).
This would suggest that therapeutic intervention that translates the initial innate immune
response of glia into an adaptive immune response may help resolve disease or slow disease
progression. Indeed, several large scale clinical trials are currently underway to determine
the efficacy of vaccines in the treatment of AD (Nitsch and Hock, 2004). Arguably, a better
understanding of TLR function in neurodegeneration would enable more effective design of
therapeutics in this emerging area.
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This thesis has examined innate immune responses of CNS cells upon stimulation with LPS,
infection with virus, and during the chronic neurodegeneration of TSE. The ability of the
immunospecialised CNS environment to detect infection despite the absence of any
recognisable immune process remains puzzling. This project aimed to explore the capability
of CNS cells to express key PRRs and in more detail TLRs that function to recognise a
variety of pathogen associated molecules. In addition, key genes involved in innate immune
responses to pathogens were assayed. The results provide a new understanding of the innate
capability of CNS cells to detect and respond to infection and are relevant not only to the
acute stage of infection but also to our understanding of the neuropathogenesis of
neurodegeneration, such as that exemplified by TSEs and AD.
Several techniques exist to describe gene expression at both the transcript and protein level.
The approach taken here to utilise microarray technology was chosen since this permits the
simultaneous analysis of many gene transcripts in one experimental sample. Using such an
approach provided information on a whole host of genes that could not have been gained
through analysis of each gene in isolation. Chapter 3 reports the development and validation
of a novel custom microarray that assayed the expression of a multitude of key gene
transcripts involved in innate immune responses. This technique required considerable
development to obtain optimal conditions for hybridisation and minimise non-specific
background signal. The process of hybridisation was found to generate considerable signal
variation across the array surface and a methodology to correct for this experimental bias
was introduced and developed. Several methodologies for normalising data sets between
arrays were investigated. Probe design demonstrated that the distance from where the probe
binds to from the 5'polyT cDNA tail had an impact on probe signal intensity. Future
microarray design should take into account these findings, by either using alternative
labelling strategies or limiting probe complementation to the extreme 5' end of the cDNA
sequence.
The microarray platform was successfully utilised to characterise gene expression in resting,
LPS-stimulated and SFV infected N9 microglia and responses generated were appropriate to
the pathogen. The analysis revealed that resting N9 microglia expressed a multitude of gene
transcripts involved in innate immune responses. These included; inflammatory mediators
such as cytokines and chemokines; markers of activated phagocytes such as the
cyloxygenases and the free radical generator NCF1 (p47phox); and pattern recognition
receptors such as scavenger receptors. Notably the level of TLR expression was not
adequately described by the microarray due to the inadequate sensitivity of the array
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platform to detect these lowly expressed transcripts. Indeed, other work has shown that even
in purified populations of macrophages TLR expression is barely detectable at the transcript
and protein level (Weiss et al., 2004). TLR 2 was, however, consistently detected by the
array. LPS stimulation profoundly changed N9 microglia gene transcript levels, underlying
the potent nature of this component of gram-negative bacterial infection. LPS induced large
changes in both proinflammatory cytokines and chemokines and several novel changes in
scavenger receptor expression. Comparison of samples assayed by both microarray and
QPCR indicated that the array could be relied upon qualitatively (if not quantitatively) to
observe up or down-regulation of transcripts. These array findings therefore need to be
validated using an alternative technique such as QPCR analysis of transcript levels or FACS
analysis of protein expression.
Microarray analysis demonstrated that SFV infection of microglia initiated a different and
appropriate response. This neuroinvasive virus is a well-established model of viral
encephalitis that has also been used extensively to describe other aspects of virus biology
such as virus-cell fusion (Gibbons et al., 2004) and has more recently been developed as a
vector for the delivery of vaccines and as a tool for gene therapy (Atkins et al., 1999;
Fazakerley, 2004). Despite the ability of microglia to respond to viral infection, activate T-
cells in vitro, express pro-inflammatory mediators and generate many of the microbicidal
molecules produced by activated macrophages; little work has been done to study the
response of microglia to virus infection. The present study provides new insight into the
nature of innate immune responses of N9 microglia at the transcript level. SFV infection
initiated substantial upregulation of several chemokines and type-I IFN, although cytokine
expression was minimal. Some of these findings were confirmed and further investigated by
QPCR analysis in chapter 5.
These microarray results demonstrated the capability of microglia to respond in a distinct
and appropriate manner to differing microbial stimuli. The rapid initiation of innate immune
responses is critical to limit the spread of infection before adaptive immune responses can be
generated. Innate immune responses can also modulate the form of adaptive immune
response. The production of pro-inflammatory cytokines in response to LPS is a typical
response of many leukocytes and serves to rapidly induce an inflammatory response that acts
to clear gram-negative bacterial infection. Indeed, gram-negative bacteria provide a
considerable challenge to the immune system due to the ability of LPS to inhibit
phagocytosis. Conversely, the production of type-I IFN is critical for effective innate
immune responses to virus infection and serves to exert potent anti-viral effects on
surrounding cells, making them refractory to active viral replication. These findings confirm
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the ability of microglia to respond to differing microbial stimuli and demonstrate microglia
possess a capability to sense infection using a series of pattern recognition receptors.
QPCRs were developed that sensitively and accurately assayed the level of gene transcripts
for the entire TLR family, several key cytokines and IFN. Glial cells expressed a multitude
of TLRs, suggesting they can recognise a wide range of microbial associated molecules. Few
other leukocytes in the body express such a broad repertoire of TLR; the extensive
expression demonstrated by glia may be an essential strategy for a tissue that at rest is
otherwise devoid of any recognisable immune process. Specificity of innate immune
responses are possible through the differential use of TIR-containing adaptors molecules
such as MyD88 and TRIF. Activation of differing TLR pathways results in the induction of
distinct patterns of gene expression that are appropriate to control the infectious agent. The
present study informs us that this model of innate immune specificity may apply to glial
cells. In addition, the expression of TLR can confer the ability to directly kill pathogens.
Macrophages deficient in TLR cannot kill phagocytosed bacteria or synthesis NO to the
same extent as wild-type cells, and this may apply to microglia as well (Weiss et al., 2004).
The implicit appropriate nature of glial responses to infectious agents was underlined by the
finding that in addition to cytokine transcripts, TLR transcript levels were also dynamically
regulated in an appropriate and specific manner. In N9 microglia, LPS stimulation resulted in
down-regulation of several TLR and upregulation of TLR 2 and 3, a response previously
described in cultured macrophages (Sweet et al., 2002; Doyle et al., 2003). This response
may serve to both limit over-excessive production of cytokines to a highly potent stimulator
of the innate immune system, whilst TLR 2 and 3 upregulation has been suggested to
provide specificity to innate immune responses. This hypothesis suggests microbe-stimulated
macrophages upregulate both TLR 2 and 3 followed by differential TLR activation; with
TLR 2 activation occurring if infection is bacterial and TLR 3 activation occurring if
infection is viral (Weiss et al., 2004). In comparison to LPS stimulation, SFV infection of
microglia upregulated several TLR, with TLR 3 exhibiting the largest increase. TLR 3
functions to recognise viral dsRNA and initiate type-I IFN responses, hence this response is
appropriate.
This thesis has explored in vivo TLR expression in the resting and virally infected CNS for
the first time. This provides us with a new insight into the innate immune capability of this
important tissue to respond to infection. Several TLRs associated with responses to either
viral structural components or viral nucleic acids were upregulated by RNA virus infection,
whilst TLRs associated with sensing bacterial components were either unaffected, or not
upregulated to a similar magnitude. TLR 2, 3 and 9 were significantly and most substantially
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upregulated during infection with either a positive-stranded RNA virus, SFV, or a negative-
stranded virus, RABV. The nature of this CNS reaction suggests upregulation of these three
TLRs may be a response common to all RNA viruses. Whether DNA viruses such as Herpes
simplex initiate similar TLR transcript level changes during CNS infection remains to be
determined. Importantly, the type of cell that contributes to these changes remains to be
determined. This thesis has shown microglia and astrocytes expressed TLRs at a comparable
level in vitro and were capable of dynamically regulating TLRs upon SFV infection. The
majority of publications have assumed the functional significance of TLR expression in
microglia is paramount due to the ability of microglia to express higher levels of
inflammatory mediators such as cytokines (Wang et al., 2004; Kurt-Jones et al., 2004b; Iliev
et al., 2004; Kielian et al., 2002; Laflamme et al., 2001; Lee and Lee, 2002; Lehnardt et al.,
2003). However, astrocytes are capable of producing cytokines and chemokines following
TMEV infection, and can activate T-cells in vitro following IFN-y stimulation (Carpentier et
al., 2005). Importantly, astrocytes play a vital role as support cells to neurones. They have a
multitude of functions that neutralise neurotoxic compounds and become activated upon
neuronal injury in numerous conditions including acute ischaemic insult, virus infection and
during chronic neurodegeneration (Liberto et al., 2004). Arguably, the ability of astrocytes to
detect infection so that they can support neurones and prevent excessive neuronal damage
associated with CNS infection may be more important than their ability to generate immune
responses. Thus TLR expression on astrocytes may not necessarily suggest a role for this cell
type in the generation of brain inflammation, but rather may further underlie the ability of
these support cells to detect situations in which neuronal damage can occur. Indeed, the
activation of astrocytes during the early stages of an immune response could be
advantageous in limiting neuronal dysfunction that occurs as a secondary process to CNS
immune responses. Thus, astrocytes may conceivably contribute to the TLR upregulation
described in vivo during SFV and RABV infection. In particular, TLR 2 upregulation was far
more substantial in astrocyte cultures, compared to microglia infected with SFV and this
may be reflected in vivo. To determine the exact cellular identity of TLR expression in vivo,
techniques must be developed that are sensitive enough to work on tissue sections. Few
commercial antibodies exist that can detect TLR expression in the CNS and work undertaken
in this laboratory (not shown here) using TLR monoclonal antibodies has failed to generate
adequate signal on cryostat sections. In addition, polyclonal antibodies appear to lack the
specificity required to label specific TLRs, presumably due to the highly conserved and
repetitive nature of TLR sequences. Conceivably, TLR transcripts could be detected in situ
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by hybridisation RNA probes. Nevertheless, further work will be required to clarify exactly
which cell types contributes to the majority of TLR expression in the brain.
The relative importance of each TLR in sensing infections and generating immune responses
remains to be clarified, however some work has begun to address this. Infection of mice
deficient in TLR 2 with Herpes simplex exhibit markedly lower levels of brain inflammation
and higher CNS titres (Kurt-Jones et al., 2004b), which suggests TLR 2 may be key to
initiating CNS immune responses to DNA viruses, whilst similar experiments demonstrated
TLR 4 expression was dispensable. TLR 2 expression is complex and not well understood
(Nilsen et al., 2004) and the results here show it is independent of type-I IFN in the case of
viral encephalitis. TLR 2 up regulation was also observed during scrapie pathogenesis, and
occurs in a variety of other model systems that involve inflammation. The functional
significance of TLR 2 upregulation during SFV or scrapie infection remains to be
determined. TLR 3 plays an important role in vivo during WNV infection to initiate brain
inflammation, whilst in vitro cultures of TLR 3 deficient microglia cannot kill neurones upon
infection with WNV, unlike their wild-type counterparts (Wang et ah, 2004). This suggests
TLR 3 is important for both the initiation of immune responses and for generating responses
that are harmful to neurones. These studies have shown the power of utilising knockout mice
to elucidate the functional significance of TLR expression during CNS infection. Insight
would be gained by investigating the course of CNS SFV infection in mice deficient in either
TLRs or adaptor molecules such as MyD88.
Type-I IFN is a potent anti-viral system critical for early innate immune responses that limit
viral replication in vivo. The dependence of TLR 3 and 9 upregulation during virus infection
of the CNS on type-I IFN is a novel finding and further describes the effects of this potent
anti-viral messenger. Two previous studies have linked TLR 3 upregulation to IFN-a/(J
production in cultured macrophages (Doyle et ah, 2003; Miettinen et ah, 2001). This present
report demonstrates that this occurs in vivo, in this case during viral encephalitis, and in
addition informs us TLR 9 expression is under IFN-mediated control. We propose that by
upregulating TLR 3 and 9, IFN-a/(3 acts to increase the sensitivity of cells in the vicinity of
virally infected cells. This parallels events with PKR another interferon inducible activator of
innate cellular defences (Meurs et ah, 1992; Tanaka et ah, 1998; Goodbourn et ah, 2000).
Basal levels of PKR detect viral RNA and induce type-I IFN synthesis. This IFN acts in both
an autocrine and paracrine way to upregulate a number of genes including PKR itself (Meurs
et ah, 1990). In this way cells in the vicinity of virally infected cells have their virus sensing
mechanisms upregulated. Here we demonstrate that this also applies to two TLR associated
with virus nucleic acid recognition, TLR 3 and 9.
218
Chapter 7 Overall discussion
To clear an actively replicating agent requires a robust immune response to limit microbial
infection. Paradoxically, activation of glia and the production of inflammatory mediators
result in the acute injury of neurones that may be vital for life-critical processes. In addition,
inflammatory processes are also involved in the generation of neurological sequeale that can
remain for the lifetime of the individual. The activation of microglia has been linked with
neuronal damage in the case of HIV-associated dementia. Apoptotic neurones are closely
associated with activated microglia (Adle-Biassette et al., 1999), whilst neurobehavioral
abnormalities in infected primates correlate with the degree of microglial activation (Berman
et al., 1999). The mechanisms that mediate glial activation are still to be clarified. However,
the expression of TLR on microglia may be one route by which these cells are activated. In
addition, the present study has reinforced the idea that microglia are capable of producing a
wide variety of inflammatory cytokines, chemokines, and the enzymes necessary for the
production of prostaglandins and microbicidal molecules such as reactive oxygen species.
However, whilst studies such as this one and others have greatly increased our understanding
on the capabilities and function of glia, the in vivo relevance of these findings during the
course of CNS virus infection are still to be convincingly demonstrated.
Viral encephalitis is a disease that kills many thousands each year and leaves surviving
patients with severe neurological sequelae. It can be caused by a variety of viruses endemic
to various regions of the world, such as Japanese encephalitis virus and Venezuelan equine
encephalitis virus. In both cases, the highest mortality is observed in immunologically naive
children and the elderly (Solomon, 2004). Little can be done for patients presenting with
viral encephalitis apart from basic bed rest and support. RABV is another important cause of
death in the developing world and invariably leads to death once the virus has infected the
nervous system. The lack of therapeutics for these diseases reflects our lack of understanding
of the pathogenic mechanisms at play. Understandably, therapeutic trials are difficult to
undertake due to the unpredictable nature of viral encephalitis incidence, and the reluctance
of clinicians to use therapeutics that may worsen the condition of patients. Alternatively,
work can be undertaken in animal models of viral encephalitis, such as that represented by
SFV infection of the laboratory mouse. This system provides a useful way of better
understanding these diseases and the fundamental interactions between host immune system,
CNS and neuroinvasive viruses. Whilst it is too early to determine whether the findings of
the present study can inform us of possible therapeutics, they do constitute a novel
description of early innate immune responses. A better understating of TLR signalling and
function in the CNS will undoubtedly increase our understanding of pathogenic mechanisms
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of viral encephalitis and enable the development of rationales for the application of novel
therapeutics.
Furthermore the expression of TLRs on glial cells has implications for a variety of other
diseases that lack an obvious infectious component. Activated microglia are associated with
a variety of neurodegenerative diseases such as Alzheimer's disease, motor neurone disease,
TSE and multiple sclerosis. Many studies have highlighted the strict association of activated
glia with neuronal dysfunction and death in these diseases, whilst in vitro models have
implicated a pro-active role for microglia in neuronal damage. The mechanism that activates
microglia in each case remains elusive. It will be interesting to investigate whether TLR
function has a role to play in the activation of glia in these diseases. Together the diseases of
chronic neurodegeneration affect a sizeable proportion of the population and are likely to
contribute a growing burden on an increasingly elderly population. Therefore work that
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Appendix 1 - solutions
2.1.1 Fixatives and solutions for cell culture and immunocytochemistry
• PBS = Phosphate Buffered Saline
o 137 mM NaCl
o 2.7 mM KC1
o 4.3 mM Na2HP03
o 1.7 mM NaH2P03
• PLP = Phosphate Lysine Periodate
o 75 ml Phosphate buffer containing 80 mM Na2HP04 and 21 M NaH2P04 pH 7.4
o 75 ml 0.2M Lysine pH7.4
o 0.9 g Sodium Periodate to give final concentration 21 mM
o 50 ml paraformaldehyde solution
■ 4% paraformaldehyde solution made up using 2 g paraformaldehyde, 100 pi 10M
NaOH and gentle heating to dissolve paraformaldehyde, followed by addition of
concentrated HC1 drop-wise until pH=7.4
o final solution of 200 ml was pH 7.4
o PLP was made up fresh and used within 24 hours
• Sucrose solutions
o 12%, 16% and 18% (wt:vol) sucrose solutions were made by the addition of 24, 32 and 36g
of sucrose respectively to 200 ml PBS.
2.1.2 Microarray solutions
• 10% SDS= sodium dodecyl sulphate
o 10 g SDS dissolved in 100ml nuclease free water
• 20XSSC = sodium chloride / sodium citrate
o NaCl: 175.3g
o Na3 citrate2 H20: 88.2g
o 800ml ofmilliQ water added
o pH7 with HC1.
o volume made up to 1 litre with milliQ water
• Sodium Borate
o 30.9g Boric Acid + 450ml milliQ water
o pH8 with NaOH , adjusted volume to 500ml
• Succinic anhydride/N-methyl-2-pyrrolidinone solution
o 210 ml N-methyl-2-pyrrolidinone solution
o 3.6 g Succinic anhydride (sigma - stored in desiccator) added and stirred very vigorously for
5 minutes until dissolved
o 7.5 ml sodium borate buffer (see above) cleaned by passing through 0.45 pm filter and added
to solution
o Solution used immediately for blocking of microarray slides
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Appendix 2 - function of genes assayed by microarray
Gene Function
Toll-like Receptors
TLR1 NM 030682 Confers specific recognition to lipoproteins with TLR2
TLR2 NM 011905 Responds to LTA, lipoproteins, peptidoqlycan
TLR3 AF355152 Recognises dsRNA
TLR4 NM 021297 Signals in response to LPS
TLR5 NM 016928 Recognises bacterial flagellin
TLR6 NM 011604 Enhances TLR2-mediated recognition of lipoproteins
TLR7 AY035889 Recognises virus ssRNA in mice
TLR8 AY035890 Recognises virus ssRNA in humans
TLR9 NM 031178 Recoqnises CpG DNA
Rp105 NM 010739 Mediates LPS recognition in B cells
Screted PRRs
CRP NM 007768 Opsonisation
LBP NM 008489 LPS Bindinq protein
MBL1 NM 010775 Bind carbohydrates
MBL2 NM 010776 Fix complement
SAP NM 011318 Opsonisation
Lectins
Mannose Receptor (MRC1) NM 008625 Endocytosis of glygosylated particulates
Mannose Receptor (MRC2) NM 008626 Endocytosis of qlyqosylated particulates
Dectin-1 (type-C Iectin/Clecsf12) AF262985 Binds p-glucans
Dectin-2 AF240357 Unknown
Clecsfl 0/CD209 NM_020001 Dendritic cell associated
Clecsf9 (Mincle) NM 019948 Induced by LPS
Clecsf5(MDL-1) NM 021364 Associates with DAP-12 to activate cell
CR3 (CD11 b) NM 008401 Adhesion, phagocytic receptor, oxidative burst
Sialoadhesin NM 011426 sialic acid-dependent interactions
CD14 NM 009841 LPS/apoptotic cell "tethering"
Scavenger Receptors
SRA-I NM 031195 Can bind LTA,LPS and recognize
SRA-II NM 030707 and in uptake of apoptotic cells, bacteria
MARCO U18424 Binds: qram +ve/-ve bacteria, modified LDL
SRCL-I BC009162 Bind E.coli, S.aureus
CD36 (SR-B) NM 007643 Binds apoptotic cells, modified LDL
SR-BI (CD36L1) NM 016741 Binds apoptotic cells, modified LDL
CD36L2 NM 007644 Role unsure, scavenger receptor
CD68 (SR-D) NM 009853 Macrophaqe/Microqlia cell marker
LOX1/OLR1 (SR-E) AF303744 Expressed on endothelial cells, binds oxLDL
M130 (CD163) AF274883 Scavenqer for Hemoqlobin
Crp-ductin (Crpd/DMBT1) NM 007769 Protective role in inflammation
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PGRP family
Pqrp AF076482 Binds peptidoqlycan
N-formyl PR
FPR1 NM 013521 migration/activation to N-formyl oligopeptides...





HM74 (Puma-g) NM 030701 Similar to FPR, function unknown/chemotaxis
NOD1 NM 021406 Binds LPS, role not characterized
NOD2 NM 021410 Binds LPS, role not characterized
TREM-1 NM 021407 Binds LPS, activates monocytes
TREM-2 XM 132577 Binds LPS, activates monocytes
Apoptotic cell recognition
PS Receptor NM_033398 Recognizes exposed Phosphotidyl serine
C1q Receptor/Ly68 NM_010740 Binds complement component C1q
C1q (alpha chain) NM 007572 Complement component
alpha V integrin NM_008402 Inteqrin that binds apoptotic cells
beta 3 integrin NM_016780 Integrin that binds apoptotic cells
beta 5 inteqrin NM_010580 Inteqrin that binds apoptotic cells
ABC1 NM_013454 Mediates apoptotic cell enqulfment
Prion protein receptors
CR1 (mCRY) NM 013499 Binds complement (C3b) that can coat PrPSc
CR2 M29281 Binds complement (C3b) that can coat PrPSc
Doppel NM_023043 Homoloqous to Prion Protein
Prnp (Prion protein) NM_011170 Central for prion disease, SOD-like activity
Protocadherin 2 (PCDHGC3J AY013811 Putative PrP receptor
Laminin Receptorl (LAMR1) NM_011029 Putative PrP receptor
Caveolin-1 NM_007616 Signaling to PrP, NO
RAGE NM 007425 Binds AD fibrils, up-requlated in AD brain
Stress genes
arachidonate 12-lipoxygenase
(ALOX12) S80446 Biochemical pathway for eicosanoid production
CD40 (TNFRSF5) NM 011611 Present on microglia - implicated in AD
CD40 Liqand (TNFSF5) NM 011616 Immune control
Crystallin alpha B NM 009964 Heat shock protein
Crystallin beta B2 NM_007773 Unknown-role in CNS neurodeqeneration
CXCR3 NM 009910 Promotes microglial survival
Hsp25/27 L11609 Heat shock protein
GFAP K01347 Expressed on activated astrocytes
Fractalkine (Scydl) NM 009142 Expressed by neurons to activate microglia
Heme oxyqenase(decyclinq)1 X13356 Anti-oxidant, implicated in scrapie
Nos1 NM 008712 Neuronal NOS
Nos2 (iNOS/Nos2a) NM_010927 Inducible form of NO synthase, due to infection
SOD1 M35725 Converts free radicals to O and peroxide
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S0D2 NM_013671 Mitochondrial free radical scavenqer
Phopholipase A2 (PLA2G4A) NM 008869 biochemical pathway for eicosanoid production
Ptqsl (Cox-1) NM_008969 Prostaqlandin biosynthesis
Ptqs2 (Cox-2) NM011198 Mitogen inducible form of Ptqsl
Catalase (CAT) NM 009804 Peroxidase, up-requlated in AD Hippocampus
GPX1 NM 008160 Protection against oxidative stress
GSS NM_008180 Makes GSH, protects against O
GSR NM_010344 Reductase of GSH
GST-Pi (GST3) BC002048 Conjugates Glutathione to toxins
Cathepsin D NM_009983 Lysosomal protein, mutant has neurodegeneration
Osi (Sqstml) NM 011018 Induced by oxidative stress in Mphapes
SLC(SCYA21) NM 011335 Chemokine
SLC1A1 NM_009199 Glutamate Transporter
SLC1A2 NM_011393 Decrease = increased Extracellular qlutatmate in ALS
SLC1A3 D63816 Neuroprotective in ischemia of retina
TNFSF6 (Fas-Liqand) NM 010177 Induces apoptosis
PAF Receptor D50872 Activates microqlia to produce H202
NCF1 AB002663 Part of the phaqocyte NADPH-oxidase system
NCF2 NM 010877 As above: qenerates free radicals to fiqht infection
Cytokines and growth factors
TNF-cc NM_013693 Pro-inflammatory, neurotoxic
INF-a 4 NM 010504 Anti-viral
INF-beta 1 NM_010510 Anti-viral
INF-Y K00083 Anti-viral
IL-1 a X01450 Induces apoptosis, pro-inflammatory
IL-1 p M15131 Mediates acute phase response
IL-6 NM_031168 Induced by IL-1 and TNF
IL-12 NM_008352 Pro-inflammatory, Th1 from Macrophages
Scya3 (MIP-a) NM 011337 Chemokine
Scya4 (MIP-P) NM 013652 Chemokine
SCYB9 (MIG) M34815 Chemokine
ScyblO (IP-10) M33266 Chemokine
CD200 (MOX2 or OX2) AF004023 Suppresses microglial activation
CD200R NM 021325 Present on microglia. Promotes quiescence
IDO NM 008324 Limits T cell activation
TGF|3 NM_011577 Anti-inflammatory, can promote AB clearance
IL-10 NM_010548 Anti-inflammatory, inhibits antigen presenting
Glia Maturation Factor |3 NM 022023 Inhibits the mitoqens ERK1/2, activates NF-KB
GDNF NM 010275 Growth factor
BDNF NM 007540 Growth factor
NGF-beta NM_013609 GF (Subunit responsible for activity)
NT3 NM_008742 Promotes survival of neurites
CTNF U05342 Neuroprotective
IGF2 NM 010514 Mitoqen, on Alan's array
FGF2 NM 008006 Protects neurones from oxidative damage
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Probe Name Target gene Accession number
12-lopxy:2024 arachidonate 12-lipoxygenase S80446
12-lopxy:2259 arachidonate 12-lipoxygenase S80446
ABC1:6829 ABC1 NM 013454
ABC1:7627 ABC1 NM 013454
Ald5H:1123 aldehvde 5-hvdroxvlase AF139532
Ald5H:117 aldehvde 5-hvdroxvlase AF139532
B-actin:1197 Beta-actin >03672
B-actin:1702 Beta-actin >03672
BDNF:597 BDNF NM 007540
BDNF:782 BDNF NM 007540
C1qAlpha:500 C1q alpha NM_007572
C1qAlpha:513 C1q alpha NM 007572
C1qR:1910 C1qR NM_010740
C1qR:2939 C1qR NM 010740
Catalase:1779 Catalase NM 009804
Catalse:1787 Catalase NM 009804
cathepsinD:1011 CathepsinD NM 009983
CathepsinD:1481 CathepsinD NM 009983
Caveolin:439 Ca\eolin NM 007616
Ca\eolin:454 Caxeolin NM 007616
CCR1:636 CCR1 (Arabidopsis) AF320624
CCR1:843 CCR1 (Arabidopsis) AF320624
CD14:1200 CD14 NM 009841
CD14:260 CD14 NM 009841
CD200:1413 CD200 AF004023
CD200:1691 CD200 AF004023
CD200R:368 CD200R NM 021325
CD200R:635 CD200R NM 021325
CD36:1298 CD36 NM 007643
CD36:2164 CD36 NM 007643
CD36L2:1001 CD36L2 NM 007644
CD36L2:1356 CD36L2 NM_007644
CD40:1196 CD40 NM 011611
CD40:1467 CD40 NM 011611
CD40L: 1028 CD40L NM 011616
CD40L:505 CD40L NM_011616
CD68:614 CD68 NM_009853 (X68273)
CD68long:1116 CD68 NM_009853 (X68273)
CelA:83 cellodextrinase (Rurrinococcus flavefaciens) X51944
Cellodex.:1215 cellodextrinase (Runinococcus flavefaciens) >61944
Cellodex.:923 cellodextrinase (Runinococcus flavefaciens) >61944
Chlorophyll:355 CHLOROPHYLL A-B BINDINGPROTBN 7 fESTI BF069666
Chlorophyll:85 CHLOROPHYLL A-B BINDING PROTBN 7 (EST) BF069666
Cleccsf9:2201 Clecsf9 NM 019948
Clecs19:2135 Clecsf9 NM_019948
Clecsf10:1140 Clecsfl 0 (Dectin-2) NM 020001
Clecsfl 0:674 Clecsfl 0 (Dectin-2) NM 020001
Clecsf12:2133 Clecsfl 2 (Dectin-1) AF262985
Clecsfl 2:2192 Clecsfl 2 (Dectin-1) AF262985
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Probe Name Target gene Accession number
Clecsf5:682 Clecs15 NM 021364









CR3:3335 CR3 NM 008401
CR3:4094 CR3 NM_008401
CRP:1431 CRP NM 007768
CRP:213 CRP NM 007768
CRP-Ductin:5915 CRP-Ductin NM 007769
CRP-Ductin:6420 CRP-Ductin NM_007769
Cryst.A2:1098 Crystallin Alpha2 NM 009964
Cryst.A2:403 Crystallin Alpha2 NM_009964
CrystB2:327 Crystallin BetaB2 NM 007773
CrystB2:367 Crystallin BetaB2 NM 007773
Cxcr3:1368 CXCR3 NM 009910
Cxcr3:1522 CXCR3 NM 009910
c-yes:4338 c-yes X67677
c-yes:4384 c-yes XB7677
Doppell:2212 Doppell NM 023043





FasL:1264 Fas-L NM 010177
Fas L: 1445 Fas-L NM 010177
Ferritin:252 Ferritin heavy chain NM 010177
Ferritin:468 Ferritin heavy chain NM_010177
Fg12:244 FGF2 NM_008006
Fg12:301 FGF2 NM_008006
Fpr:787 FPR NM 013521
Fpr:825 FPR NM 013521








Frac. 1939 Fractalkine (Scydl) NM 009142
Frac.:2918 Fractalkine (Scydl) NM 009142
Gdnf:2952 GDNF NM_010275
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Probe Name Target gene Accession number
Gdnf:2992 GDNF NM 010275
Gfap:1371 GFAP K01347
Gfap:1921 GFAP K01347
GMFb:3760 GMFb NM 022023
GMFb:4067 GMFb NM 022023
GNAS:1936 GNAS NM_010310
GNAS:2241 GNAS NM_010310
GPX1:348 GPX1 NM 008160
GPX1:863 GPX1 NM 008160
GSK3b:1205 GSk3b NM 019827
GSK3b:808 GSk3b NM 019827
GSR:1231 GSR NM_010344
GSR: 1244 GSR NM_010344
GSS:1299 GSS NM_008180
GSS:624 GSS NM 008180
GST-Pi: 702 GST-Pi (B) BC002048
GST-Pi: 707 GST-Pi (B) BC002048
FlemeOx.:1314 HemeOxygenase X13356
FlemeOx.:1429 HemeOxygenase X13356
HM74:1212 HM74 (puma-g) NM 030701
HM74:1863 HM74 (puma-g) NM 030701
Hsp25:736 Hsp25/27 L11609
Hsp25:745 Hsp25/27 L11609
IDO:1107 DO NM 008324
IDO:1312 IDO NM 008324
IFNa4:232 IFNalpha4 NM 010504
IFNa4:29 IFNalpha4 NM 010504
IFNb:457 IFNbeta NM 010510
IFNb:507 IFNbeta NM 010510
IFNg:773 lFNgamma K00083
IFNg:862 IFNgamma K00083
IGF2:3007 IGF2 NM 010514
IGF2:4032 IGF2 NM 010514
IL-10:692 IL-10 NM 010548
IL-10:889 IL-10 NM_010548
IL-12b: 1446 IL-12b NM 008352
IL-12b: 1562 IL-12b NM 008352
IL-1 aii: 1027 IL-1 a >01450
IL-1 aii: 1836 IL-1 a XD1450
IL-1 b: 1125 IL-1 b M15131
IL-1 b:612 IL-1 b M15131
IL-6:149 IL-6 NM 031168
IL-6:514 IL-6 NM 031168
lnteg.aV:3061 Integr n alpha V NM 008402
lnteg.aV:3226 Integr n alpha V NM 008402
Integ.b3:2367 Integr n beta 3 NM_016780
Integ.b3:2506 Integr n beta 3 (CD61) NM 016780
Integ.b5:1204 Integr n beta 5B NM_010580
Integ.b5:2246 Integr n beta 5B NM_010580
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Probe Name Target gene Accession number
Lac.dehy:1491 Lactate dehydrogenase NM_010699
Lac.dehy:1602 Lactate dehydrogenase NM 010699
LamR:664 Laminin Receptor NM_011029
LamR:676 Laminin Receptor NM 011029




Lpo: 1188 lianin peroxidase L08963
M 130:2853 M130 AF274883
M 130:3823 M130 AF274883
MARCO: 137 MARCO U18424
MARCO: 1446 MARCO U18424
Mbl 1:400 Mbl 1 NM_010775
Mbl 1:51 Mbl 1 NM 010775
Mbl2:939 Mbl2 NM_010776
Mbl2:955 Mbl2 NM 010776
Mrc 1:4659 Mrc1 NM 008625
Mrc 1:4829 Mrc1 NM 008625
Mrc2:2784 Mrc2 NM 008626
Mrc2:4501 Mrc2 NM 008626
NCF1:145 NCF1 AB002663




NGFb:772 NGFbeta NM 013609
Nod1:1451 Nodi XM 132577
Nod 1:964 Nodi XM 132577
Nos 1:3936 Nos1 NM 008712




NT3:563 NT3 NM 008742
Osi:1747 Osi NM_011018
Osi:1835 Osi NM 011018
P2AG4A:1715 P2AG4A NM 008869
P2AGA4A:2201 P2AG4A NM_008869
PafR:1091 PAF Receptor D50872
PafR: 132 PAF Receptor D50872
Pbp:661 Pbp NM_018858







Prnp:1473 Prnp NM 011170
Prnp:1824 Prnp NM 011170
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Probe Name Target gene Accession number
ProtoCadg:4180 Protocadherin 2 (PCDHGC3) AY013811
ProtoCadg:4240 Protocadherin 2 (PCDHGC3) AY013811
PSR: 1081 PSR NM 033398
PSR:629 PSR NM 033398
Rgs-1:1259 Rgs-1 (Cox1) NM 008969
Rgs-1:2595 Rgs-1 (Cox1) NM 008969
Rgs-2:3181 Rgs-2 (Cox2) NM 011198
Rgs-2:3843 Rgs-2 (Cox2) NM 011198
RAGE: 1296 RAGE NM 007425
RAGE:486 RAGE NM_007425
Rheb:473 Rheb (Ras homolg) AB039919
Rheb:763 Rheb (Ras homolg) AB039919
Rp105:2124 Rp105 NM 010739
Rp105:2828 Rp105 NM 010739
SAP:764 SAP NM 011318
SAP:923 SAP NM 011318
Scya3:472 Scya3 (MIP1-alpha) NM 011337
Scya3:636 Scya3 (MIP1-alpha) NM 011337
Scya4:431 Scya4 (MlP1-beta) NM 013652
Scya4:451 Scya4 (MlP1-beta) NM 013652
Scybl 0:267 Scybl0 (IP-10) M33266
Scybl 0:786 Scybl0 (IP-10) M33266
Scyb9:1098 Scyb9 (MIG) M34815
Scyb9:956 Scyb9 (MIG) M34815
SDO-1:375 SOD-1 M35725
Sialoadhesin:6487 Sialoadhesin NM 011426
Sialoadhesin:6600 Sialoadhesin NM 011426
SLC:158 SLC (SCYA21) NM 011335
SLC:658 SLC (SCYA21) NM 011335
SLC1A1 SLC1A1 NM 009199
SLC1A1 SLC1A1 NM 009199
SLC1A2:1591 SLC1A2 NM 011393




SOD-2:407 SOD-2 NM 013671
SOD-2:605 SOD-2 NM 013671
SRA-I:1024 SRA-I NM 031195
SRA-I:1505 SRA-I NM 031195
SRA-II:1983 SRA-I I NM 030707
SRA-II:2139 SRA-I I NM 030707
SRB-I:2222 SRB-I (CD36L1) NM 016741
SRB-I:908 SRB-I (CD36L1) NM 016741
SRCL2277 SRCL BC009162
SRCL2536 SRCL BC009162
TGFb:1371 TGFbeta NM 011577
TGFb:714 TGFbeta NM 011577
TLR1full:2416 TLR1 NM 030682
TLR1full:2431 TLR1 NM 030682
TLR2:2621 TLR2 NM 011905
TLR2:2626 TLR2 NM 011905
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TLR9:3386 TLR9 NM 031178
TNFa:1326 TNFalpha NM 013693
TNFa:1495 TNFalpha NM_013693
TNFa:1508 TNFalpha NM 013693
TREM-1:482 TREM-1 NM 021406
TREM-1:713 TREM-1 NM 021406
TREM-2:741 TREM-2 NM 021410
TREM-2:754 TREM-2 NM_021410
TREM-3:633 TREM-3 NM 021407
TREM-3:707 TREM-3 NM_021407
Tubal: 1509 Tubal NM_011653





Zeta-p: 184 zeta proteasome AF019661
Zeta-p:607 zeta proteasome AF019661
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ABC1:7627 AGI I I I ICAAAIACAI IAGAIGCIUGIAAGCAGCAAAGAI IAGGAGGGAA




























































Fas L: 1264 GCCAAGAGAAI I I IAACCATTGAAGAAGACACCTTTACACTCACTTCCAG




















GMFb:4067 I I IGIGCTAGTTCATACCGCATG I I IAI I I IGGAGTCI I I IGGTAAGCAT
GPX1:863 CTGTGTCATTGTCACCTTTTGGATAGCCTCATAGTCAGGGATAAGGAACT
GPX1:348 AGGGGAAI I I IAGAI IG I I IGAGAAG IGGGAAGIGAAIGGTGAGAAGGCT
GSR: 1244 AAGACAATGTGAAAATCTACTCGACTGCCTTTACCCCGATGTATCACGCT
GSR: 1231 CATAAGTATGGGAAAGACAATGTGAAAATCTACTCGACTGCCTTTACCCC
GSS:1299 GTAI I 11 IGGAGTCTATGTCAGACAGGGAACAACACTGGTGATGAACAAG
GSS:624 CTAATGCGGTGGTGCTACTGATTGCTCAAGAGAAGGAAAGGAACATATTT
GST-Pi:707 CTTCTTGTCCCCG I I I IGCCAGCACTAATAAAG I 1 1GTAAGACAGAAAAA
GST-Pi:702 AAGAGCTTCTTGTCCCCGTTTTCCCAGCACTAATAAAGTTTGTAAGACAG
HemeOx.:1429 GGGGTGGGTGGGAAAGAATTATTTAATAGTTGTAACCTTGGTCTCTAACT
HemeOx.:1314 1 IGIGIGIGGIAI 1 IG IG IG 1 IG 1 1 1 1 1 IAI IAI 1 IGGGGAG 1 IG IAGGA
HM74:1863 GGGCGGTTCATTACTTGGGTTTCTGTACTTTAACATCTACCATTTCAATA
HM74:1212 GAACAGGGTAACATCTTCAGATTTGGCTTACGCTTTCTTGGAACTTCTAG

















IL-1 aii: 1027 GCAAACCCTAGTGGAGCCACCCCGACATATGATACTATCTGTTATTTTAA
IL-1 aii: 1836 TGAAGTTTCTTTTCTAGAATGTAATCAGTGTTTCCCCTGGATTCCAATTT
































NCF2:1664 GAGAAG ICIAGGAICIACAAAGCIGAAGCAAAG IG I IG I I I I ICCCCI IG
NCF2:343 AGAATGGAGAAGTACGACCTTGCTATCAAAGACCTTAAAGAGGCCTTGAC
NGFb:772 AGTGCTGGCCGAGGTGAACATTAACAACAGTGTATTCAGACAGTACTTTT
NGFb:287 GTGCATAGCGTAATGTCCATGTTGTTCTACACTCTGATCACTGCG I 11 I I





















Prnp:1824 AGAGAIAAAGIGGGAI AGO I IGAGGI IGGAGIG IGGAI I I IGIGIAIAGA
Prnp:1473 AGGGCACTAGAATGATCTTTAGCCTTGCTTGGATTGAACTAGGAGATCTT
ProtoCadg:4240 GTAGAATAGCCAATAGTATAGTGTGGTGTGCI I I IAGGIGATGGCGAGTG
ProtiCadg:4180 ATAGAACTTCCTCTGCCCTAGCCCTTACAGTAGTGTAGAAGATCCCCCTC
PSR:1081 TGGCACAAGACGGTAAGAGGGAGACCAAAGTTATCAAGGAAGTGGTATAG
PSR:629 TGGAAGACTACAAGGTGCCCAAG I I 11 IGAGAGATGATCI I I IGCAATAC
Ptgs-1:2595 GTCAAGGCAGTAAGGTGTTCTTGGGAGCCACACTTAGACTCTTTCCAAAG
Ptgs-1:1259 AG 11 i I i A11 IAAGAGI ICIAIGGIGG IGGAGIAIGGGG I IGAGGCAGIG

























SLC1A3:146 TCTCAGGTCCTGAI I I IGCGI I IGIAATATAAGTGAACTAACAAGGCGTG
SOD-1:375 AAGATGACTTGGGCAAAGGTGGAAATGAAGAAAGTACAAAGACTGGAAAT
SOD-1:153 AGTATGGGGACAATACACAAGGCTGTACCAGTGCAGGACCTCAI I I IAAI
SOD-2:605 TGGGAGCACGCTTACTACCTTCAGTATAAAAACGTCAGACCTGACTATCT





SRB-I:2222 GGGGI I I I IGIAI GG IGIGIGGIAIGI GAG IGAAI IAAGGAGIG IAGG IG
SRB-I:908 GACTCAGCAAGATCGATTATTGGCATTCAGAGCAGTGTAACATGATCAAT











TLR1 fu 11:2416 CACCTCAATGATGTTGCTGCTCTGGGGAGTTCTAATAATAGTACCATTCA
TLR2:2626 GCAGGAAGTG I I 11GGGTAAATCTGAGAACTGCAATAAAGTCCTAGGTTC
TLR2:2621 GGCCAGCAGGAAG IG I I I IGGG IAAAICIGAGAACIGCAAIAAAG ICC IA
TLR3:2740 ATCTCGGAATTCAGCACATTAAACTCATTTGAAGATTTGGAGTCGGTAAA
TLR3:2727 AAGTAGCACTTGGATCTCGGAATTCAGCACATTAAACTCATTTGAAGATT






TLR6:2490 ACTGTGG I I I I GAG rTCCTACCTGGAGGTACTTCTGTTGTGGTGTCTTAG
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c-yes:4384 CACCAGAAACGAAAGTTGTTAAAAGCAGCCTTCTAGCACAAACACI I I I I





Tubal: 1522 I IAIGAAIGAI IGAI I I IGACAGAGACCCCAAGCIGGGGAI I ICACI IAI
Tubal: 1509 IACAG I I AG I GAG I IAIGAAIGAI IGA I I I IGAGAGAGAGGGGAAGGIGG
Vimentim:1588 GGAGCGCAAGATAGATTTGGAATAGAAAGAAGCTCAGCACTTAACAACTG











B-actin:1702 GCCTTAATACTTCAI i i I IG I I I I IAAI I ICTGAATGGCCCAGGTCTGAG










Chlorophyll:355 IGGGAI I I IGAI IGGAGAAI I GG IAAGAAAGAI IGGIGIGI IGAAGAGIG
Chlorophyll:85 AGGAGG I IG I I I IGI I AG IGGAAGGAAAI IGAGGG IGAAAAAGGAGAGAG









Appendix 7: SpotReport Validation System
Arabidopsis thaliana mRNA spikes (in vitro transcribed, polyadenylated RNA)
mRNA spike Length (bp) Accession
number
Photosystem I chlorophyll a/b binding protein(Cab) 500 X56062
RUBISCO activase (RCA) 513 X14212
Ribulose-l,5-bisphosphate carboxylase large sub unit (rbcL) 521 U91966
Lipid transfer protein 4 (LTP4) 527 AF159801
Lipid transfer protein 6 (LTP6) 477 AF159803
Papain-type cysteine endopeptidase (XCP2) 507 AF191028
Root cap 1 (RCP1) 533 AF168390
NAC1 (NAC1) 457 AF198054
Triosphosphate isomerase (TIM) 498 AF247559
PRKase gene for ribulose-5-phosphate kianse (PRKase) 497 X58149
Arabidopsis thaliana 70-mer oligonucleotides that hybridise to the above targets
were supplied by Stratagene (probe sequences are not in the puiblic domain).
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